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A principle challenge of modern biology is to understand how the human genome is 
organised and regulated within a nucleus.  The field of chromatin biology has made 
significant progress in characterising how protein and DNA modifications reflect 
transcription and replication state.  Recently our lab has shown that the human 
genome is organised into large domains of altered DNA helical twist, called DNA 
supercoiling domains, similar to the regulatory domains observed in prokaryotes.  In 
my PhD I have analysed how the maintenance and distribution of DNA supercoiling 
relates to biological function in human cells. 
DNA supercoiling domains are set up and maintained by the balanced activity of 
RNA transcription and topoisomerase enzymes.  RNA polymerase twists the DNA, 
over-winding in front of the polymerase and under-winding behind.  In contrast 
topoisomerases relieve supercoiling from the genome by introducing transient nicks 
(topoisomerase I) or double strand breaks (topoisomerase II) into the double helix.  
Topoisomerase activity is critical for cell viability, but the distribution of 
topoisomerase I, IIα and IIβ in the human genome is not known.  Using a chromatin 
immunoprecipitation (ChIP) approach I have shown that topoisomerases are enriched 
in large chromosomal domains, with distinct topoisomerase I and topoisomerase II 
domains.  Topoisomerase I is correlated with RNA polymerase II, genes and under-
wound DNA, whereas topoisomerase IIα and IIβ are associated with each other and 
over-wound DNA.  This indicates that different topoisomerase proteins operate in 
distinct regions of the genome and can be independently regulated depending on the 
genomic environment. 
Transcriptional regulation by DNA supercoiling is believed to occur through changes 
in gene promoter structure.  To investigate DNA supercoiling my lab has developed 
biotinylated trimethylpsoralen (bTMP) as a DNA structure probe, which 
preferentially intercalates into under-wound DNA.  Using bTMP in conjunction with 
microarrays my lab identified a transcription and topoisomerase dependent peak of 
under-wound DNA in a meta-analysis of several hundred genes (Naughton et al. 
(2013)).  In a similar analysis, Kouzine et al. (2013) identified an under-wound 
promoter structure and proposed a model of topoisomerase distribution for the 
regulation of promoter DNA supercoiling.  To better understand the role of 
supercoiling and topoisomerases at gene promoters, a much larger-scale analysis of 
these factors was required.  I have analysed the distribution of bTMP at promoters 
genome wide, confirming a transcription and expression dependent distribution of 
DNA supercoils.  DNA supercoiling is distinct at CpG island and non-CpG island 
promoters, and I present a model in which over-wound DNA limits transcription 
from both CpG island promoters and repressed genes.  In addition, I have mapped by 
ChIP topoisomerase I and IIβ at gene promoters on chromosome 11 and identified a 
different distribution to that proposed by Kouzine et al. (2013), with topoisomerase I 
maintaining DNA supercoiling at highly expressed genes.  This study provides the 
first comprehensive analysis of DNA supercoiling at promoters and identifies the 
relationship between supercoiling, topoisomerase distribution and gene expression. 
In addition to regulating transcription, DNA supercoiling and topoisomerases are 
important for genome stability.  Several studies have suggested a link between DNA 
supercoiling and instability at common fragile sites (CFSs), which are normal 
structures in the genome that frequently break under replication stress and cancer.  
bTMP was used to measure DNA supercoiling across FRA3B and FRA16D CFSs, 
identifying a transition to a more over-wound DNA structure under conditions that 
induce chromosome fragility at these regions.  Furthermore, topoisomerase I, IIα and 
IIβ showed a pronounced depletion in the vicinity of the FRA3B and FRA16D CFSs.  
This provides the first experimental evidence of a role for DNA supercoiling in 
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The principle challenge of the post-genomic era is to understand how a human 
genome is regulated within a cell, and how the coordinated regulation of genetic 
information in each cell contributes to tissue, organ and organism structure and 
function in health and disease.  The field of chromatin biology has documented a 
variety of proteins, protein modifications and DNA modifications that reflect and 
determine the transcription and replication state of a genomic region.  The ENCODE 
project attempts to take this functional classification further by mapping many of 
these factors at high resolution across several defined cell types (Dunham et al., 
2012).  However, this catalogue of bound proteins and chemical modifications only 
covers part of the regulatory potential within chromatin.   
DNA molecules are not uniform linear sequences of nucleotide pairs, but varied and 
dynamic structures that contribute to their own packaging and regulation.  
Alternative DNA helices, alternative DNA structures and changes in the helical twist 
of the DNA molecule are all likely to contribute to the regulation of the human 
genome (Bates and Maxwell, 2005).  In addition, a number of diseases have been 
associated with alternative DNA structures, either directly (e.g. fragile X syndrome 
(Bacolla and Wells, 2009)) or through increased genome instability (e.g. common 
fragile sites (Zlotorynski et al., 2003)).  Changes in DNA helical twist, called 
supercoiling, are of particular interest as they have been shown to regulate 
transcription in vitro and in prokaryotes (Peter et al., 2004; Tabuchi and Hirose, 
1988, 1988; Weintraub et al., 1986).  Our lab recently identified domain scale 
changes in DNA helical twist in the human genome, called supercoiling domains, 
which echo the regulatory domains of prokaryotes (Naughton et al., 2013a).  As in 
prokaryotes, these DNA supercoiling domains are maintained by transcription and 
topoisomerase activity.  However, the individual roles of topoisomerase I, IIα and IIβ 
in regulating DNA supercoiling in the human genome are unknown, as their genomic 
distributions have not been well characterised.  In addition, although the relationships 
between topoisomerases, RNA polymerase II and DNA supercoiling are critical for 
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transcription at gene promoters (Lee et al., 1993; Lyu et al., 2006; Sano et al., 2008; 
Tabuchi and Hirose, 1988), the distribution of topoisomerases and DNA supercoiling 
at promoter regions have been poorly characterised (Kouzine et al., 2013; Naughton 
et al., 2013a).  Understanding the distribution of topoisomerases and DNA 
supercoiling at different scales will help identify their relationship with genome 
regulation.  Furthermore, DNA supercoiling is thought to influence genome stability 
and contribute to the expression of common fragile sites (CFSs) (Burrow et al., 2010; 
Gellibolian et al., 1997), but the distribution of DNA supercoils has not been 
determined at these regions in vivo.  This thesis aims to characterise the inter-
relationships between topoisomerases and DNA supercoiling and their joint role in 
the regulation of gene expression and genome stability in human cells. 
 
1.1 Chromatin structure and regulation 
Each human cell contains almost 2 metres of DNA coiled and folded into a nucleus 6 
µM in diameter in a nucleoprotein structure called chromatin (Wolffe, 1998).  This 
feat of compaction is performed at several levels, from the coiling of the DNA 
molecule to the condensation of entire metaphase chromosomes.  The standard 
model of chromatin structure (Figure 1.1) posits the polymer of nucleotide pairs 
twists into a double helical conformation and winds 147 base pairs (bp) of DNA 
around histone protein octamers connected by short regions of ‘linker’ DNA.  This 
forms a ‘beads on a string’ structure which coils into a 30 nm fibre, higher order-
fibres and on to large scale chromatin structures.  This nucleoprotein structure 
provides multiple scales at which genes can be regulated, although many of the 













Figure 1.1 DNA packaging into chromatin.  The DNA double helix (a) 
wraps around histone octamers and together with linker histones forms 
nucleosome arrays (b) which coil into higher order chromatin fibres (c) that 
further organise into large scale chromatin structures (d) and territories within 





1.1.1  DNA  
DNA is a polymer of deoxyribonucleotide pairs which carries the genetic 
information and forms the backbone of chromatin structure (Figure 1.1a).  Although 
frequently represented as a linear sequence of base pairs onto which important 
regulatory proteins and modifications bind (e.g. UCSC genome browser), in reality 
the heterogeneous structure of individual bases and their combined structure in a 
DNA molecule carry significant regulatory potential.   
 
1.1.1.1 Nucleotide biochemistry 
The fundamental components of DNA are the nucleotide bases (Bates and Maxwell, 
2005; Watson and Crick, 1953).  The structure of each nucleotide can be partitioned 
into a phosphate group, deoxyribose sugar and a variable nucleotide base (Figure 
1.2a).  The phosphate and deoxyribose components constitute the backbone of DNA, 
forming phosphodiester linkages between consecutive bases on a single strand of the 
DNA helix.   The variable nucleotide bases interact between complementary single 
stranded DNA molecules to form the double helix, through either adenine to thymine 
(A to T) or guanine to cytosine (G to C) interactions (Figure 1.2a).  Together these 
nucleotide interactions make up the structure of the double helix.  Vitally, the order 
with which the nucleotides are arranged within this double helix forms the genetic 
blue print of an organism. 
The signature defined by the genetic code is based on differences in the chemical 
structure of each nucleotides variable base.  Nucleotides can be separated on the 
structure of their variable base into purines (adenine and guanine) and pyrimidines 
(cytosine and thymine), based on the presence or absence of an imidazole ring 
(Figure 1.2a)  (Bates and Maxwell, 2005).  The distinct structure of each nucleotide 
exposes different chemical bonds and shapes for the interaction of DNA binding 
proteins and modification by DNA modifying enzymes.  Furthermore, the structure 
and stability of base-pairing is influenced by the chemistry of nucleotide interactions, 
with GC base pairs having three hydrogen bonds that confer a stronger interaction 
compared to the two hydrogen bonds of AT nucleotides under the rules of Watson-
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Crick base pairing (Figure 1.2a).  In addition the propeller twist of a base pair, in 
which one base is twisted relative to the other in a similar way to the propeller of a 
helicopter, is different between AT and GC base pairs in a sequence context 
dependent manner and can vary between 5° and 25° (Calladine, 2004) (discussed 
further in Section 1.1.1.2).   
In addition to variability in the structure of canonical nucleotides, chemical 
modifications can influence the chemical and structural properties of nucleotides and 
the DNA helix.  The best studies example of DNA nucleotide modification is 
methylation of cytosine at position 5 (Figure 1.2b), with some studies referring to 
this as the ‘fifth base’ (e.g. Wu et al., 2010).  This modification acts as a docking site 
for methyl-cytosine specific DNA binding proteins and promotes the formation of 
the Z-form alternative DNA helix (Section 1.1.1.4). 
It is critical to understand this heterogeneity in nucleotide structure, base pair 
stability, propeller twist and chemical modification to appreciate genome structure 

















Figure 1.2 The chemical structure of DNA base pair interactions.  a) 
The interactions between adjacent bases on the same strand are through 
phosphodiester bonds.  The interactions between base pairs are through 
hydrogen bonds and are identified by a broken red line.  General nucleotide 
components are identified by broken grey lines.  b) Chemical structure of 




1.1.1.2 Double helix structures 
The discovery of the DNA double helix identified the structure and mechanism by 
which genetic information is stored, transcribed and replicated (Watson and Crick, 
1953).  The double helix is one solution to the challenge of packaging hydrophobic 
nucleotide bases within the water rich environment of the nucleus (Calladine, 2004).  
A simple ladder design for DNA, with the hydrophobic bases in the centre and the 
hydrophilic backbone either side, would expose bases to water and be unstable.  
However, a twisted ladder allows bases to stack on top of one another in a way that 
prevents their exposure to water.  This twisted ladder is the double helix.   
Helical structure can be profoundly influenced by the properties of nucleotides in 
base-pairs and within their local sequence context.  A major structural property of 
individual base pairs is differences in propeller twist, as discussed in Section 1.1.1.  
Propeller twist influences flexibility at the dinucleotide step, with high propeller 
twist making stacking into a dinucleotide step more awkward (El Hassan and 
Calladine, 1996).  Therefore, sequences that generate high propeller twist produce 
structural discontinuities in the DNA, which may be recognised by DNA binding 
proteins.  In addition, structural properties of base pairs with respect to one another 
that can influence DNA helical structure, most notably differences in twist, roll and 
slide (Calladine, 2004).  Twist is the rotation of one base pair relative to another, 
about an axis that runs vertically through neighbouring base pairs.  This differs from 
roll, which is the rotation of one base pair relative to another along its long axis (i.e. 
one that runs horizontally through a base pair).  Finally, slide is the position of a base 
pair relative to the adjacent base pair along its long axis.  These three properties vary 
between different sequence combinations and can generate structural discontinuities 
and different double helical structures, including favouring alternative DNA helices. 
A popular misconception is that the structure of DNA is a regular repeating pattern 
of the double helix identified by Watson and Crick (1953).  This B-form DNA, with 
a deep major groove and shallow minor groove (Figure 1.3), may represent much of 
the DNA in vivo but there are other helices including A-form and Z-form DNA.  
Both A- and B- form DNA are right handed helices, but the major and minor groove 
of A-form DNA have similar width and depth (Figure 1.3) (Bates and Maxwell, 
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2005).  This exposes a distinct charge distribution which may influence the binding 
of specific A-DNA binding proteins (Rohs et al., 2010).  Importantly, almost all 
external features of A- and B- form DNA can be determined from their values of 
twist, roll and slide (Calladine, 2004).  On the other hand, Z-form DNA represents a 
major structural rearrangement in which a left handed helix forms a ‘zig-zag’ pattern 
(Figure 1.3), which is almost ‘inside out’ compared to A- or B- form DNA (Wang et 
al., 1979).  This exposes another charge distribution for the formation of DNA-
protein interactions (Rohs et al., 2010).  The structures of DNA bases that form Z-
form DNA are not well understood (Calladine, 2004), but it is likely that a major 
factor in this structure is unusual values for twist, roll and slide.  These ‘alternative’ 
DNA helices were originally thought to be effects produced by structural techniques, 
but substantial evidence now indicates that they are present in DNA and are 
potentially functional in vivo.  Common sequence and context dependent regions of 
A form and AB intermediates have been identified by crystallography and NMR, 
indicating that similar structures can be seen under different experimental conditions 
(Hays et al., 2005; Ng et al., 2000).  Furthermore, antibodies to Z-DNA structures 
have identified this structure in Drosophila and human (Nordheim et al., 1981; 
Wittig et al., 1991, 1992).  In addition, all three DNA helices have been crystallised 
in association with DNA binding proteins, including TATA binding protein with A-
form DNA (Kim et al., 1993; Lu et al., 2000) and ADAR1 with Z-form DNA 
(Schwartz et al., 2001).  Therefore, at least three forms of DNA helix occur in vivo.  
Whether these proteins bind DNA helices in the alternative conformation, induce the 
conformation or stabilise a transient structure is currently unknown.   
Understanding the distribution of different DNA helices in vivo may to help identify 
their function and the mechanisms that regulate their distribution.  At present there 
are no techniques for mapping the relative distribution of A- and B- form DNA, 
although one potential method could be to use chemical probes that differentiate 
between the width and depth of the major and minor grooves.  On the other hand, the 
distribution of Z-DNA has been mapped at a small number of locations using anti-Z 
DNA antibodies to regions of the fly (Nordheim et al., 1981) and human genome 
(Wittig et al., 1991, 1992).  Z-DNA is generally identified at GC rich regions of the 
genome, particularly in the vicinity of gene promoters, and is present in a DNA 
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supercoil dependent manner(Wittig et al., 1989).  The identification of ADAR1 as a 
specific Z-DNA binding protein, with an unknown function in the context of this 
alternative DNA helix, suggests a selective pressure for Z-DNA binding proteins 
(Herbert et al., 1995, 1997).  Therefore, the relationship between transcription and 
DNA helical structure in the vicinity of gene promoters indicates an potential 
relationship between DNA structure and gene activity, but the mechanism and 




























Figure 1.3  DNA helical structure.  The three most common forms of the 
DNA double helix are A, B and Z form.  B form is the typical form identified by 
Watson and Crick (1953) and is characterised as a right handed helix with a 
clear difference in groove width between the major and minor groove.  The A 
form is also a right handed helix, although the major and minor grooves are 






1.1.1.3 Alternative DNA structures 
Heterogeneity of DNA structure is not limited to double helices, with other 
alternative DNA structures including cruciforms, triple helices and G-quadruplexes 
being described (Bates and Maxwell, 2005; Brázda et al., 2011; Lipps and Rhodes, 
2009; Shlyakhtenko et al., 2000).  Cruciform structures are formed from the 
unwinding and pairing of two single strands to form intra-strand double helices 
(Figure 1.4).  They can occur on sequences that form palindromes in the double 
stranded DNA, where a sequence is followed immediately or with a short linker by a 
reverse of the same sequence (Bates and Maxwell, 2005).  Despite unfavourable 
thermodynamics, there is substantial evidence that cruciform structures form in vivo 
and are important in the regulation of some genes (reviewed in Brázda et al., 2011).  
Similar to cruciforms, DNA triplexes form on under-wound DNA through an 
interaction of the double helix with a third single stranded DNA in a parallel or anti-
parallel orientation (Figure 1.4) (Bates and Maxwell, 2005).  In this structure the 
third DNA strand lies in the major groove, forming non-Watson-Crick base pairs 
with purine bases.  This leaves a single stranded DNA that was originally paired with 
the third helix in the triplex.  The presence of DNA triplexes is associated with some 
triplet repeats in vivo (Wojciechowska et al., 2006), which have been implicated in 
neurological conditions including fragile X syndrome (Section 1.3).   Similarly, G-
quadruplexes are a four-stranded structure formed by two hairpins in opposing DNA 
strands (Figure 1.4) (Bates and Maxwell, 2005).  They are associated with genomic 
features including centromeres and telomeres, as well as important processes 
including transcription, recombination and replication (Biffi et al., 2013; Lipps and 
Rhodes, 2009).  A recent study confirms the presence of these structure in vivo, 
identifying a cell-cycle dependent regulation consistent with a replication dependent 
formation in vivo (Biffi et al., 2013).  A common feature of all alternative structures 
is the requirement for a stretch of nucleosome-free unwound DNA.  Localised under-
winding of DNA occurs in transcription dependent DNA supercoiling (Section 
1.2.4), again supporting a relationship between DNA structure, transcription and 








Figure 1.4  Alternative DNA structures.  For cruciform and G-quadruplex 
structures one strand of the DNA is coloured red and the other blue.  In the 
case of triplex DNA, the colouration is supplemented with green to represent 
Watson and Crick base-pairing in the triplex and yellow represents non-





1.1.1.4  DNA sequence motifs 
The order of nucleotides has a number of vital functions within the genome, from 
encoding proteins to regulating gene expression and genome structure.  In general, 
proteins detect specific binding motifs by first recognising a large-scale feature of the 
molecule such as the shape/curvature of the helix and then probing the details of the 
bases within (Calladine, 2004).  Therefore, important structural properties at 
sequence motifs include both DNA helical structure (Section 1.1.1.2) and nucleotide 
chemical structure (Section 1.1.1.1).   
One example of a transcription factor associated with a DNA sequence motif is that 
TATA box binding protein (TBP) which binds the TATA-box nucleotide motif with 
a degree of sequence redundancy (Calladine, 2004).  Structural studies of the 
interaction between TBP and the TATA box identify an A-form DNA helix within 
the protein binding site (Kim et al., 1993).  Whether TBP identifies DNA in an A 
form conformation or regions that have a propensity to form A form DNA upon 
protein binding is unknown, but it may be this property of DNA structure that TBP 
initially identifies before probing the sequence of the bases within.  Other 
transcription factors and structural proteins have consensus binding sequences, which 
are also likely to combine helical structure and nucleotide sequence to determine 
interactions in vivo (Portales-Casamar et al., 2010).  These DNA sequence motifs 
represent the smallest scale of DNA structure with specific regulatory potential. 
In addition to short motifs of specific sequence there are longer regions of general 
nucleotide enrichment which have regulatory potential.  The best example is that of 
CpG islands, which are regions of elevated CpG density found at the promoter of 
~70% of human genes  (Ehrlich et al., 1982).  CpG rich DNA sequences have been 
shown to form G-quadruplexes, Z-form DNA and other alternative structures 
(Section 1.1.1.3), particularly in the vicinity of promoter regions.  Furthermore, 
methylation of the cytosine nucleotide (Section 1.1.1.1) at CpG island promoters 
correlates with gene repression (Keshet et al., 1985; Weber et al., 2007).  This 
modification recruits methyl-CpG specific histone modification proteins (Jones, 
2012) and stabilises Z-DNA helices (Behe and Felsenfeld, 1981) which may mediate 
gene repression, although no direct causal relationship has been determined.  Other 
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regions elevated for nucleotide sequence at a large scale include the repeat regions of 
telomeres, centromeres and rare fragile sites (Gellibolian et al., 1997) as well as the 
AT-rich regions found at common fragile sites (Section 5.1).  In each case, DNA 
helical structure has been implicated in stability and function at these regions of the 
genome.  This indicates that large scale sequence distributions are important for the 
regulation of transcription, replication and genome stability in vivo. 
 
1.1.2  Nucleosomes 
The first level of packaging of eukaryotic DNA into chromatin is the nucleosome, 
made up of a core particle, linker histone and linker DNA (Figure 1.1b).  The core 
particle is an octamer of histone proteins constraining 147 bp of DNA to its outer 
surface (Davey et al., 2002; Luger et al., 1997).  Core particles are connected by 
linker DNA, which varies in length between 7 bp and 101 bp in an organism and cell 
line dependent manner (Van Holde, 1989).  An array of nucleosomes form the classic 
‘beads on a string’ structure (Thoma et al., 1979).  Each of the constituents of this 
lower-order chromatin fibre can be exchanged with alternative proteins or chemically 
modified, influencing chromatin structure and function.  
In the context of the nucleosome the DNA molecule is frequently portrayed as a fibre 
wrapped around a cylinder, much like cotton wrapped around a reel.  It is important 
to note that the structure of the nucleosome is influenced as much by DNA 
sequence/structure as by protein structure (Rohs et al., 2010).  In this equal 
partnership, the position of the core particle on the DNA backbone, the length and 
structure of the linker DNA and the subsequent folding into higher order chromatin 
fibres will each be influenced by heterogeneity within the DNA molecule (Section 
1.1)   
 
1.1.2.1 Core histones 
Core histone proteins compact the DNA and make protein-protein interactions with 
themselves and other chromatin binding proteins (Wolffe, 1998).  The core particle 
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comprises pairs of the histone proteins H2A, H2B, H3 and H4 which bind 147 bp of 
DNA to the outer surface through electrostatic interactions (Yager et al., 1989).  
Each core histone is a small basic protein (11-16 KDa) with relatively high levels of 
argenine and lysine (>20% of amino acids).  Their structure comprises a histone-fold 
domain at the carboxyl (C-) terminus that interacts with DNA and other core histones 
(histone core), and a charged amino (N-) terminus that contains the majority of lysine 
residues (histone tail) (Arents et al., 1991; Wolffe, 1998).  Post-translational 
modifications of the N-terminal tails or replacement of core histones with specific 
histone variants can indicate altered states of genome regulation, including 
transcription and DNA repair.   
 
1.1.2.2 Histone modifications 
Post-translational modifications of histone proteins generally reflect the underlying 
regulation of the genome.  For example trimethylation of histone H3 lysine 4 
(H3K4me3) indicates an active promoter, whilst trimethylation of histone H3 lysine 
27 (H3K27me3) indicates transcriptional inactivity (Ernst et al., 2011; Kouzarides, 
2007).  Using a combination of histone modification distributions, defined by ChIP-
seq, several groups have attempted to identify functional classes of chromatin in vivo 
(Ernst et al., 2011; Hon et al., 2009).  One classification mapped nine histone 
modifications and several chromatin associated proteins, establishing 15 chromatin 
states which include ‘active promoter’, ‘strong enhancer’, ‘weak transcribed’ and 
‘polycomb repressed’ (Ernst et al., 2011).   
The identification of chromatin states provides a useful segregation of the genome, 
but in most cases the relationship between histone modifications and genome 
regulation is purely correlative.  There are two mechanisms by which histone 
modifications have been shown to directly alter chromatin structure or gene 
regulation, through the disruption of nucleosome-nucleosome contacts and the 
recruitment of non-histone protein.  The stability of fibre-fibre interactions can be 
influence by histone acetylation, which neutralises the basic charge of lysines on the 
histone tail (Kouzarides, 2007; Wolffe, 1998).  For example, acetylation of H4K16 
has been shown to disrupt the formation of the 30 nm fibre (Shogren-Knaak et al., 
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2006).  The relationship between fibre-fibre interactions and other histone 
modifications is largely unknown, although it has been suggested that 
phosphorylations may also influence nucleosome interactions (Kouzarides, 2007).  
The recruitment of non-histone proteins by histone modifications is better 
characterised, with chromodomain proteins recognising methylation, bromodomain 
proteins recognising acetylation and 14-3-3 proteins recognising phosphorylations 
(Kouzarides, 2007).  Examples of proteins which specifically interact with particular 
histone modifications include JMJD2A, CHD1 and NURF to H4K4me, PC2 to 
H3K27me and HP1 to H3K9me (Huang et al., 2006; Kouzarides, 2007; Sims et al., 
2005; Wysocka et al., 2006). 
To identify if specific histone modifications are essential for genome regulation in 
vivo several groups have knocked-out individual modifying enzymes in cell lines and 
model organisms.  Knock-outs for methyltransferases that modify H3K9me1 and 
H4K20me1 are essential for mouse development and survival, but not cell survival or 
replication (Dodge et al., 2004; Pinheiro et al., 2012).  On the other hand, knocking-
out the methyltransferase that modifies H3K9me3 is non-lethal, although the mice 
survive at sub-Mendelian frequencies and have a predisposition to cancer (Peters et 
al., 2001).  In each of these knock-out experiments a significant increase in genome 
instability was observed, although this did not prevent cell survival or replication, 
indicating a context or cell-type dependent requirement for specific modifications in 
vivo.  How other histone modifications influence genetic regulation, cell survival and 
development is difficult to establish through knock-out experiments, as one protein 
can often modify multiple sites and one site can be modified by multiple proteins.  
For example, the CBP/300 protein can acetylate at least seven different lysine 
residues on four different histones, whilst the H3K4me3 modification can be placed 
by at least nine different proteins (Kouzarides, 2007).  In addition, many histone-
modifiying enzymes have additional non-histone substrates and It may be that knock-
out experiments influence cell survival and genome stability through indirect 
mechanisms.  Finally, our understanding of histone modifications is further limited 
by current research trends, which are focused on methylation and acetylation whilst 
neglecting the vast repertoire of phosphorylations, deaminations, ADP-ribosylations, 
ubiquitinations and sumoylations (Bannister and Kouzarides, 2011).  Therefore, 
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although histone modifications are assumed to have biological consequences, in 
many cases these are unproven in the context of the local chromatin state.  
 
1.1.2.3 Histone variants 
Canonical histone proteins within a core particle can be replaced with variant 
histones for H2A, H2B and H3.  These histone variants reflect structural and 
regulatory specialisations within the chromatin structure (Sarma and Reinberg, 
2005).  For example, the histone H3 variant CENPA is found exclusively in 
centromeres where it performs an essential function, with CENPA knock-out mice 
exhibiting early embryo lethality (Howman et al., 2000).  Other histone variants 
identify regions of active transcription (H2ABBD), enhancer/promoters (H2AZ) or X 
inactivation (macroH2A)  (Costanzi and Pehrson, 1998; Ku et al., 2012; Tolstorukov 
et al., 2012).  The post-translational modification of histone variants can further 
indicate genomic changes, with the phosphorylation of serine 139 of H2AX 
representing an early step in the repair of double strand DNA breaks (Rogakou et al., 
1998).  Therefore, histone variants and their modifications present a further 
indication of genetic regulation at the scale of the nucleosome. 
 
1.1.2.5 Linker regions 
Linker DNA varies from 7 bp to 101 bp in an organism and cell type specific manner 
and is usually bound by the linker histone protein histone H1 (Van Holde, 1989).  
The linker histones which bind the DNA exiting the core particle (Thomas, 1999) 
have been shown in vitro to stabilise the chromatin fibre (Thoma and Koller, 1977; 
Thoma et al., 1979), inhibit transcription (O’Neill et al., 1995) and prevent 
nucleosome sliding (Pennings et al., 1994).  The linker DNA is of particular 
significance for the study of DNA structure, as this nucleosome free DNA can form 
alternative DNA structures and contain unrestrained DNA supercoils in the context 




1.1.2.6 Nucleosome positioning 
There is a dynamic competition for DNA binding between transcription factors and 
nucleosomes, the balance of which can be regulated to influence transcription at gene 
promoters.  For example, constitutively expressed genes have an ‘open’ promoter 
structure which is often depleted for nucleosomes over a region ~150 bp upstream of 
a transcription start site, and is therefore available for transcription factor binding 
(Cairns, 2009).  On the other hand, regulated genes have ‘covered’ promoters that 
position nucleosomes over the promoter region to limit transcription factor binding 
and rely on an active chromatin remodelling complex to reposition nucleosomes and 
activate genes (Cairns, 2009).  A number of sequence parameters regulate the DNA 
positioning on the surface of the core particle, based primarily on the variable path of 
DNA around the histone octamer.   In this path the first and last 10 bp of DNA are 
almost straight (Richmond and Davey, 2003), followed by curved DNA until two 
very sharp bends approximately one and four helical turns either side of the centre of 
the core particle DNA (Hogan et al., 1987; Wolffe, 1998).  Owing to the fact that 
some DNA sequences are intrinsically straight, curved or easily bent, there is a 
degree of sequence preference for the formation of a core particle.  Important 
features include the overall ability of the 147 bp to bend around a histone octamer 
(Drew and Travers, 1985; Struhl and Segal, 2013) and the deformability of the DNA 
20-30 bp either side of the DNA centre (FitzGerald and Simpson, 1985; Wolffe, 
1998).  The stability of DNA interactions with the surface of the core-particle can be 
further enhanced by a 10 bp periodicity of A-tracts which form a narrow minor 
groove on the inside edge of the DNA helix, bending the DNA around the core 
histones (Rohs et al., 2009).  In yeast, the periodicity of A-tracts is a general feature 
of genome organisation (Segal et al., 2006) and it is predicted that similar structural 
features occur across eukaryotes (Struhl and Segal, 2013).  To test the influence of 
sequence on core-particle positioning in vivo Segal et al. (2006) developed a tool to 
predict core-particle position in the yeast genome.  This tool predicts the position of 
~50% of nucleosomes to within 35 bp, indicating that DNA sequence is one 
determinant of core histone position in vivo.  In this manner, DNA sequence and 
structure influences nucleosome position and therefore regulatory potential.  For 
example, the primary determinant of a ‘open’ chromatin structure is an underlying 
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enrichment for poly(dA:dT) sequences that disfavour nucleosome binding (Hughes et 
al., 2012; Segal and Widom, 2009), a feature absent from ‘covered’ promoters.  A 
sequence common at ‘covered’ promoters is the TATA box, which preferentially 
binds the surface of the core-particle preventing TBP binding and subsequent 
transcription (Patikoglou and Burley, 1997).  Activation of ‘covered’ promoters 
requires the switching, sliding or removal of nucleosomes from transcription factor 
binding sites by chromatin remodelling complexes. 
Complementing the sequence based positioning of nucleosomes, chromatin 
remodelling complexes restructure, mobilise and eject nucleosomes in an ATP-
dependent manner to regulate access to DNA (Saha et al., 2006).  For example, there 
is a strong positioning of the +1 nucleosome upstream of the TSS in yeast that is 
dependent on chromatin remodellers but not on sequence (Zhang et al., 2011).  There 
are five known families of chromatin remodellers that affect the structure of 
nucleosome and nucleosomes arrays in distinct manners; SWI/SNF, ISWI, 
NURD/Mi-2/CHD, INO80 and SWR1.  SWI/SNF and ISWI have been studied in 
particular detail and have very different functions in vivo.  ISWI is important for the 
ordering and phasing of nucleosomes on the chromatin fibre following replication, 
with a role in promoting gene activation and repression (Corona and Tamkun, 2004).  
SWI/SNF, on the other hand, disorders nucleosomes at promoter regions, which can 
promote or disrupt the binding of transcription factors and gene activation (Martens 
and Winston, 2003; Saha et al., 2006).  The mechanism of repositioning by 
‘nucleosome sliding’, shared by SWI/SNF and ISWI, involves binding a nucleosome 
at a defined position and breaking the histone-DNA interactions to create a wave of 
DNA tension (i.e. DNA supercoiling) on the octamer surface that propagates around 
the nucleosome in a direction determined by the chromatin remodelling complex 
(Saha et al., 2006).  Whether unconstrained DNA supercoiling can similarly 
influence nucleosome positioning in vivo is uncertain, although a recent meta-
analysis of 445 transcription start sites suggests that nucleosome positioning is not 
significantly affected by differences in unrestrained supercoiling (Kouzine et al., 
2013).  However, a minority of promoters with sequence features that have the 
propensity to form alternative DNA helices or structures may strongly influence 
nucleosome positioning.  In this way, DNA supercoiling could contribute to the 
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remodelling of nucleosomes with and/or without the aid of chromatin remodelling 
complexes.   
 
1.1.3  Higher-order chromatin fibres 
The lower order chromatin fibre represents the first level of chromatin compaction, 
with nucleosomes compacting the genome ~7 fold over naked DNA (Németh and 
Längst, 2004).  In order to fit the human genome within a cell nucleus the genome 
must be compacted ~10,000 fold (Calladine, 2004), through a hierarchy of higher-
order chromatin fibres (Figure 1.1c).  Visualising the compaction of chromatin fibres 
under different ionic conditions in vitro indicates that the first level of higher order 
compaction is a 30 nm fibre (Thoma et al., 1979).  This 30 nm fibre is believed to 
form a solenoid (Kruithof et al., 2009) or zigzag (Schalch et al., 2005) helical 
structure, which compacts the genome by ~50 fold (Németh and Längst, 2004). 
Despite extensive evidence that chromatin folds into the 30 nm fibre and beyond 
under physiological conditions (reviewed in Wolffe (1998)), the presence of a 30 nm 
fibre has not been conclusively demonstrated in vivo and remains controversial 
(Fussner et al., 2011; Maeshima et al., 2010; Staynov, 2008). Beyond the 30 nm fibre 
compaction of the chromatin fibre is even less well defined, with additional folding 
and coiling predicted to form a ~100 nm chromonema fibres, 200-300 nm fibres and 
eventually metaphase chromosomes (Bak et al., 1977; Belmont and Bruce, 1994; 
Sedat and Manuelidis, 1978; Taniguchi and Takayama, 1986).  
 
1.1.4  Large-scale chromatin structures 
The chromatin fibre has been shown to form large-scale looped domains by both 
cytological and molecular biology techniques.  Large-scale DNA loops were first 
identified by electron microscopy of E. coli chromosomes in which loops averaging 
38 to 77 kb were seen emanating from a central scaffold in a rosette like structure 
(Kavenoff and Ryder, 1976). The separation of the E. coli genome into distinct 
supercoil domains is further supported by a molecular study that determined the 
number of DNA nicks required to relax all supercoils in the genome (Worcel and 
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Burgi, 1972).  In this study DNA is released in a highly folded conformation by 
careful lysis of E. coli cells and analysed by sucrose gradient sedimentation 
following treatment with DNaseI.  DNaseI introduces nicks into the DNA that relieve 
supercoils from the genome.  In E .coli supercoils compact the genome through 
writhe (Section 1.2.2), therefore nicking leads to a less compact genome that 
sediments more slowly through a sucrose gradient.  By varying the concentration of 
DNaseI, the authors establish that between 6 and 40 nicks are required to relieve all 
DNA supercoils.  These results are interpreted as a separation of the E. coli genome 
into between 12 and 80 distinct DNA loops with an average size of between 58kb 
and 383kb.  In eukaryotes a similar segregation of the genome into distinct DNA 
supercoil domains was identified in the interphase genome of Drosophila using a 
similar nicking technique, which identified distinct domains of ~85 kb (Benyajati 
and Worcel, 1976). In addition, looped structures have been observed cytologically 
in human metaphase chromosomes, although it is not known whether these are 
preserved in interphase (Earnshaw and Heck, 1985; Paulson and Laemmli, 1977).  
Together this data identifies that prokaryotic and eukaryotic genomes are organised 
into distinct 50-100 kb domains which may be related to cytologically defined DNA 
loop structures.  Therefore, the compartmentalisation of the genome into looped 
domains may represent a conserved mechanism for the separation of structure and 
function. 
To establish the distribution of looping in the interphase genomes at high resolution 
and in three dimensions the ‘chromosome conformation capture’ (3C) method was 
developed (Dekker et al., 2002).  In this technique nuclei are cross-linked using 
formaldehyde so that regions of the genome that are in physical contact are bound 
covalently to neighbouring proteins and DNA.  Cross-linked DNA is digested with a 
restriction enzyme and DNA strands are ligated at a very low DNA concentration, so 
that the ligation of cross-linked fragments is much more probable than between 
random fragments.  To identify cross-links and quantify their frequency, ligation 
products are analysed by PCR or deep sequencing.  Using variations on the 3C 
technique (reviewed in De Wit and De Laat, 2012), interactions have been identified 
at scales from kilobases to megabases.  For example, the transcription dependent 
interaction of the HoxD gene with its long range regulatory elements (Montavon et 
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al., 2011), and all DNA interactions within a 4.5 Mb region surrounding the X-
inactivation centre (Nora et al., 2012), indicating a relationship between genome 
structure and gene regulation in vivo.  To identify the conformation of chromatin 
genome wide, ligation products were subjected to deep-sequencing (Hi-C) (Dixon et 
al., 2012).  Through Hi-C ‘topological domains’ were identified in the interphase 
human genome with a median size of 880 Kb.  These domains are largely invariant 
between cell types and even between human and mouse, and may represent a general 
structural organisation of genomic regions. Together, this data supports a genome 
organisation made up of large structural loops containing small regulatory loops, 
which organise the genome at scales of tens to hundreds of kilobases. 
The above cytological, differential centrifugation and high-throughput chromatin 
conformation methods each identify domains of tens to hundreds of kilobases within 
the human genome.  Whether each of these observations reflect the same underlying 
structure or distinct features of the genome remains unproven and is an important 
question within the field of chromatin biology, but is beyond the scope of this study. 
 
1.1.5  Chromatin organisation in the nucleus 
The distribution of large-scale chromatin structures and whole chromosomes within 
an interphase nucleus is non-randomly organised in vivo.  Chromosomes form 
distinct territories where they are more likely to form intra-chromosomal interactions 
than inter-chromosomal interactions.  Chromosome territories were initially 
identified cytologically through the use of fluorescent probes for whole 
chromosomes (Boyle et al., 2011) and subsequently confirmed by Hi-C based 
molecular studies (Dixon et al., 2012; Lieberman-Aiden et al., 2009).  In addition to 
the intra-chromosomal interactions, a number of reproducible inter-chromosomal 
interactions have been identified between specific loci by molecular (Dixon et al., 
2012; Lieberman-Aiden et al., 2009; de Wit et al., 2013) and cytological techniques 
(Branco and Pombo, 2006; Kalhor et al., 2012; de Wit et al., 2013).  For example, in 
embryonic stem cells the Nanog gene forms inter-chromosomal interactions with 
other pluripotency genes including Esrrb and Zfp281 in a tissue specific manner (De 
Wit et al., 2013).  It has therefore been suggested that chromosome territories are 
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composed of a condensed ‘core’ surrounded by a de-condensed ‘corona’ (Bickmore 
and Van Steensel, 2013).  In this model the ‘corona’ contains generally active loci 
that visibly loops to make contacts with distal regions in the ‘corona’ of the same 
chromosome or with loci in the ‘corona’ of neighbouring chromosomes (Bickmore 
and Van Steensel, 2013).  A recent study indicates that it is the distribution of the 
contacts in the ‘corona’, rather than changes in the overall folding of chromosomes, 
that regulates gene expression through the three dimensional structure of the genome 
(De Wit et al., 2013).  Together this data shows that the three dimensional 
organisation of chromatin domains within and between chromosomes is a critical 
component of gene regulation in vivo.  
 
1.2 DNA supercoiling 
 
1.2.1  Defining DNA supercoiling 
DNA supercoiling is a transient and context dependent structural change in which the 
helix is over- or under- wound.  At the simplest level supercoiling is a mathematical 
description of topological changes in any circular or constrained-linear double helix.  
The following section will define the terms for DNA supercoiling used throughout 
this thesis. 
1.2.1.1 Linking number, twist and writhe 
The topological properties of the DNA double helix can be defined by equation 
‘linking number (L) = twist (T) + writhe (W)’, with linking number corresponding to 
the number of times one strand crosses the other when the DNA is made to lie on a 
flat plane and twist/writhe describing the distribution of these cross-overs between 
the number of helical turns in a length of DNA (twist) and the additional coiling of 
the double-helix (writhe ) (Figure 1.5a).  When each strand of the double helix 
remains unbroken the relationship between twist and writhe can change, but the 
linking number cannot.  For example, in the top left panel of Figure 1a the 210bp 
relaxed plasmid has a linking number of 22 which is distributed entirely in twist, but 
a change in twist of -2 requires a compensatory change in writhe of +2 (positive 
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writhe) in the top right panel.  As DNA is a dynamic molecule, it can accommodate 
different states of twist and writhe, with important biological consequence (see 
Section 1.2.5).  
 
1.2.1.2 Relaxed DNA double helix 
In the case of the DNA double helix the chemical structure determines a preferred 
helical state which corresponds to the lowest energy form of the molecule.  The 
average helical repeat of linear DNA with ends free to rotate, or nicked circular 
DNA, is 10.5bp per turn.  A covalently closed circular DNA molecule with this 
repeat is called relaxed DNA and for a given length DNA the linking number of 
DNA is determined by the equation ‘relaxed linking number (L0) = number of base 
pairs (N)/10.5’ (Figure 1.5b - L0 = 20).  Therefore, in relaxed DNA ‘L = L0’. 
 
1.2.1.3 Positive and negative DNA supercoiling 
In supercoiled DNA ‘L ≠ L0’, introducing energy that distorts the twist and/or writhe 
from that of the relaxed double helix.  A DNA helix that increases linking number 
compared to a relaxed helix is positively supercoiled (‘L > L0’) whereas one that 
decreases linking number is negatively supercoiled (‘L < L0’).  The negatively 
supercoiled plasmid in the bottom panel of Figure 1.5a has a linking number value of 
18 compared to 20 in the relaxed plasmid, which can be accommodated by a 
decrease in twist of -2 or the introduction of -2 negative writhe.  The reverse is true 
of the positively supercoiled plasmid in the top panel of Figure 1.5a (L=22), which 
distorts the helix through an increase in twist (+2) or a positive change in writhe 
(+2).  Therefore, positive and negative supercoiling are defined by a difference in 
linking number compared to L0 and are absolute measures of DNA topology.     
 
1.2.1.4 Under-wound and over-wound DNA 
The techniques used in this thesis cannot determine the absolute level of DNA 
supercoiling and instead determine the relative supercoiling across regions of the 
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human genome.  A relative measure of DNA supercoiling is the specific linking 
difference (σ), which can be summarised in the equation ‘σ = (L - L0) / L0)’.  As σ is 
proportional to the number of base pairs it can be used to directly compare different 
regions of DNA, with lower σ values being relatively under-wound DNA when 
compared to higher σ values (which are relatively over-wound).   In this thesis the 
relative supercoiling of different DNA regions are compared using a chemical probe 
(see Chapter 4), and the L and L0 remain unknown.  However, the same definition of 
DNA supercoiling can be applied as we are interested in the difference rather than 
the absolute levels of supercoiling.  As an example, in the model in Figure 1.5c there 
is a clear difference between the over-wound and under-wound region, even though 
we do not know the linking number properties.  Therefore, in this thesis the 
definition of under- and over- wound DNA, in terms of specific linking difference, 
can be represented by ‘under-wound < σ < over-wound’. 
 
1.2.1.5 Definitions of supercoiling used in this thesis 
For complete clarity Figure 1 models the definitions of supercoiling used in this 
thesis.  Positive and negative supercoiling are absolute measurements of linking 
number compared to a relaxed circular or constrained DNA molecule and are used 
only when discussing the work of others (e.g. Baxter et al., 2011; Bermúdez et al., 
2010; Kouzine et al., 2008).  When discussing the experiments of this thesis, DNA 
supercoiling is referred to by the relative terms under-wound or over-wound, which 
are analogous to a comparison of specific linking difference. 
In addition, the localisation of DNA supercoils is often referred to as ‘upstream’ or 
‘downstream’ of a particular position on the DNA, such as a gene or transcribing 
polymerase.  ‘Upstream’ is defined as 5’ and ‘downstream’ is 3’ of the position of 







Figure 1.5 Properties of DNA supercoiling.  a)  Supercoiled and b) 
relaxed DNA defined in terms of linking number (L), twist (T) and writhe (W).  
Figure adapted from Sinden (1994).  C) DNA supercoiling defined in terms of 




1.2.2  DNA supercoiling in chromatin 
The net DNA supercoiling of prokaryotic and eukaryotic genomes is comparable, 
with one under-wound supercoil per 200 bp in E. coli and Drosophila (Benyajati and 
Worcel, 1976).  This supercoiling is present in two distinct forms, those restrained in 
the core particle (or prokaryotic equivalent) and those unrestrained in the linker 
DNA.  The distribution of restrained/unrestrained DNA supercoils is distinct between 
prokaryotes and eukaryotes, with only ~50% of prokaryotic supercoils being protein 
bound (Pettijohn and Pfenninger, 1980) compared to almost all eukaryotic supercoils 
(Bates and Maxwell, 2005; Sinden et al., 1980).  This will result in different 
structural and functional consequences for the packaging and regulation of 
prokaryotic and eukaryotic genomes.  
In prokaryotic genomes the high levels of unrestrained DNA supercoiling and 
reduced association of DNA with histone-like proteins results in a highly writhed 
DNA molecule (Postow et al., 2004; Sherratt, 2003).  This writhe contributes to the 
packaging and regulation of the prokaryotic genome.  In eukaryotes, our 
understanding of how unrestrained supercoiling is accommodated into DNA in the 
context of chromatin is very limited.  In part, this stems from a poor understanding of 
the structures adopted by the higher order chromatin fibre (Section 1.1.3) and the 
influence of alternative histones and modifications on chromatin fibre plasticity 
(Gilbert and Allan, 2013).  However, it appears that chromatin is highly 
accommodating of DNA supercoiling (Kouzine et al., 2008; Naughton et al., 2013a) 
and in vitro evidence indicates that the dissipation of supercoils is unhindered by the 
chromatin macromolecule (Bancaud et al., 2006).  Additionally, evidence suggests 
that yeast chromatin has a greater propensity to absorb DNA supercoiling, whereas 
the chromatin of higher eukaryotes transmits DNA supercoiling, supporting a model 
in which chromatin influences the dynamics of DNA supercoiling (Gilbert and Allan, 
2013; Morse et al., 1987).  Whether unrestrained DNA supercoiling in chromatin is 
mainly manifest as twist or writhe is currently unknown and remains the object of 
fierce speculation. 
To further understand the distribution of DNA twist and writhe in chromatin it is 
important to establish the supercoiling density (σ) that is expected to occur within 
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chromatin associated DNA, and to establish the biophysical limitations of DNA at 
this supercoil density.  To determine the σ value for a 1 kb region of chromatinised 
DNA placed between highly expressed divergent promoters, Kouzine et al. (2008) 
stably transfected a plasmid construct into human cells and used the Cre recombinase 
system to excise DNA circles that trap local DNA supercoils.  Using this system the 
σ value for DNA upstream of two highly transcribed (divergent) promoters was 
calculated at -0.07.  In addition, at this level of σ Kouzine et al. (2008) also show that 
the FUSE element melts and the FBP and FIR transcription factors bind DNA.  
Therefore, σ = -0.07 can be generated within the context of human cells by highly 
expressed divergent promoters, and likely represents an upper estimate to the σ value 
present upstream of active gene promoters in vivo.  Subsequent discussion of 
supercoiling within the context of chromatin will be framed in the context of σ 
values close to -0.07. 
To establish the likely distribution of twist and writhe within chromatin associated 
DNA, it is important to identify how much twist can be accommodated by naked 
DNA before a forced transition to writhe or alternative DNA conformations.  
Through an analysis of electron micrographs of supercoiled plasmids Boles et al. 
(1990) identify that below σ = -0.016 DNA supercoiling is only accounted for by 
twist and that writhe occurs in a disordered manner.  When σ > -0.016 the 
contribution of twist and writhe to the linking number has a ratio of 1:2, which is 
consistent at all values tested up to σ = -0.06.  Therefore, in naked DNA plasmids 
twist can account for ~1/3 of under-wound DNA supercoils under biologically 
relevant levels of DNA supercoiling.  To extend these observations and establish the 
maximum levels of twist a DNA molecule can withstand before forcing a structural 
transition, Bryant et al. (2003) measured twist using a force-measuring optical trap 
under conditions that precluded the formation of writhe. When the DNA is 
maintained under tension it can hold a remarkable amount of twist, with σ values of  
-0.10 and 0.32 observed for under- and over- wound B form DNA respectively.  
Beyond these levels of DNA supercoiling structural transitions occur, identified 
through a change in the relative extension of DNA.  Therefore, on the balance of 
experimental data DNA appears capable of constraining significant levels of twist 
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and writhe, the balance of which is influenced by tension and/or topological 
constraint within the DNA.  
In the context of chromatin it remains unclear whether twist or writhe contributes 
most to the accommodation of unrestrained DNA supercoils.  The wrapping of DNA 
into nucleosomes limits the localisation of unrestrained supercoils to the linker 
regions and the formation of a higher order chromatin fibre, with protein-protein 
interactions between histones in adjacent regions of the fibre, may influence the 
capacity of the DNA to form writhe.  Therefore, a naked DNA plasmid represents a 
poor model for understanding twist and writhe in the chromatin context.  No direct 
measurement of twist and writhe have been performed on chromatin fibres, but we 
can infer that the distribution of these properties probably falls somewhere between 
naked DNA in solution (1:2 twist:writhe) and naked DNA under tension (1:0 
twist:writhe).  The true distribution of DNA supercoils will be dependent on a 
number of properties of the chromatin fibre including the level of unrestrained DNA 
supercoiling, the length of linker DNA, nucleosome stability on supercoiled DNA 
and differences in chromatin fibre stability.   
In support of a significant contribution of twist to the distribution of unrestrained 
under-wound supercoiling in chromatin, several studies have shown that psoralen 
binds DNA in eukaryotes in a supercoil dependent manner (Bermúdez et al., 2010; 
Matsumoto and Hirose, 2004; Naughton et al., 2013a; Saffran et al., 1988; Sinden et 
al., 1980).  The binding of psoralen to under-twisted (as opposed to under-wound, 
which includes writhe) DNA is thermodynamically favoured, as the intercalation of 
the drug induces a slight over-twisting of the helix which returns the DNA towards a 
lower energy ‘relaxed’ state.  It is on the basis of this relationship between twist, 
DNA supercoiling and psoralen binding that the bTMP pull-down developed in our 
lab is based (Naughton et al., 2013a).  However, the presence of twist does not 





1.2.3  Restrained DNA supercoiling and the linking 
number paradox 
Extensive experimental data has shown that each nucleosome restrains a single 
under-wound supercoil in the toroidal writhe of the bound DNA helix (e.g. Luger et 
al., 1997; Richmond and Davey, 2003).  However, the length of DNA bound by a 
nucleosome wraps around the outer surface ~1.8 times and should therefore constrain 
~1.8 under-wound supercoils per nucleosome.  The difference between the observed 
and expected constrained DNA supercoils in a nucleosome is called the ‘linking 
number paradox’ (Bates and Maxwell, 2005).  Extensive structural studies have 
identified peculiarities in the nucleosome bound DNA structure that partially explain 
the linking number discrepancy.  These include straight DNA sections that do not 
curve around the nucleosome (Richmond and Davey, 2003) and an over-wound 
helical structure that cancels out some of the plectonemic writhe through twist 
(Hayes et al., 1991).  Regardless of the mechanism, the DNA supercoils constrained 
by the nucleosome contribute to the compaction of the genome, and may act as a 
store of potential energy within the chromatin that is released into the DNA with the 
dissociation of the nucleosome.  This difference between observed and expected 
serves as a reminder of the hidden complexity of DNA and its influence on DNA-
protein interactions, chromatin structure and subsequent gene regulation. 
 
1.2.4  Introduction and removal of DNA supercoils 
Interactions between protein and DNA generally involve a twisting, bending or 
wrapping of the double helix, in each case generating DNA supercoils  (Bates and 
Maxwell, 2005).  This is especially true in the case of polymerases, which constantly 
introduce over- and under-wound supercoils into the DNA as they transcribe or 
replicate.  In addition, the products of DNA replication can coil around one another 
to produce inter-strand catenanes which must be separated to prevent the formation 
of DNA knots and for the separation of sister chromatids (Postow et al., 2001).  The 
relief of DNA supercoils and catenanes is performed by DNA topoisomerases, 
through the transient introduction of nicks and double strand breaks into the DNA 
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backbone.  The activity of these topoisomerases is conserved and essential for all 
cellular life (Forterre and Gadelle, 2009).  In addition, some specialised 
topoisomerases (e.g. DNA gyrase)  have evolved in microorganisms that introduce 




1.2.4.1.1 RNA Polymerase 
In order to read a single strand of DNA, RNA polymerase requires the localised 
unwinding of the double helix as it passes along a region of the genome.  The size of 
the polymerase complex, with a combined mass of greater than 2 MDa (He et al., 
2013), means that the complex does not rotate with the pitch of the helix during 
transcription.  Therefore, as the polymerase passes between the strands of the double 
helix, it generates an over-wound helix ahead of itself and an under-wound helix 
behind (Figure 1.6).  This is known as the twin supercoil domain model (Liu and 
Wang, 1987).  In this model RNA polymerase introduces one positive and one 
negative supercoil per rotation of the double helix (i.e. ~10.5 bp).  Experiments in 
vitro and in transfected plasmids in vivo confirmed this models validity in biological 
systems (Giaever and Wang, 1988; Hirose and Suzuki, 1988).  The simultaneous 
introduction of positive and negative supercoils suggests that when the polymerase is 
removed the over-wound and under-wound supercoils can diffuse back through the 
DNA and cancel one another out.  However, transcription on a circular plasmid in 
Xenopus oocytes generates an under-wound DNA template (Dunaway and Ostrander, 
1993), indicating that over-wound DNA is preferentially relieved during 
transcription.  The preferential release of over-wound supercoils will prevent their 
build up ahead of RNA polymerase, which can slow and eventually prevent 
transcription by inhibiting DNA strand separation and stalling RNA polymerase (Ma 
et al., 2013a).  Furthermore, high levels of under-wound supercoiling must also be 
relieved to prevent the formation of single stranded DNA or alternative DNA 
structures, which can also stall RNA polymerase (French et al., 2011; Ma et al., 
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2013a).  Therefore, transcription by RNA polymerase II generates DNA supercoils in 









Figure 1.6 Transcription alters DNA supercoils.  The binding of the 
RNA polymerase complex to the DNA requires the localised unwinding of the 
double helix (a).  As transcription proceeds the DNA is over-wound ahead of 
the RNA polymerase and under-wound behind, generating positive and 







1.2.4.1.2 DNA Polymerase 
DNA polymerase also requires the localised unwinding of the DNA double helix, 
generating over-wound supercoils ahead as it replicates the DNA (Postow et al., 
2001).  However, the newly replicated DNA strands upstream of the polymerase 
have no net supercoiling, as they are formed by the addition of nucleotides to a single 
stranded DNA molecule.  As supercoiling refers to the linking number of a double 
helix, a single stranded DNA molecule cannot contain supercoiling and the newly 
replicated DNA will correspond to the lowest energy form of the double helix.  
However, if the supercoils generated ahead of the polymerase are not relaxed then 
the replication fork swivels to unwind the helix ahead of the fork, causing the 
replicated strands behind the polymerase to coil around one another and form double 
strand pre-catenanes (Baxter and Aragón, 2010).  This formation of precatenanes is 
most common at the termination of replication where two polymerases, each 
generating over-wound supercoils, converge on an ever shortening region of DNA.  
In order to resolve replicated genomes and segregate chromosome appropriately into 
daughter cells, these pre-catenanes must be removed by the action of type II 




















Figure 1.7 DNA replication introduces DNA supercoils.  Following a 
similar mechanism to that of transcription, the processing of DNA polymerase 








Topoisomerases relieve supercoils and catenanes from the DNA through the 
introduction of single strand nicks or double strand breaks, classified as type I and 
type II topoisomerases respectively.  Although the precise compliment of 
topoisomerases varies from species to species, their function is conserved, with all 
cellular organisms having at least one type I and type II topoisomerase (Forterre and 
Gadelle, 2009).  The topoisomerase classification can be further divided, based on 
the mechanism of DNA strand cleavage and supercoil relaxation, into topoisomerase 
IA, IB, IC, IIA and IIB.  Confusingly, the ‘types’ and ‘names’ of topoisomerase often 
appear similar, but signify different enzymes.  For example, human topoisomerase III 
enzymes are classified as type IA topoisomerases and topoisomerase IIβ is classified 
as a type IIA topoisomerase (see Table 1.1).  In addition, specialised prokaryotic 
topoisomerases such as DNA gyrase use ATP to introduce DNA supercoils into the 
DNA.  Identifying the presence, function and distribution of different classes of 
topoisomerase in vivo is necessary to understand how organisms maintain DNA 




















Table 1.1 Topoisomerase classification.  Topoisomerases ‘class’ 
separates proteins based on structure and relatedness.  Topoisomerase 








1.2.4.2.1 Topoisomerase type I 
 
Topoisomerase type IA 
Type IA topoisomerases cleave a single strand of the double helix to form a 5’-
phosphotyrosyl linkage (Liu and Wang, 1979) creating an enzyme-bridged single 
stranded gap in the double helix with sufficient width to allow the passing of a 
second DNA segment (mechanism reviewed in Schoeffler and Berger, 2008).  
Prokaryotes and archea have topoisomerase I and III enzymes that use the 
topoisomerase IA mechanism (Srivenugopal et al., 1984), whilst human cells only 
have topoisomerase III enzymes.  The prokaryotic and archeal topoisomerase I 
enzymes only relax negative supercoils, because the topoisomerase IA mechanism 
requires a single stranded DNA substrate formed by the localised unwinding of the 
DNA double helix, a process resisted by positively supercoiled DNA (Kirkegaard 
and Wang, 1985).  The relaxation of negative supercoils by prokaryotic 
topoisomerase I proceeds to an equilibrium point at which the DNA is still under-
wound.  This is important for organisms such as E. coli where the under-wound 
structure of the genome is vital for genome packaging and regulation (Postow et al., 
2004; Sinden and Pettijohn, 1981).  The decatenation activity of prokaryotic 
topoisomerase I is poor, whereas topoisomerase III is an effective decatenase and a 
poor relaxase (Hiasa et al., 1994).  The difference in activity between topoisomerase 
I and III is mediated through a 17 amino acid insertion required for the DNA linking 
activity (Li et al., 2000).  In humans topoisomerase IIIα is a single stranded DNA 
decatenase (Yang et al., 2010) that is important for recombination through the 
dissolution of alternative DNA conformations (Wu and Hickson, 2003).  A further 
role for topoisomerase IIIα has been identified in the resolution of ultra-fine 
anaphase bridges between sister chromatids, working together with the DNA 
helicases BLM and RMI1 in the final stages of chromosome separation (Chan et al., 
2007; Yang et al., 2010).  The mechanisms and functions of topoisomerase IIIβ are 
less well studied, although the high sequence similarity in the catalytic core suggests 
a similar role in vivo (Champoux, 2001).  Together this data indicates that type IA 
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topoisomerases in human cells are specialised replication enzymes that work in 
conjunction with DNA helicases. 
One further type IA topoisomerase adapts the ‘enzyme-bridged single strand DNA 
gap’ mechanism to introduce positive supercoils into the DNA of hyperthermophilic 
bacteria and archea.  These reverse gyrase proteins are composed of the core 
catalytic fold of type IA topoisomerases and a helicase-like domain which work 
together to relax negative supercoils, introduce positive supercoils and preventing the 
temperature-related degradation of nicked DNA (Schoeffler and Berger, 2008).  The 
positive supercoiling of hyperthermophilic genomes, facilitated by reverse gyrase, is 
important for genome stability and may help re-nature DNA melted by high 
temperature conditions (Kampmann and Stock, 2004; Schoeffler and Berger, 2008).  
This highly specialised protein is an extreme example of the importance of DNA 
supercoiling in genome stability and regulation. 
 
Topoisomerase type IB 
Topoisomerase IB enzymes form a single strand break in which the 3’ phosphate 
forms a phosphotyrosyl linkage with the enzyme (Figure 1.8a), whilst the DNA 
downstream of the break rotates under the free energy of the unrestrained 
supercoiling in the helix (Figure 1.8b)(Champoux and Dulbecco, 1972; Koster et al., 
2005).  Type IB enzymes include topoisomerase I in eukaryotes, poxvirus and some 
bacteria.  The topoisomerase protein clamps tightly around the DNA (Champoux, 
2001; Leppard and Champoux, 2005), forming several protein-DNA interactions 
which slow the rotation and position the break for re-ligation (Koster et al., 2005; 
Stewart et al., 1998).  This mechanism releases a single supercoil from the helix per 
revolution, with multiple revolutions occurring between strand break and religation 
in a torsion-force dependent manner (Koster et al., 2005).  The controlled rotation 
mechanism removes both over-wound and under-wound supercoils from the DNA, 
which are necessary for topoisomerase binding (Madden et al., 1995).  However, the 
relaxation of positive supercoils by topoisomerase I occurs around 50 times faster 
than negative supercoils (Frøhlich et al., 2007) and it has been suggested that positive 
supercoils may specifically recruit topoisomerase I (Leppard and Champoux, 2005).  
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Topoisomerase I is enriched in transcribed genes in Drosophila (Gilmour et al., 
1986), co-localises with RNA polymerase II associated transcription factors 
(Kretzschmar et al., 1993) and enzyme activity (Stewart et al., 1990), is associated 
with RNA polymerase I and rDNA transcription (Christensen et al., 2004), localises 
to replication forks (Leppard and Champoux, 2005) and is linked to open chromatin 
and gene expression (Durand-Dubief et al., 2010; Filion et al., 2010) (Section 3.1).  
However, our understanding of the relevance of topoisomerase I co-localisation and 
function is currently restricted as the precise distribution has not been mapped for 
any significant portion of the human genome.  Unsurprisingly for a protein intimately 
linked with transcription and replication, topoisomerase I is required for viability in 
fly and mouse (Lee et al., 1993; Morham et al., 1996), but yeast topoisomerase I 
knock-outs are viable (Kim and Wang, 1989).  This may be a reflection of 
differences in gene size, developmental complexity or the complement and function 





















Figure 1.8 Topoisomerase IB mechanism.  a) The formation of a 3’ 
phosphotyrosyl linkage between the topoisomerase enzyme and DNA 
stabilises the enzyme induced nick.  b) Schematic of the controlled rotation 






Topoisomerase type IC 
Topoisomerase V is a type I topoisomerase that is structurally and phylogenetically 
distinct from other identified topoisomerases, but is mechanistically similar to 
topoisomerase IB enzymes (Schoeffler and Berger, 2008).  This topoisomerase has 
only been identified in thermophylic archea of the genus Methanopyus that inhabit 
hydrothermal vents (Forterre and Gadelle, 2009) and is most notable for performing 
its enzymatic activity optimally at 108°C (Kozyavkin et al., 1995).  The convergent 
evolution of topoisomerase IB and IC enzymes further supports the importance of 
DNA supercoil relief through transient single strand breaks in cellular organisms. 
 
 
1.2.4.2.2 Topoisomerase type II 
 
Topoisomerase type IIA 
Topoisomerase II enzymes are complex multi-subunit molecular machines which 
form enzyme-bridged breaks in double stranded DNA (Figure 1.9a/b), through which 
a second double stranded DNA helix is passed (Figure 1.9b) (Liu et al., 1980).  In 
general, this releases positive and negative DNA supercoils two at a time and can 
decatenate inter-wound helices and DNA knots.  Type IIA enzymes include 
eukaryotic topoisomerase IIα and IIβ, viral and bacteriophage topoisomerase II, 
bacterial and archeal DNA gyrase and bacterial topoisomerase IV (Champoux, 2001; 
Schoeffler and Berger, 2008).  The functions of topoisomerase IIA enzymes are wide 
ranging, with forms that preferentially relieve supercoils, introduce supercoils and 
decatenate. 
Topoisomerase II enzymes are type IIA topoisomerases that are present in 
eukaryotes, viruses and bacteriophages (Table 1.1).  They function both to relieve 
supercoils and decatenate DNA strands, with many organisms expressing different 
forms specialised to these different functions.  One study in yeast supports 
topoisomerase II as the major relaxase in chromatin, as opposed to naked DNA  
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(Salceda et al., 2006).  Using a yeast minichromosome system they show that 
topoisomerase II is 5 times more efficient than topoisomerase I at relieving 
supercoils from a chromatinised template.  This observation seems at odds with the 
published distributions of these enzymes in higher eukaryotes, with topoisomerase I 
associated with actively transcribed genes and topoisomerase II associated with AT-
rich regions of the genome (Gilmour et al., 1986; Käs and Laemmli, 1992).  The 
authors account for this apparent contradiction by postulating that chromatin may 
buffer the driving torque required for topoisomerase I, therefore topoisomerase II is 
generally more efficient on a chromatin template, except in the immediate vicinity of 
a polymerase where molecular crowding prevents the formation of writhe and 
generates high levels of twist for release by topoisomerase I.  Whether this model is 
specific for yeast, or even just yeast minichromosomes, has not been established.  
Therefore, on the basis of this model topoisomerase II may be more important in the 
vicinity of transcribed regions for the release of DNA supercoils, and should be 
considered in an interpretation of topoisomerase II distribution in vivo. 
In higher eukaryotes topoisomerase IIα and topoisomerase IIβ are evolutionarily 
conserved proteins that are likely to perform different functions within the cell 
(Champoux, 2001).  Topoisomerase IIα is essential for chromosome segregation and 
performs a redundant role in chromosome condensation in human cells (Carpenter 
and Porter, 2004), indicating a role in the decatenation of DNA.  Supporting this, the 
expression of topoisomerase IIα varies through the cell cycle, with expression 
highest in S phase through to G2-M phase where decatenation is critical (Woessner 
et al., 1991).  The observation that topoisomerase IIα preferentially binds positively 
supercoiled DNA (McClendon et al., 2005) may indicate a further role in DNA 
replication, resolving the positive supercoils ahead of the polymerase and the 
catenanes behind in a cell cycle dependent manner.  Topoisomerase IIβ, on the other 
hand, is expressed throughout the cell cycle (Woessner et al., 1991) and shows no 
preference for binding supercoiled DNA (McClendon et al., 2005).  If topoisomerase 
II enzymes are the more efficient relaxase in chromatin, then it is likely that 
topoisomerase IIβ performs this role throughout the cell cycle in higher eukaryotes.  
One function of topoisomerase IIβ is in the regulation of transcription initiation and 
repression (Ju et al., 2006; Lyu et al., 2006; McNamara et al., 2008).  However, cell 
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lines in which topoisomerase IIβ has been knocked out are viable (Nitiss, 2009a).  
This indicates that unlike topoisomerase IIα, topoisomerase IIβ is not required in the 
cell cycle or for survival.  The basis of the functional difference between 
topoisomerase IIα and IIβ has been of much interest, particularly as they share a 72% 
amino acid sequence identity, and must lie in the more variable non-catalytic C-
terminal domain (Champoux, 2001).  Whether this affects the spatial distribution of 
topoisomerase IIα and IIβ in the genome is unknown.  Cytological studies have 
indicated that in human chromosomes topoisomerase II enzymes form one 
component of the chromosome scaffold in metaphase (Earnshaw and Heck, 1985) 
and form the base of large chromatin loops (Paulson and Laemmli, 1977).  
Topoisomerase II may form a structural component of these loops and regulate DNA 
supercoiling within.  However, in these studies the majority of protein was stripped 
from the metaphase chromosomes, therefore the scaffold may be just one example of 
a feature associated with topoisomerase II.  For example, it has been shown that 
topoisomerase IIβ is enriched at some promoters and it has been suggested that this 
distribution may be a general feature of promoters in the genome (Kouzine et al., 
2013; Lyu et al., 2006; Sano et al., 2008).  In prokaryotes type IIA topoisomerases 
either relieve DNA supercoils and catenanes or introduce negative supercoils in an 
ATP dependent manner.  Prokaryotic topoisomerase IV has a similar structure and 
function to eukaryotic topoisomerase II enzymes, but with a preference for positively 
supercoiled and catenated substrates (Crisona et al., 2000; Zechiedrich et al., 1997).  
DNA gyrase, on the other hand, adapts the type II topoisomerase mechanism to 
actively introduce negative supercoils into the DNA (Gellert et al., 1976).  The 
mechanism of DNA gyrase activity involves wrapping one strand of DNA around the 
enzyme so that the same strand is both broken and passed through itself, introducing 
two negative supercoils per reaction (Schoeffler and Berger, 2008).  DNA gyrase 
activity is required for DNA replication in many prokaryotes, but is absent from 
human cells, and is therefore a major target for antibiotics (Engle et al., 1982).  
Together, the activity of topoisomerase IV and DNA gyrase maintain the high levels 
of negative supercoiling present in the E. coli genome.  This is a further example of 




Topoisomerase type IIB 
The single type IIB topoisomerase identified thus far is topoisomerase VI, which is a 
distant relative of type IIA topoisomerases present in archea, plants and some 
bacteria (Forterre and Gadelle, 2009; Schoeffler and Berger, 2008).  Topoisomerase 
VI has a similar mechanism to type IIA topoisomerases, relaxing positive and 
negative supercoils and decatenating through a strand passage mechanism.  The 
discovery of topoisomerase VI is relatively recent for a type II topoisomerase 





















Figure 1.9 Topoisomerase IIA Mechanism.  a) The formation of 3’ 
phosphotyrosyl linkages between the topoisomerase enzyme and both 
strands of a DNA double helix.  b) Schematic of the strand passage 
mechanism.  The green DNA strand is broken through the mechanism in a) 





1.2.5  DNA supercoiling in vivo 
In the cellular context it is conceivable that DNA supercoiling introduced by 
transcription and replication is completely removed from the DNA by topoisomerase 
enzymes to leave the genome in a relaxed state.  In prokaryotes this is clearly not the 
case, with genomes maintaining significant unconstrained negative supercoils 
(Sinden and Pettijohn, 1981; Sinden et al., 1980).  More recently domains of 
unrestrained supercoils have been observed in the DNA of yeast, fly and human 
(Bermúdez et al., 2010; Matsumoto and Hirose, 2004; Naughton et al., 2013a). This 
indicates that DNA supercoiling may have a biological role in eukaryotes similar to 
that observed in prokaryotes. 
 
1.2.5.1 Biological roles of DNA supercoiling 
Supercoiling introduces energy into the DNA which can be dissipated through the 
fibre or localised to distort the structure of the double helix.  Both of these 
manifestations of DNA supercoiling have been shown to influence transcription by a 
number of mechanisms, including the selective binding of transcription factors to 
altered DNA structures (e.g. Kouzine et al., 2008), an increased transcription 
efficiency on an under-wound DNA template (Dunaway and Ostrander, 1993; 
Weintraub et al., 1986) and the large-scale decompaction of chromatin structure 
(Matsumoto and Hirose, 2004; Naughton et al., 2013a).  The dissipation of DNA 
supercoiling through the DNA fibre has been shown to generate domain scale 
(Matsumoto and Hirose, 2004; Naughton et al., 2013a) or genome-wide (Sinden and 
Pettijohn, 1981; Sinden et al., 1980) under-wound DNA structures in eukaryotes and 
prokaryotes respectively.  Early studies of DNA supercoiling in transfected plasmids 
identified that under-wound DNA is transcribed more efficiently than linear or 
nicked DNA in E. coli (Weintraub et al., 1986) or Xenopus oocytes (Dunaway and 
Ostrander, 1993), providing the first evidence of the regulatory potential of DNA 
supercoiling in vivo.  Subsequent genome wide analyses in prokaryotes identified 
that many, but not all, genes are regulated by DNA supercoiling (Lyu et al., 2006; 
Peter et al., 2004).  Taken together, these studies support the direct regulation of 
genes by DNA supercoiling in plasmid and prokaryotic systems.  In eukaryotes there 
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is a strong correlation between under-wound DNA and gene expression, supporting a 
similar regulatory mechanism.  For example, domains of under-wound DNA on 
human chromosome 11 are significantly enriched for transcription, RNA polymerase 
II, open chromatin and DNaseI hypersensitivity when compared with relaxed or 
over-wound domains (Naughton et al., 2013a).  The inhibition of transcription by 
RNA polymerase II leads to a significant re-organisation of DNA supercoil structure 
at transcriptionally active regions, which corresponds to a more compact large-scale 
chromatin structure.  Furthermore, expression of Drosophila hsp70 following heat 
shock coincides with a localised under-winding of DNA structure and 
decondensation of the chromatin structure (Matsumoto and Hirose, 2004).  Together, 
these studies support a general mechanism in which domain scale DNA supercoil 
structure, transcription and chromatin accessibility are all inextricably linked for 
large-domains across the human and fly genome, a mechanism first proposed at  the 
chicken β-globin locus by Villeponteau et al. (1984).  One particularly attractive 
model is that these supercoil domains co-transcriptionally regulate neighbouring 
genes, with the activation of one gene having a direct influence on others through the 
dissipation of DNA supercoils.  This could account for the ‘transcription ripple 
effect’ observed by Ebisuya et al. (2008), in which the activation of a gene leads to a 
delayed increase in expression of neighbouring genes.  This ripple effect occurs over 
domains of ~100kb, remarkably similar in size to the supercoiling domains we have 
observed.  Also, the co-expression is independent of gene pair orientation, supporting 
the domain scale DNA superoil distribution (Naughton et al., 2013a), rather than the 
more focal supercoils generated by divergent transcription (Naughton et al., 2013b).  
Validating this model is beyond the scope of this thesis, but may provide a 
mechanism by which the observations of Ebisuya et al. (2008) can be explained. 
In addition to domains scale changes in DNA supercoiling, transcription alters DNA 
supercoiling at promoter regions.  Transcription at gene promoters is not restricted to 
the production of full-length mRNA, with extensive short RNA transcription 
occurring close to the TSS in the sense and anti-sense direction (Core et al., 2008; 
Preker et al., 2008; Seila et al., 2009).  In mammals ~80% of transcribed genes 
exhibit divergent transcription at the promoter, generating under-wound DNA 
supercoils into the promoter region.  This transcription could represent ‘sloppy’ 
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transcription initiation events or the generation of an under-wound DNA structure at 
the promoter region could be functional, as suggested by Seila et al. (2009).  
Supporting a model whereby the transcription of short RNAs alters promoter DNA 
structure, our lab has identified changes in promoter DNA supercoiling that are 
dependent on the transcription of short RNAs but not long RNAs (Naughton et al., 
2013b).  The resulting under-wound DNA structure may facilitate promoter 
unwinding and transcription. 
The identification of domains of DNA supercoiling in prokaryotes and eukaryotes 
indicates a conserved regulatory mechanism.  To establish how under-wound DNA 
facilitates transcription, transcription rate was measured for linear and supercoiled 
circular DNA containing the Bombyx mori fibroin gene at three different steps: 
transcription initiation, conversion to an elongation complex and subsequent 
elongation (Tabuchi and Hirose, 1988).  In this system, transcription initiation is 
much more rapid on an under-wound template compared to a linear DNA, whereas 
the rate of elongation is unaffected.  This is consistent with observations that under-
wound DNA facilitates the binding of transcription factors and the pre-initiation 
complex at many gene promoters (Mizutani et al., 1991a, 1991b; Tabuchi and 
Hirose, 1988).  This suggests that large-DNA supercoil domains may be set up and 
maintained for the preservation of DNA structure at gene promoter regions.  In 
support of this, promoter regions have been shown to have a distinct, generally 
under-wound structure in vivo (Jupe et al., 1993; Kouzine et al., 2013; Ljungman and 
Hanawalt, 1992, 1995; Naughton et al., 2013a).  Furthermore, the generation of an 
under-wound DNA structure by bivalent transcription at active gene promoters can 
additionally regulate promoter supercoiling at mammalian genes (Naughton et al., 
2013b; Seila et al., 2009).  
There are several possible mechanisms through which under-wound DNA facilitates 
transcription initiation and gene expression, although a general model for DNA 
supercoil dependent regulation is yet to emerge.  For example, under-wound DNA 
could promote the localised unwinding of the double helix upstream of the 
transcription start site, which is necessary for the production of a transcription bubble 
and subsequent transcription.  Conversely, the localised over-winding of DNA would 
49 
 
make unwinding at the transcription start site less energetically favourable and may 
negatively regulate gene expression.  Other supercoil dependent transitions in  DNA 
structure at promoter regions include the melting of the Far UpStream Element 
(FUSE) of the human c-myc gene (Kouzine et al., 2004, 2008).  The FUSE element is 
located 1.2 kb upstream of the transcription start site and unwinds when the gene is 
transcribed.  This occurs on both a circular and linear template, indicating that DNA 
supercoils can build up in the absence of local constraint.  The melting of the FUSE 
element by DNA supercoiling provides a substrate for the FUSE-binding protein 
(FBP) and the FUSE-interacting repressor (FIR) which modulate c-myc expression.  
The structure of FUSE is highly dynamic, with the unwound DNA structure lost 
within 10 seconds following transcription inhibition.  This provides the first specific 
example of DNA supercoiling as a real-time sensor and regulator of transcription and 
it is likely that many similar examples will be identified in the future.  Other general 
examples of DNA structures that occur preferentially on an under-wound template, 
and may therefore act as sensors/regulators of gene expression, include alternative 
DNA structures and Z-form DNA.  Alternative DNA structures such as cruciforms 
and G-quadruplexes   require the local unwinding of the DNA double helix to allow 
non-‘Watson and Crick’ base-pairing.   On the other hand, Z-form DNA is stabilised 
by under-wound supercoils without a loss of ‘Watson and Crick’ base interactions.  
The formation of these supercoil dependent DNA structures is most common in the 
vicinity of promoter elements, with G-quadruplex and Z-DNA motifs concentrated in 
these regions (Cer et al., 2011).  Furthermore, the identification of proteins that 
specifically bind these structures, such as ADAR1 with its specific Z-DNA binding 
domain(Herbert et al., 1997), supports the hypothesis that these DNA structures have 
regulatory potential.  Therefore, under-wound DNA supercoiling promotes the 
unwinding of the DNA double helix, particularaly at specialised motifs, which can 
influence expression directly, or through the formation of alternative DNA structure, 





1.2.5.2 Distribution of DNA supercoiling in vivo 
1.2.5.2.1  Domain scale distribution of DNA supercoiling 
As previously mentioned, the functional distribution of DNA supercoiling was first 
identified in E. coli, where the genome is maintained in a state of net unconstrained 
negative supercoils (Sinden et al., 1980).  The distribution of negative supercoils in 
the E. coli genome is dependent on the underlying looped rosette structure 
(Neidhardt and Curtiss, 1999), which organises the genome into around 50 distinct 
supercoiling domains of around 100 kb (Sinden and Pettijohn, 1981).  Variable 
supercoiling within each looped domain is thought to contribute to the coordinated 
expression of neighbouring genes.  To test this in E. coli Peter et al. (2004) identified 
300 ‘supercoiling sensitive genes’ by analysing gene expression changes following 
topoisomerase inhibition.  Monitoring the expression of these genes following DNA 
relaxation by restriction enzyme digestion of DNA in vivo identified that genes 
within ~11 kb of each other are typically co-transcriptionally regulated in a 
supercoiling dependent manner (Postow et al., 2004).  This range can encompass 
several genes, which in E. coli have an average length of ~1 kb and are organised at a 
high gene density (Blattner et al., 1997).  These 11 kb domains are substantially 
smaller than the 50-100 kb topological loops, supporting the model proposed by 
Jeong et al. (2004) that the E. coli genome is structured as large scale supercoiling 
domains (~100 kb) and more transient smaller scale supercoiling domains (~10 kb) 
that co-exist to regulate transcription at different levels.  The transience of the 
smaller loops is further supported by the absence of defined boundaries in the 10 kb 
domains (Postow et al., 2004).  Together this data indicates that in E. coli, domains 
of altered DNA supercoiling exist at different scales and regulate gene expression in 
vivo. 
The functional distribution of supercoiling in eukaryotes has been more difficult to 
establish, due to the added complexity of different levels of chromatin organisation.  
Early studies comparing the supercoiling in Drosophila and E. coli genomes 
concluded that no net unrestrained supercoiling is present in eukaryotic genomes 
(Sinden et al., 1980).  Instead, the DNA supercoiling of eukaryotic genomes was 
thought to be predominantly constrained by histone proteins.  Stripping histone 
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proteins from Drosophila DNA leaves one negative supercoil per 200 bp, the same 
net supercoil density as in E. coli, indicating a conserved net supercoil density 
between species (Benyajati and Worcel, 1976).  Furthermore, the partial relaxation of 
constrained supercoils by DNAaseI in histone depleted Drosophila genomes 
identifies that distinct ~85 kb  domains of DNA occur in eukaryotes (Benyajati and 
Worcel, 1976), similar to the large scale structural domains observed in E. coli 
(Sinden and Pettijohn, 1981).  This data suggests a conserved large-scale genome 
structure, but that unconstrained DNA supercoiling and the associated regulatory 
mechanisms are a primarily prokaryotic phenomenon. 
The identification of micro-domains of negatively supercoiled DNA at eukaryotic 
gene promoter and enhancer elements using psoralen suggested that the importance 
of unrestrained DNA supercoils in eukaryotic gene regulation had been 
underestimated by previous studies (Jupe et al., 1993; Ljungman and Hanawalt, 
1992, 1995).  Psoralen is a planar molecule that preferentially intercalates with 
under-wound DNA (Bermúdez et al., 2010) and forms covalent cross-links with the 
DNA upon UV exposure (Cech and Pardue, 1977) (Section 5.1).  Localised 
enrichments for under-wound DNA were identified at promoters in human 
(Ljungman and Hanawalt, 1992), fly (Jupe et al., 1993) and hamster (Ljungman and 
Hanawalt, 1995).  Extending the use of psoralen to identify the relative distribution 
of unrestrained DNA supercoils across eukaryotic genomes identified large scale 
domains similar to those observed in prokaryotes.   In general, the preferential 
intercalation of psoralen is two-fold enriched in under-wound DNA (Kouzine et al., 
2013; Naughton et al., 2013a) and therefore remained undetectable at most loci prior 
to immunofluorescence studies or high resolution, large scale 
immunoprecipitation/array based approaches.  Initial observations of psoralen 
enrichment by immunofluorescence in Drosophila polytene chromosomes identified 
~150 domains of enriched psoralen binding that are lost upon nicking or transcription 
inhibition (Matsumoto and Hirose, 2004).  In this study the authors indicate that the 
under-wound DNA accounts for only a minority of the genome, although their assay 
is based on the lowest observable threshold of fluorescence and is likely to identify 
only the most intense peaks of under-wound DNA.  To identify the relative 
distribution of supercoiling at high resolution, the relative enrichment of psoralen 
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was measured across the genome of yeast using tiling microarrays (Bermúdez et al., 
2010).  Yeast cells were incubated with psoralen, UV cross-linked and the extracted 
DNA denatured and digested with exonucleases to leave only the DNA cross-linked 
by psoralen molecules, which were hybridised to tiling microarrays.  Using this 
technique a domain scale change of ~100 kb was observed between wild type and 
topoisomerase depleted cells, indicating that topoisomerases can remodel the DNA 
structure of large domains in eukaryotes.  This analysis supports the presence and 
regulation of unrestrained DNA supercoils in eukaryotic cells, but is at a relatively 
low resolution, with one probe every 2 kb (i.e. less than one per gene), and fails to 
take into account the well documented sequence preference of psoralen (e.g. Kanne 
et al., 1982).  To further investigate the distribution of DNA supercoiling in the 
human genome our lab has developed a different approach based on the pull-down of 
a bTMP molecule (Naughton et al., 2013a).  In this methodology bTMP (Saffran et 
al., 1988) is incubated with live cells, photo-crosslinked with UV light and the DNA 
isolated, purified, pulled-down with avidin and hybridised to Agilent tiling 
microarrays.  The data is truly ‘high resolution’, with 50 bp probes spaced every 100 
bases, and covers 20 Mb of the human genome encompassing gene rich, gene poor 
and other regions hypothesised to be influenced by DNA supercoiling state.  
Domains of over-wound, under-wound and stable DNA were identified across the 
loci, with a median size of ~100 kb.  These DNA supercoiling domains are relieved 
with the introduction of DNA nicks by bleomycin and are maintained by 
transcription and topoisomerase activity.  Under-wound DNA domains correspond to 
transcriptionally active open chromatin whilst over-wound domains are 
transcriptionally inactive, supporting the in vitro models of transcription regulation.  
Together, this data in fly, yeast and human indicates that unrestrained supercoils are 
pervasive in eukaryotic genomes and are maintained by transcription and 




1.2.5.2.2  Organisation of DNA supercoiling around gene 
promoters 
The presence of unrestrained supercoiling in the genomes of eukaryotes has reignited 
an interest in the role of DNA supercoiling in gene regulation.  The regulation of 
transcription initiation at gene promoters has been demonstrated to be the primary 
influence of DNA supercoiling (Section 1.2.5.1) supported by several studies that 
have identified an under-wound DNA structure at active and poised promoters (Jupe 
et al., 1993; Ljungman and Hanawalt, 1992, 1995).  To identify the general DNA 
structure of gene promoters, two recent studies have performed a meta-analysis of 
psoralen distribution over a large number of promoter regions (Kouzine et al., 2013; 
Naughton et al., 2013a).  Our lab performed a meta-analysis of the promoters of 584 
human genes, identifying a general under-wound DNA structure which is more 
enriched at transcriptionally active genes (Naughton et al., 2013a).  This under-
wound structure is lost when the DNA is nicked with bleomycin and in the presence 
of transcription or topoisomerase inhibitors.  Supporting this, a recent analysis of 445 
gene promoters also identifies an enrichment for under-wound DNA at gene 
promoters that is more pronounced in transcriptionally active genes (Kouzine et al., 
2013).  Together these studies support a specialised DNA supercoiling structure at 
gene promoters, but so far the scope is too limited to uncover specific classes of 









1.3 DNA structure, topoisomerases and disease 
 
1.3.1  DNA structure and disease 
DNA supercoiling and topoisomerases are important factors in human disease.  The 
best defined example of the relationship between DNA structure and disease is in 
neurological disorders characterised by tri- and tetra-nucleotide repeat expansions, 
including myotonic dystrophy type 1 (DM1), myotonic dystrophy type 2 (DM2), 
fragile X-syndrome and Friedreich ataxia (Bacolla and Wells, 2009).  In these 
diseases a massive expansion of repeat sequences occurs at rare fragile sites, which 
do not encode genes but have the potential to form hairpin, triplex and quadruplex 
structures.  The instability and mutagenic effects associated with this repeat 
expansions have been shown to be a direct consequence of alternative DNA structure 
formation (Wojciechowska et al., 2006).  Furthermore, DNA supercoiling can build 
up in the inherently flexible triplet repeat regions and it has been suggested that DNA 
supercoiling mediates the expansion of these repeat regions (Gellibolian et al., 1997).   
Other unstable sequences that are associated with alternative DNA structure include 
common fragile sites (CFSs).  CFSs sites are chromosome regions that reproducibly 
form breaks, constrictions, gaps or fail to compact upon partial replication inhibition 
(Lukusa and Fryns, 2008).  DNA within fragile sites is highly flexible and has a 
propensity to form alternative DNA structures (Burrow et al., 2010).  The high DNA 
flexibility at CFSs may allow the build-up of DNA supercoils, as hypothesised at 
rare fragile sites (Gellibolian et al., 1997), which could abrogate topoisomerase 
function causing strand breakage (Lukusa and Fryns, 2008).  CFSs form a normal 
component of the chromatin structure and are conserved in mouse and chicken 
(Helmrich et al., 2006; Le Tallec et al., 2013), although why a conserved chromatin 
structure forms frequent breaks and rearrangements under replication stress is not 
well understood.  In human cells there 88 documented common fragile sites (CFSs), 
which are associated with deletions and rearrangements in various cancer types, 
autosomal recessive juvenile Parkinsonism and Duchenne muscular dystrophy 
(Lukusa and Fryns, 2008; Mitsui et al., 2010).  The complement of CFSs expressed 
following partial replication stress varies between cell types, with FRA3B and 
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FRA16D being the most common CFSs in lymphoblastoid cells and sites at 3q13.3 
and 1p31.1 being most common in fibroblasts (Le Tallec et al., 2011).  This indicates 
that the expression of CFSs has an epigenetic component, with sequence, replication 
and other molecular characteristics indicating a role for DNA supercoiling (Section 
5.1).  To better understand how DNA supercoiling influences CFSs, it is therefore 
important to map the distribution and maintenance of DNA supercoiling at these loci. 
 
1.3.2  Topoisomerases and disease 
Topoisomerases have been implicated in scleroderma, an auto-immune disease 
characterised by lesions of the skin and in severe cases internal organs (Gabrielli et 
al., 2009).  In patients with the Scl-70 disease sub-type, antibodies to topoisomerase I 
are found at high concentrations in the blood (Guldner et al., 1986).  In other patient 
sub-types, antibodies to other proteins important for DNA supercoiling and 
chromatin structure have been identified including RNA polymerase, topoisomerase 
II and centromeric proteins (Gabrielli et al., 2009).  Why these patients have 
antibodies to these proteins is unknown, although the different symptoms and 
features of genome instability presented by patients with different autoantibodies 
suggests a direct role for the antibody in the disease phenotype (Gabrielli et al., 2009; 
Jabs et al., 1993).  For example, peripheral blood lymphocytes from scleroderma 
patients with anti-centromere antibodies show significantly higher aneuploidy than 
patients without anti-centromere antibodies or controls (Jabs et al., 1993).  However, 
a specific molecular or cytological phenotype for scleroderma patients with anti-
topoisomerase antibodies has not been determined and the function of these 
antibodies in scleroderma patients is unknown. 
Topoisomerases have also been critical in the treatment of diseases, in particular 
cancer.  Topoisomerase activity is essential in rapidly dividing cells (Section 
1.2.4.2), therefore topoisomerase inhibitors have been used extensively as a target in 
chemotherapy (Nitiss, 2009b; Pommier, 2006).  Topoisomerase poisons act in 
several ways to prevent relaxase and decatenase activities by inhibiting 
topoisomerase I or topoisomerase II enzyme activity.  The topoisomerase I inhibitors 
based on camptothecin and indenoisoquinolines trap the enzyme in a covalent 
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complex with DNA that prevents the religation of the nicked DNA helix, trapping 
the enzyme on the DNA (Pommier, 2006).  The mechanisms of topoisomerase II 
inhibition are more varied, with molecules that prevent the opening of the protein to 
allow the binding of the first (aclarubicin) or second (ICRF-187) DNA strand, those 
that prevent the formation of a double strand break (melbarone) or those that prevent 
the release of the strand passed through the double strand break (etoposide) (Nitiss, 
2009a).  In the laboratory, these drugs have been particularly useful for identifying 


















1.4 Thesis aims 
The relationship between DNA supercoiling, transcription and gene expression is 
well characterised in vitro and in transfected plasmids (Dunaway and Ostrander, 
1993; Ma et al., 2013a; Weintraub et al., 1986), but the distribution and function 
within the human genome is largely uncharacterised.  DNA with a more under-
wound structure has a higher rate of transcription and the polymerase pauses less 
frequently and for a shorter duration (Ma et al., 2013a).  Furthermore, under-wound 
DNA promotes the binding of transcription factors, the formation of a pre-initiation 
complex and transcription initiation (Kouzine et al., 2008; Mizutani et al., 1991a, 
1991b; Tabuchi and Hirose, 1988).  These properties indicate that under-wound 
DNA supercoiling can facilitate transcription initiation and gene expression. 
The characterised presence of DNA supercoiling in the human genome was, until 
recently, limited to a small number of promoter regions (Ljungman and Hanawalt, 
1992).  This was due to insufficient large-scale techniques for the study of DNA 
structure in vivo.  Recent work in our lab has used bTMP pull-down and microarray 
analysis to identify large DNA supercoil domains and smaller scale promoter 
enrichments in the human genome (Naughton et al., 2013a).  Using this technique it 
was demonstrated that both domain-scale and promoter-scale DNA supercoil 
distributions are dependent on transcription and topoisomerase activity.  However, to 
date the distribution of topoisomerase I, IIα and IIβ enzymes in the human genome 
have been poorly characterised (Cowell et al., 2012; Khobta et al., 2006; Kouzine et 
al., 2013).  I have undertaken a detailed study of topoisomerase distribution by 
chromatin immunoprecipitation and microarray analysis (ChIP-chip) (Chapter 3).  I 
have analysed the distribution of topoisomerases over large-scale regions and around 
gene promoters to identify their relationships with each other, DNA supercoiling, 
RNA polymerase II and sequence. 
DNA supercoiling has been shown to primarily influence gene expression through 
increased transcription initiation (Tabuchi and Hirose, 1988).  Recent analyses of 
several hundred gene promoters have identified a transcription and expression 
dependent enrichment of under-wound DNA around the transcription start site, 
supporting this model of gene regulation (Kouzine et al., 2013; Naughton et al., 
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2013a).  To identify genome-wide the distribution and regulatory potential of DNA 
supercoiling at gene promoters, bTMP pull-down experiments were performed and 
hybridised to genome wide promoter microarrays.  I have analysed this data with 
respect to known and novel properties of gene promoters to characterise the 
relationship between DNA supercoiling, sequence distribution and gene expression 
(Chapter 5).   
In addition to a role in gene expression, DNA supercoiling has been indirectly 
implicated in regions of genome instability called common fragile sites (CFSs).  
Properties of CFSs include the convergence of DNA supercoil generating replication 
forks, enrichment for AT-rich flexible DNA that can absorb DNA supercoils  and  
the formation of alternative structures which are stabilised in supercoiled DNA 
(Gellibolian et al., 1997; Letessier et al., 2011; Lukusa and Fryns, 2008; Le Tallec et 
al., 2011, 2013; Zlotorynski et al., 2003).  To determine experimentally if changes in 
DNA supercoiling are associated with expressed CFS, I have performed bTMP pull-
down experiments under conditions that express FRA3B and FRA16D and 
hybridised these to tiling microarrays covering these CFSs (Chapter6).  Through an 
analysis of the ‘core’ and ‘flanking’ regions of FRA3B and FRA16D fragility, I have 











2.  Materials and methods 
 
2.1  Common reagents, stock solutions and buffers 
Acrylamide – 30% stock solution of 29:1 acrylamide/bisacrylamide were purchased 
from Severn Biotech ltd. 
Carnoy’s fixative 75% methanol 25% acetic acid. 
Chloroform:Isoamyl Alcohol comprised of chloroform and isoamyl alcohol mixed at 
a ratio of 24:1. 
Coomassie Brilliant Blue Stain – 45% methanol, 10% glacial acetic acid and 0.05% 
Coomassie Blue R250. 
Coomassie Brilliant Blue Destain – 10% glacial aceitic acid and 10% methanol. 
DNA Loading Buffer – 5x TBE, 40% sucrose, 0.1% orange G 
DNA Markers – 100 bp ladder (NEB) was dissolved at 500 µg/ml in 1x DNA 
Loading Buffer.  500 ng – 1 µg was normally loaded per lane. 
EDTA – Ethyl diamine-tetraaceitic acid (disodium salt) was dissolved at 0.5 M in 
distilled water and adjusted to pH8.0 with NaOH. 
Genomic Lysis Buffer – 150 mM NaCl, 10 mM EDTA pH 8.0, 0.5% SDS. 
Gentle Lysis Buffer – PBS supplemented with 5 mM EDTA, 0.5% Triton X-100, 
250 μM PMSF, 1 mM DTT and NaCl to a final concentration of 150 mM-1 M. 
Maleic Acid Buffer – 100 mM maleic acid, 150 mM NaCl, adjusted to pH7.5 with 
solid NaOH. 
MOPS Running Buffer – 50 mM MOPS, 50 mM Tris-HCl pH 7.6, 1 mM EDTA, 
0.1% SDS. 
PBS – Dublecco’s PBS.  Comprised 10 mM phosphate, 0.137 M NaCl, 27 mM KCl.  
Solution sterilised by autoclaving. 
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Phenol:Chloroform:Isoamyl alcohol - phenol, chloroform and isoamyl alcohol mixed 
at a ratio of 25:24:1. 
Proteinase K was dissolved at 50 mg/ml in 50 mM Tris-HCl (pH 7.5), 2.5 mM CaCl2 
and 50% glycerol and stored at -20°C. 
Semi-Dry Transfer Buffer – 24 mM Tris-HCl pH7.6, 192 mM glycine, 10% SDS, 
20% methanol. 
SDS Lysis Buffer – 50 mM Tris-HCl pH 6.8, 1% β-mercaptoethanol, 2% SDS, 0.1% 
bromophenol blue, 10% glycerol. 
Sonication Buffer – 5 M urea, 2 M NaCl. 
SDS – 10% and 20% stocks were prepared in distilled water. 
Sodium Acetate – 3 M pH 5.2 
SSC (20x stock) – 3 M NaCl, 0.3 M sodium citrate. 
TBE Buffer (10x stock) – 500 mM Tris-borate, 1 mM EDTA. 
TBS-T – 137 mM NaCl, 2.7 mM KCl, 25 mM Trsi-HCl pH 7.6, 0.1% Tween 20. 
TE Buffer – 10 mM Tris-HCl pH 7.6, 1 mM EDTA. 
TEEP20N – 10 mM Tris-HCl pH 7.6, 0.5 mM EDTA, 0.5 mM EGTA, 0.25 mM 
PMSF, 0.05% NP40, 20 mM NaCl. 
TEEP80N – 10 mM Tris-HCl pH 7.6, 0.5 mM EDTA, 0.5 mM EGTA, 0.25 mM 
PMSF, 0.05% NP40, 80 mM NaCl. 






2.2 Cell culture 
 
The cell lines used were human retinal pigmented epithelial (RPE1) and human 
lymphoblastoid (SWEIG and Neo3) cells.  Cells were maintained at 37°C in a 
humidified atmosphere containing 5% CO2.  RPE1 cells were cultured in Roswell 
Park Memorial Institute media (RPMI, Invitrogen) supplemented with 3 mM 
glutamine, 10% FCS, 100 U/ml penicillin, 100 μg/ml streptomycin, 8.1 mg/L phenol 
red, 2 mg/ml pyruvate, 6 mg/ml oxalacetic acid, 1x MEM non-essential amino acids 
(Invitrogen) and 3.75 mM MOPS.  Neo3 and Sweig cells were cultured in Dubleco’s 
modified eagle media/nutrient mixture F12 (DMEM/F12, Invitrogen) supplemented 
with 3 mM glutamine, 0.34% sodium bicarbonate, 10% heat-inactivated fetal calf 
serum, 100 U/ml penicillin, 100 μg/ml streptomycin and 8.1 mg/L phenol red.  Fetal 
calf serum (FCS) provides basic nutrients, hormones and growth factors.  All cell 
culture manipulations were undertaken in a laminar flow hood.  To avoid bacterial 
and fungal contamination of the cell cultures, all objects and surfaces were sprayed 
with 70% ethanol before use. 
 
2.2.1  Passaging cells 
All media and solutions were pre-warmed to 37°C in a water bath before use.  For 
adherent cells (RPE1) the culture medium was aspirated and the cells rinsed in PBS.  
Trypsin/Versene solution was added to cover the cells and the cultures incubated at 
37°C until the cells detached.  The flasks were tapped to ensure complete 
dissociation of cells from the surface and checked visually with a microscope.  
Culture medium was added to inactivate the trypsin and the cell clumps dissociated 
by gentle pipetting.  The cells were transferred to a 15 ml Falcon tube and pelleted by 
centrifugation (1200 rpm, 4 minutes, room temperature in a benchtop centrifuge).  
The cell pellet was resuspended in 5 ml fresh culture medium and re-seeded at a 
suitable density.   
For non-adherent cells (SWEIG, Neo3) the suspension was transferred to a 15 ml 
Falcon tube, dissociating cell clumps by pipetting, and pelleted by centrifugation.  To 
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wash the cells the pellet was resuspended in 5 ml PBS and re-pelleted by 
centrifugation.  The cell pellet was resuspended in 5 ml complete medium, cells 
werecounted using a Coulter Particle Count and Size Analyser, and adjusted to give a 
density of 300,000 cells/ml.   
 
2.2.2  Cryopreservation and liquid nitrogen recovery 
Cells were harvested as described in Section 2.2.1 and the pellet resuspended in 1 ml 
Freezing Media (10% DMSO, 90% fetal calf serum) per 3 million cells.  The cells 
were frozen in 1 ml aliquots, initially at -80°C for 24 hours before being transferred 
to liquid nitrogen for long term storage.  To recover cells from liquid nitrogen 
aliquots were rapidly defrosted in a 37°C water bath, added to pre-warmed media in 
a small flask and cultured. 
 
2.2.3  Drug treatment 
To dissect the molecular basis of RNA polymerases, topoisomerases and common 
fragile sites, cells were treated with a number of inhibitors.  To stall topoisomerases 
prior to chromatin immunoprecipitation the topoisomerase I inhibitor camptothecin 
(5 μM) and the topoisomerase II inhibitor ICRF193 (35 μM; Biomol) were added to 
cells for 3 hours.  To inhibit transcription α-amanitin (50 µg/ml) was added to cells 
for 5 hours and wash-out samples were taken 3 hours after replacing the media 
following α-amanitin treatment.  To express common fragile sites low concentrations 
of the DNA polymerase inhibitor aphidicolin was added to cells for 24 hours (0.4 
µM for RPE1 cells, 0.6 µM for Neo3 cells) and to arrest cells at metaphase the 






2.3  DNA preparation and analysis 
 
2.3.1  Genomic DNA preparation 




 cultured cells.  Cells were 
harvested as described and resuspended in 500 μl PBS.  An equal volume of 2x 
Genomic Lysis Buffer was added and incubated at room temperature for 10 minutes.  
The sample was treated with RNAase A/T1 (40 µg/ml RNAase A, 100 U/ml 
RNAaseT1) and incubated at 37°C for 30 min, followed by proteinase K (200 μg/ml) 
at 50°C overnight.  The following day the samples were extracted twice with 
phenol:chloroform by adding an equal volume of 25:24:1 
Phenol:Chloroform:Isoamyl Alcohol (minimum sample size 100 μl), inverting to 
mix, and incubating on ice for 5 min.  The sample was centrifuged at 14,000 rpm for 
5 min at room temperature in a bench top centrifuge.  The DNA-containing aqueous 
phase was transferred to a fresh tube, leaving peptides in the residual phenol.  To 
remove residual phenol an equal volume of chloroform:isoamyl alcohol was added to 
the sample, incubated on ice and centrifuged.  DNA was precipitated by adding 
NaAc to 0.3 M, 2-2.5 volumes of EtOH and glycogen (1 µg/µl) as carrier, mixing 
thoroughly by inversion and incubating for > 30 min on dry ice or overnight at -
20°C.  To pellet the precipitated DNA, samples were centrifuged at 14,000 rpm for 
30 min at room temperature in a benchtop centrifuge.  To removed salts the pellet 
was washed once in 70% ethanol and centrifuged at 14,000 rpm for 5 min.  The 
supernatant was removed and the pellet air dried, followed by re-suspension in ultra-
pure water (MilliQ) or TE buffer.  
 
2.3.2  DNA quantification 
DNA sample concentration and purity was assessed using a nanodrop 
spectrophotometer.  The A260 value was used to calculate the sample concentration, 
with 1A260 equivalent to 50 μg/ml of double stranded DNA.  The spectrum of 




2.3.3  Agarose gel electrophoresis 
DNA preparations were size fractionated by horizontal gel electrophoresis through 1-
2 % agarose gels in TBE Buffer.  Buffers were supplemented with 0.5 μg/ml 
ethidium bromide and electrophoresed at 90 V for approximately one hour.  DNA 
samples were loaded in 1x DNA Loading Buffer alongside 1 Kb or 100 bp standards.  
The DNA was imaged following electrophoresis on a UV transilluminator or laser 
scanner (Fuji FLA5100).   
 
 
2.4 Protein preparation and analysis 
 
2.4.1  Preparing protein extracts 
Whole cell protein extracts were prepared by washing cells in PBS then lysing with 
1x SDS Lysis Buffer in the plate.  The cells were recovered by scraping and were 
transferred to a 1.5 ml Eppendorf tube, boiled at 95°C for 5 minutes to inactivate 
proteases and sonicated to solubilise (5 seconds, 5 μ). 
 
2.4.2  Poly-acrylamide gel electrophoresis (SDS-PAGE) 
Protein lysates were analysed Bis-Tris acrylamide gels constructed in 1.0 mm thick 
plastic cassettes with a twelve well comb.   First a resolving gel was prepared with 
7%, 10% or 12% 29:1 acrylamide/bis-acrylamide in resolving buffer (357 mM Bis-
Tris pH 8.0, 1:5000 ammonium perisuphate (APS), 1:500 
tetramethylethylenediamine(TEMED)).  The gel solution was poured into the 
cassette and a water saturated butanol overlay carefully applied.  Once the gel was 
set (30 minutes) the butanol overlay was flushed.  A stacking gel was prepared (5% 
29:1 acrylamide/bis-acrylamide, 357 mM Bis-Tris pH 8.0, 1:1250 APS, 1:333 
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TEMED) and poured on top of the resolving gel.  A gel comb was placed in the top 
of the gel and allowed to set (5 minutes).  The gel was mounted in the electrophoresis 
apparatus in MOPS Running Buffer.  The comb was removed and the wells were 
flushed.  Protein samples in 1x SDS Lysis Buffer and size standards were applied to 
the wells of the gel and electrophoresed, typically at 200 V for 1 hour.  To assess 
protein sample quality and relative concentration between samples, proteins were 
stained with Coomassie brilliant blue. 
 
2.4.3  Western blotting 
To analyse specific proteins the fractionated protein samples were transferred from a 
gel to a polyvinylidene fluoride (PVDF) membrane by either wet transfer (> 90 KDa) 
(Amersham Transphor Unit) or semi-dry transfer (< 90 KDa) (BioRad Transblot 
SD).  The PVDF membrane was soaked briefly in methanol before washing in Wet- 
or Semi-Dry- Transfer Buffer.  The transfer apparatus was then assembled in the 
appropriate Transfer Buffer.   
For antibody probing the membranes were blocked with 5% non-fat dry milk protein 
(Marvel) in TBS-T for 1 hour at room temperature.  Membranes were incubated in 
primary antibody diluted in block for 1 hour at room temperature or overnight at 
4°C.  To remove unbound primary antibody membranes were washed 3x 10 minutes 
in TBS-T.  Membranes were then incubated with a horseradish peroxidase (HRP) 
conjugated secondary antibody in block for 1 hour at room temperature.  Membranes 
were again washed 3x for 10 minutes in TBS-T to remove non-specific binding.  The 
signal was visualised using chemiluminesence (ECL, Thermo Scientific).  An equal 
volume of each ECL solution was added to the membrane and incubated at room 
temperature for 1 minute.  The membrane was exposed to film (Fuji) and developed. 
 
2.4.4  Immunofluoresence 
To analyse the distribution of specific proteins in cells, cells were fixed, probed with 
antibodies to the protein of interest and imaged by fluorescent microscopy.  Adherent 
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cells were seeded onto sterile glass slides and grown for 24 hours, whilst non-
adherent cells were cytospun onto slides following the manufacturer’s instructions 
(Thermo Cytospin).  Slides were washed gently with PBS and the cells fixed in 4% 
paraformaldehyde (PFA) for 7 minutes rocking at room temperature.  Fixed slides 
were washed 3x 5 minutes in PBS and the cell/nuclear membranes permeabilised 
with 0.2% Triton X100 for 10 minutes.  Slides were again washed 3x 5 minutes in 
PBS.  To block non-specific binding cells were incubated in 5% horse serum (HS) 
for 30 minutes under parafilm in a humidified chamber.  Primary antibodies were 
diluted 1:50 in 5% HS and applied to the slides which were incubated overnight 
under parafilm in a humidified chamber.  The following day slides were rinsed 3x for 
5 minutes in PBS and incubated for 1 hour in secondary antibody diluted 1:100 in 
5% HS.  Slides were mounted in Vectashield and DAPI (500 ng/ml) and sealed with 
rubber cement (Pang).  After 1 hour the slides were imaged by fluorescent 
microscopy (Zeiss) at 40x or 100x magnification, using IPLab software to control the 
microscope. 
   
 
2.5 Chromatin preparation and analysis 
 
2.5.1  Salt extraction method   
To characterise the stability of protein-DNA interactions in chromatin a salt 
extraction method was used.  Adherent cells were seeded into 10 cm Petri dishes and 
grown overnight to 80% confluency.  If required, the cells were first fixed at a range 
of formaldehyde concentrations for 10 minutes.  Cells were washed in ice cold PBS 
and incubated in 1.2 ml Gentle Lysis Buffer supplemented with NaCl to the required 
final concentrations (either 150 mM, 300 mM, 500 mM, 750 mM or 1 M) for 30 
minutes at 4°C.  Cell lysates were transferred to a 1.5 ml Eppendorf tube with a cell 
scraper and centrifuged at 14,000 rpm for 15 minutes at 4°C in a benchtop 
centrifuge.  The supernatant containing the soluble sample was transferred to a new 
tube and the insoluble sample was resuspended in 1.2 ml ice cold lysis buffer.  A 50 
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μl sample of the ‘chromatin associated’ and ‘free’ protein was combined with 2x 
SDS Loading Buffer, incubated at 95°C for 5 minutes, sonicated and analysed by 
SDS-PAGE and western blotting.       
  
2.5.2  Chromatin preparation by sucrose gradient 
sedimentation 
2.5.2.1  Nuclei preparation 
To isolate nuclei cell membranes were lysed under conditions that leave the nuclear 
membrane intact.  Cells were harvested as described and pellets resuspended in 5 ml 
ice cold NBA Buffer (85 mM KCl, 10 mM Tris-HCl pH 7.6, 5.5% sucrose, 0.5 mM 
spermidine, 0.2 mM EDTA, 0.25 mM PMSF).  To lyse the cell membranes 5 ml of 
ice cold NBB Buffer (85 mM KCl, 10 mM Tris-HCl pH 7.6, 5.5% sucrose, 0.5 mM 
spermidine, 0.2 mM EDTA, 0.25 mM PMSF, 0.2% NP40) was added and the 
solution incubated on ice for 3 minutes, inverting periodically to mix.  Nuclei were 
pelleted by centrifugation at 2500 rpm for 4 minutes at 4°C.  The supernatant was 
aspirated and the pellet resuspended in 5 ml NBR Buffer (85 mM KCl, 10 mM Tris-
HCl pH 7.6, 5.5% sucrose, 0.5 mM MgCl2, 1.5 mM CaCl2, 0.25 mM PMSF).  The 
nuclei were again centrifuged at 2500 rpm for 4 minutes at 4°C and the pellet 
resuspended in 200 μl NBR Buffer.  The concentration of nuclei was determined by 
adding 5 μl of nuclei in NBR to 95 μl NBR Buffer and incubated with 1 μl DNaseI 
(100 µg/ml) for 5 minutes at room temperature.  To this fragmented DNA sample 
400 μl of Sonication Buffer was added and the DNA concentration measured using a 
spectrophotometer.  
 
2.5.2.2  Preparation of soluble chromatin 
To prepare soluble chromatin nuclei were adjusted to 20 A260 and 1 ml aliquots were 
RNase treated (10 minutes, room temperature) and the DNA briefly digested with 10 
U/ml MNase at room temperature for 10 minutes.  To inactive the MNase 20 mM 
EDTA was added and the nuclei were pelleted by centrifugation at 5000 rpm for 30 
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seconds.  The supernatant was discarded and the nuclei resuspended in 850 μl 
TEEP20N Buffer and left overnight at 4°C to release soluble chromatin.  Soluble 
chromatin was recovered by taking the supernatant following centrifugation at 
13,000 rpm for 5 minutes at 4°C. 
 
2.5.2.3  Sucrose gradient sedimentation 
To purify soluble chromatin samples were centrifuged onto a 50% sucrose cushion in 
TEEP80N Buffer.  To prepare sucrose gradients 1.5 ml 50% sucrose in TEEP80N 
was pipetted into an SW55 (Beckman) tube and 10% sucrose in TEEP80N layered 
carefully on top.  A chromatin sample up to 1 ml was carefully layered on top of the 
gradient.  The sample was centrifuged at 50,000 rpm for 50 minutes at 4°C in an 
ultracentrifuge.  Following centrifugation samples were fractionated by upwards 
displacement into 12 aliquots, with the first aliquot taken from the top (i.e. lowest 
sucrose density).  The relative concentration of DNA in each sample was measured 
by UV absorbance at 260 nm during the fractionation and the peak fractions 
containing the chromatin were stored at 4°C for further analysis. 
 
2.5.3  Chromatin immunoprecipitation (ChIP) 
2.5.3.1 Sonicated chromatin preparations 
To investigate the distribution of proteins on DNA in cells the ChIP technique was 
used.  For each condition cells were seeded in duplicate into 10 cm Petri dishes and 
grown to 80% confluency.  To stabilise protein-DNA interactions cells were cross-
linked with 0.5% formaldehyde for 10 minutes at room temperature.  To quench the 
unreacted formaldehyde 100 mM glycine was added and the cells incubated for 5 
minutes.  Cells were washed twice in ice cold PBS and transferred to a 1.5 ml 
Eppendorf tube using a cell scraper.  Cells were pelleted by centrifugation at 2,000 
rpm for 4 minutes at 4°C.  The supernatant was removed and the pellets were 
resuspended in 200 μl ChIP Lysis Buffer.  Duplicate plates were combined to give a 
total of 400 μl and the chromatin fragmented by 13 rounds of 30 seconds on/off 
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sonication at 2 μ on ice (Soniprep 150 probe sonicator, MSE).  Following sonication 
cell debris was recovered by centrifugation at 14,000 rpm for 15 minutes at 15°C and 
the supernatant divided into two 200 μl aliquots as technical replicates.  Chromatin 
samples were used immediately or stored at -20°C. 
 
2.5.3.2 Immunoprecipitation 
Sonicated chromatin samples were diluted in 1300 μl ChIP Dilution Buffer and a 50 
μl aliquot taken as ‘input’.  Chromatin samples were pre-cleared for 1 hour by 
rotating at 4°C with rabbit immunoglobulins and immunogen coated beads 
appropriate for the specific primary antibody used and blocked with salmon sperm 
DNA.  The beads were separated from the supernatant using a magnetic rack 
(Dynabeads) or centrifugation at 2000 rpm for 2 minutes (agarose beads) and the pre-
cleared chromatin supernatant was transferred to a new 2ml tube.  To 
immunoprecipitate a specific protein of interest, 50 μl of primary antibody and 50 μl 
of appropriate beads were added to the chromatin sample and incubated at 4°C 
overnight on a wheel. 
The following day non-specific protein associations were washed from the beads by 
successive 5 minute incubations at 4°C in TSEI, TSEII, Buffer 3 and twice in TE.  
Bound chromatin was eluted by incubating the beads in 250 μl of ChIP Elution 
Buffer for 30 minutes at room temperature.  The beads were separated from the 
supernatant and transferred to another 1.5 ml Eppendorf tube.  A second elution from 
the beads in 200 μl ChIP Elution Buffer for 15 minutes was combined with the first, 
giving the immunoprecipitated chromatin sample. 
 
2.5.3.3 DNA purification and microarray hybridisation 
To reverse the DNA-protein formaldehyde cross-links samples and inputs were 
incubated in 200 mM NaCl for 6 hours at 65°C.  To purify the DNA samples were 
treated with proteinase K (100 μg/ml) for 1 hour at 55°C and purified using a Qiagen 
MinElute PCR purification kit, following the manufacturer’s instructions and eluting 
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in 10 μl of PCR grade water.  Input DNA concentrations were measure at 260 nm 
and diluted to 3 ng/μl.  Samples and 10 μl of diluted inputs were whole genome 
amplified (Sigma GenomePlex) following the manufacturer’s instructions.  
Amplified DNA samples were quantified and visualised by agarose gel 
electrophoresis.  If necessary the samples were re-amplified (Sigma GenomePlex re-
amplification).  Amplified ChIP samples and inputs were sent to the VUMC 
microarray facility for random prime labelling with Cy3 or Cy5 (ENZO) and 
microarray hybridisation.  Following hybridisation and washing following the 
manufacturer’s instructions slides were scanned on an Agilent Microarray scanner at 
2 micron resolution, generating a TIFF file for analysis by Agilent feature extraction 
software.  This software produces a PAIR file of probe intensities, which forms the 
basis of all subseqent analysis.     
 
2.5.4  Chromosome analysis 
To analyse chromosome structure and genome stability, brightfield microscopy on 
Giemsa stained metaphase chromosomes was performed under conditions that induce 
common fragile sites.  Cells were seeded into T25 flasks and allowed to settle.  To 
induce common fragile site expression the DNA polymerase inhibitor aphidicolin 
was added to cells.  Following 24 hours aphidicolin treated and control cells were 
harvested as described.  Cell pellets were resuspended in 5 ml PBS to wash and 
centrifuged at 1200 rpm for 4 minutes at room temperature to re-pellet cells.  To 
swell the cells the cell pellet was resuspended in 75 mM KCl applied by pastette with 
gentle vortexing up to a volume of 10 ml and incubated for 10 minutes at room 
temperature.  The swelled cells were collected by centrifugation at 1200 rpm for 4 
minutes at room temperature and resuspended in Carnoy’s fixative with gentle 
vortexing up to a volume of 10 ml and incubated for 10 minutes at room temperature.  
These fixed cells were re-pelleted by centrifugation and resuspended in Carnoy’s 
fixative twice more and stored at -20°C overnight before use.   
Following overnight incubation samples were warmed by hand, pelleted by 
centrifugation and resuspended in an appropriate amount of fresh Carnoy’s buffer.  
Microscope slides were stored in ethanol with a drop of HCl to give micro-scratches 
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on the slide surface.  Slides were removed from the ethanol, excess ethanol removed 
with tissue and air dried.  To drop the fixed metaphase preparations the slide was 
humidified by gentle blowing and a small volume of fixed cells dropped by pastette 
from a height of 15 cm and dispersed with a gentle blow.  Slides were allowed to air 
dry and the success of a drop was assessed by phase contrast microscopy.  Cell 
concentration and droplet size were then adjusted to get the optimum metaphase 
conditions.  Once conditions were optimised, air dried slides were baked at 65°C for 
1 hour or left on the bench for several days.  Slides were then stored at room 
temperature until use. 
To identify chromosomal aberrations in metaphase chromosomes, samples were 
karyotyped by Giemsa banding.  Slides were rehydrated in PBS for 2 minutes and 
trypsin treated for 1 minute to improve subsequent staining.  Trypsin was inactivated 
with PBS+MgCl2 and the slides were stained for 13 minutes in 6% Giemsa rocking 
at room temperature.  Slides were washed 3x 5 minutes in tap water, air dried and 
fixed/mounted in DEPEX mounting medium for imaging by brightfield microscopy. 
 
 
2.6 bTMP analysis of DNA supercoiling 
 
2.6.1  bTMP synthesis 
BTMP was synthesised by Nicolaos Avlonitis of the University of Edinburgh 
Chemistry department to produce the molecule first described in Saffran et al. 
(1988).  The synthesised molecule was stored in powdered form at -20°C, with a 




2.6.2  bTMP sequence specificity 
2.6.2.1 bTMP oligonucleotide photo-crosslinking 
To identify whether bTMP preferentially binds GC or AT dinucleotides a 
photocrosslinking experiment was performed on poly-GC and poly-AT 
oligonucleotides (Sigma).  Furthermore, to identify whether bTMP preferentially 
binds A form, B form or A/B intermediate form DNA helical structures, a photo-
crosslinking experiment was performed on oligonucleotides that form these 
structures (Table 2.1) (Hays et al., 2005). 5 μg of oligonucleotides and 30 ng of 
bTMP were diluted to 100 μl in TE Buffer and incubated in one well of a 96 well 
plate for 10 minutes in the dark at room temperature, alongside no DNA and no 
bTMP controls.  To photo-crosslink the bTMP to the DNA, samples were incubated 
for 15 minutes in 320-400 nm UV light.  Non cross-linked control samples were 
further incubated in dark for 15 minutes.  DNA oligonucleotides were purified using 
a QiaQuick PCR clean up kit (Qiagen) and eluted in 30 μl PCR quality water 
(MilliQ).  DNA samples were prepared for dotblot by adding 1 μl of 20x SSC to 9 μl 










2.6.2.2 bTMP photo-crosslinking mass spectrometry 
To identify the sequence bias of bTMP photo-crosslinking 5 μl of sonicated genomic 
DNA (300-500 bp) was combined with 3 μg of psoralen in a total of 60 μl TE and 
incubated in the dark at room temperature for 10 minutes, followed by 15 minutes in 
320–400 nm UV light.  Non-crosslinked control samples were incubated for a total 
of 25 minutes in the dark.  DNA was purified from unbound psoralen using a G50 
sephadex column and diluted to 20 ng/ul.  A 50 μl aliquot of psoralen-bound and 
control DNA was incubated in RNaseAT1 for 4 hours at 37°C and the DNA purified 
from ribonucleotides in a G50 sephadex column.  These DNA samples were digested 
to mononulotides in Mononucelotide Digestion Mix for 6 hours at 37°C.  Photo-
crosslinked samples and non-crosslinked controls were analysed by HPLC-MS to 
identify bTMP bound nucelotides, in conjunction with the Chemistry department. 
 
2.6.3  bTMP in cell DNA photo-crosslinking 
To analyse DNA supercoiling bTMP molecules were photo-crosslinked in living 
cells.  Cells were seeded in duplicate in 10 cm Petri dishes and grown to 80% 
confluency overnight.  The following day cells were washed 3x in PBS followed by 
bTMP at 500 ng/ml (RPE1) or 1.4 μg/ml (Neo3) in a total volume of 1 ml PBS under 
a parafilm disk, to ensure an even distribution of drug across the plate.  Cells were 
incubated in bTMP for 20 minutes in the dark followed by 10 minutes photo-
crosslinking in 320-400 nm UV light.  Cells were washed 3x in PBS and scraped into 
a 1.5 ml Eppendorf tube in 1 ml PBS.  Samples were centrifuged at 2000 rpm for 4 
minutes at 4°C, the supernatant discarded and resuspended in 200 μl ChIP Lysis 
Buffer.  Duplicate plates were combined to give 400 μl total.  bTMP cross-linked 
samples were fragmented by 13 rounds of 30 seconds on/off sonication at 2 μ on ice.  
Following sonication samples were incubated in 10 μg/ml proteinase K for 4 hours or 
overnight at 55°C.  DNA was isolated by phenol:chloroform extraction and 




2.6.4  bTMP DNA dotblot 
To confirm photo-crosslinking of bTMP into DNA in cells, 1 μl of photo-crosslinked 
DNA sample was diluted to give 10 μl in 1x SSC Buffer and applied to a charged 
nitrocellulose membrane (GE healthcare) 2 μl at a time.  After each 2 μl application 
the membrane was allowed to air dry before repeat applications to the same spot.  A 
serial dilution of biotinylated-oligonucleotides was included as a biotin-standard.  
Following sample application the DNA was UV crosslinked to the membrane at 150 
mJ/cm
2
.  The membrane was blocked in 1x Blocking Reagent (Roche) diluted in 
Maleic Acid Buffer for 30 minutes rocking at room temperature.  Following blocking 
the membrane was incubated in avidin-conjugated HRP antibody in 1x Blocking 
Reagent for 1 hour rocking at room temperature or 4°C overnight.  The membrane 
was washed twice in Maleic Acid Buffer and twice in TBS-T for 5 minutes rocking 
at room temperature.  The signal was visualised using chemiluminesence (ECL, 
Thermo Scientific) and exposed to X ray film (Fuji) and developed. 
 
2.6.5  bTMP immunoprecipitation 
To enrich for the under-wound DNA preferentially bound by bTMP 
immunoprecipitation for the biotin tag was carried out on bTMP photo-crosslinked 
DNA samples.  Samples were divided into two technical replicates, with one stored 
at -20°C.  The samples for immunoprecipitation were diluted in 900 μl TE Buffer 
and 50 μl taken as ‘input’.  To each sample 50 μl of pre-washed streptavidin coated 
magnetic beads were added and incubated for 2 hours at room temperature then 4°C 
overnight on a wheel.  The following day non-specific DNA was washed from the 
beads by 5 minute washes at 4°C in buffers TSEI, TSEII, Buffer 3 and twice in TE 
on a wheel.  Bound DNA samples and were eluted from the streptavidin beads in 50 
μl Biotin Elution Buffer at 90°C for 10 minutes and the immunoprecipitated DNA 
sample transferred to a new tube.  The samples were made up to 200 μl with PCR 
quality water and the DNA purified with a Qiagen MinElute PCR purification kit 
following the manufacturer’s instructions and eluting in 10 μl PCR grade water.  
Samples were amplified and the DNA quantitified by spectrophotometer and agarose 
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gel electrophoresis, before being sent to the VUMC microarray facility for labelling 
and microarray hybridisation. 
 
2.7  Microarray Design 
 
To identify the distribution of topoisomerases and changes in DNA supercoiling at 
common fragile sites, microarrays were custom designed to cover regions of the 
genome with distinct chromatin features; including gene rich, gene poor, common 
fragile sites and telomeric loci (Table 2.2).  These 180k probe arrays were designed 
by Agilent to have unique 50 bp probes with a coverage of 1 probe per 60 bp.  
Previous studies in the lab had used these custom arrays to determine DNA supercoil 
domains by psoralen-IP and the distribution of RNA polymerase II (Naughton et al., 
2013).  This was directly comparable with my data allowing a thorough investigation 
of the interplay between DNA structure, transcription and topoisomerase activity at 
these loci.  For a more comprehensive analysis of topoisomerases at gene promoters, 
ChIP samples were hybridised to Nimblegen chromosome 11 tiling arrays, which 
contain 2,509 transcription start sites.  To investigate the distribution of DNA 
supercoiling at promoters genome-wide by psoralen-IP, samples were hybridised to 
Nimblegen 2.1M promoter arrays (name).  These microarrays cover regions 7 kb 
upstream to 2 kb downstream of each promoter in the human genome, with a 












Table 2.2 Custom tiling microarray design. 
 
 
2.8 Bioinformatic analysis 
 
To analyse the microarray data generated by ChIP-chip and psoralen-IP experiment 
and relate these results to the work of others a bioinformatic approach was employed.  
Unless otherwise stated, all analysis was performed in the R language (http://www.r-
project.org/) (version 2.15.1) and associated packages, in particular those of 
Bioconductor (http://www.bioconductor.org/).  Other analysis was performed in Perl, 
Galaxy (http://galaxyproject.org/) and using UCSC binary utilities through UNIX 
(http://hgdownload.cse.ucsc.edu/admin/exe/linux.x86_64/). 
 
2.8.1  Datasets 
Novel tiling array datasets were generated by ChIP-chip in RPE1 cells for 
topoisomerase I, topoisomerase IIα and topoisomerase IIβ and by psoralen-IP in 
Region Size (Mb) Probes Spacing Chr Start End 
IGBP1 2 11047 60 X 68369744 70369744 
LDHA 2 15176 60 11 17417960 19417960 
11p15.5 2.8 26126 60 11 1 2800000 
Enr312 0.7 6965 60 11 131031152 131732236 
Enr332 0.6 5501 60 11 64120923 64720922 
Xq25 3.9 21830 60 X 119145001 123045000 
RNU2 0.5 3259 60 17 41124772 41624771 
RNU1 0.55 4447 60 1 16570000 17120000 
11p13 5.5 43382 60 11 27100001 32600000 
FRA3B 5.1 26807 100 3 58600001 63700000 
FRA16D 2.5 15305 91 16 77512501 80012500 
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NEO3 cells under control, α-amanitin, α-amanitin reverse, aphidicolin, bleomycin 
and genomic DNA conditions.  Novel promoter array datasets were generated for 
psoralen-IP samples under control, α-amanitin, α-amanitin reverse and genomic 
DNA conditions.    
Other datasets in the lab were compared with the custom tiling, chromosome 11 and 
promoter array data.  These included RPE1 datasets using the same custom 
microarray platform for RNA-polymerase ChIP-chip, cDNA and psoralen-IP 
samples under control, α-amanitin, α-amanitin reverse, bleomycin and genomic DNA 
conditions.  Genome wide expression array data (Illumina HT12 array) for RPE1 
cells was also generated within the lab.  Expressed genes were called based on the 
top quartile of expression values and non-expressed genes on the bottom quartile of 
expression values. 
External datasets were used extensively including the ENCODE project 
(http://genome.ucsc.edu/ENCODE/) and BioMart database 
(http://www.biomart.org/biomart/martview/) to identify datasets including gene 
positions, CpG islands positions, transcription factor binding sites, structural protein 
binding sites, etc. 
 
2.8.2  General bioinformatic analyses 
2.8.2.1 Parametric and non-parametric statistics 
The correct use of parametric and non-parametic statistics give increased statistical 
power.  Parametric methods make assumptions about the data, such as the 
expectation that the data is normally distributed, which should be met in order for the 
analysis to be considered robust.  In some cases, I have displayed or analysed data 
using a parametric test where a non-parametric test would have been more 
appropriate (e.g. used a t test rather than Mann-Whitney U).   In each case tested, a 





To identify whether there is a relationship between two samples the Pearson’s 
product-moment correlation coefficient was performed using the ‘cor.test’ function.  
The Pearson’s correlation calculates the covariance of the two samples and divides 
this by the product of their standard deviations.  The correlation between the two 
samples is expressed as a value between 1 (perfect correlation), 0 (no correlation) 
and -1 (perfect anti-correlation).  The probability that this correlation represents a 
significant deviation from chance is given as a p-value. 
 
2.8.2.3 Student’s t test 
A two-tailed two-sample t test identifies whether the difference between two samples 
is significant by comparing sample population means.  The ‘t.test’ command was 
used and the significance determined from the assigned p-value. 
 
2.8.2.4 Data distribution 
A number of commands were used to determine the distribution of data both 
numerically and graphically.  The ‘summary’ and ‘boxplot’ commands were used to 
represent the median, interquartile range and outliers of datasets either numerically 
or graphically.  In most cases the boxplot outliers were not informative and were 
removed from figures (‘outline=F’).  To represent the distribution of a single dataset 
in a continuous manner, histograms were plotted with the ‘hist’ command.  Other 
types of graph were produced with the ‘plot’ command, including line graphs 
(‘type=l’) and scatter plots (‘type=p’).  To represent the density of data within a 
scatter graph, which was often obscured due to the high number of datapoints, the 
‘smoothScatter’ command was used. Venn diagrams were plotted using the ‘venn’ 




2.8.2.5 Two colour microarray data processing and analysis 
Microarray scans were provided by the VUMC microarray facility as TIFF images 
and PAIR raw intensity files.  Each TIFF image was inspected for scratches, bubbles 
and other hybridisation artefacts before subsequent analysis.  Signal intensity files 
were read into R using the Ringo Bioconductor package designed for the analysis of 
two-colour oligonucleotide arrays (Toedling, 2012; Toedling et al., 2007).  The 
relative distribution of signal intensity for each fluorophore was established within 
and between arrays using the ‘plotDensities’ command and the signal intensity bias 
identified using ‘ma.plot’.  Normalisation of signal differences within and between 
arrays was performed in an experiment dependent manner using either Variant 
Stabling Normalisation (VSN) or a combined loess/scale normalisation in the 
‘Limma’ Bioconductor package.  The post-normalisation data was checked by 
‘plotDesities’ and ‘ma.plot’ to ensure a more similar relative distribution and no 
signal bias.  Once satisified the probe signal values were combined with their 
corresponding genomic position for further analysis in R and written to BED files for 
analysis in the UCSC genome browser and Galaxy. 
 
2.8.2.6 Custom track analysis with the UCSC genome 
browser 
To analyse the distribution of custom datasets with respect to genomic position and a 
vast array of biological information, the normalised microarray data was uploaded to 
the UCSC genome browser.  Smaller files were uploaded directly as a BED file with 
a track header used to build the image, for example: 
track type=bedGraph name=”my bed” description=”a graph of my bed” 
visibility=full color=200,100,0 altColor=0,100,200 priority=20 graphType=bar 
autoScale=off 
Larger datasets were converted to the bigwig file format using the 
‘bedGraphToBigWig’ programme and uploaded via an FTP server.  In this case only 
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a portion of the data required is stored on the UCSC server, with the full dataset 
remaining on the local server.  To load bigwig data a track header was pasted into the 
‘Paste URLs or data’ box of the ‘Add Custom Track’ window, for example: 
track type=bigwig name=”my bigwig” description=”a graph of my bed” 
bigDataUrl=ftp://ecrc##.med.ed.ac.uk/test_mydata.bw 
 
2.8.3  Distribution of data around gene promoters 
To directly compare the distribution of data for each promoter on the array a number 
of analysis tools (e.g. k-means clustering) require a matrix with the distribution 
organised into a set number of columns.  To produce this, the distribution of data 
around each transcription start site was binned into 400 bp bins overlapping by 200 
bp in the region 7 kb upstream to 2.8 kb downstream.  This data matrix was produced 
by taking the median value of the probes within each bin for each TSS.  If a bin 
contains no probes a value was imputed using the ‘na.approx’ command in the ‘zoo’ 
package, with the exception of the first or last bin which was replaced with the mean 
value for the promoter distribution.  The imputation was performed up to a maximum 
of 3 missing values in a row and required 39 of the 49 bins to contain values.  Any 
transcription start site which did not meet these criteria was discarded.  Subsequent 
analysis of data at gene promoters used data in this matrix format, for the 
identification of median distributions around gene promoters, classification by 
kmeans analysis, etc.  
 
2.8.4  Data smoothing by rolling median 
To present the patterns of topoisomerase ChIP enrichment in Zoo plots and in the 
UCSC genome browser a 27 probe rolling median was used to clarify the patterns of 
data enrichment.  Data smoothing was achieved using the ‘rollMedian’ function in 
the ‘zoo’ package.  Subsequent analysis was performed on non-smoothed data, with 





2.8.5  Determining topoisomerase domains with an 
edge filter 
To identify the boundaries of domains of topoisomerase enrichment and depletion a 
rolling window edge filter was used to identify positions at which topoisomerase 
enrichment/depletion changes markedly.  The mean values for 200 (topoisomerase I) 
or 400 (topoisomerase IIα/IIβ) probe windows up- and down- stream of a particular 
position were compared and a stringent difference cut-off determined to establish 
boundaries (arbitrarily defined topoisomerase I cut off 0.15, topoisomerase II cut off 
0.1).  Boundaries were compared with the raw signal to ensure a high degree of 
similarity.  This analysis identifies domains successfully, with the caveats that 
smaller peaks of enrichment, regions with low probe density and variable regions are 
not easily categorised.  The mean signal value was determined between each set of 
boundaries and enriched domains identified as those domains with a positive mean 
value.   
 
2.8.6  Determining distributions around transcription 
start sites 
Topoisomerase, RNA polymerase and DNA supercoil data were analysed relative to 
the transcription start site by producing matrices as outlined in Section 2.8.3.   The 
datasets were separated into expressed and non-expressed genes and the relative 
distributions compared by taking the median value for each distribution around the 
TSS.  The difference between distributions was identified by performing a t-test that 
compared the distributions of data in set bins.  To identify enrichment at random 
positions on the chromosome 11 array, and therefore determine that enrichment at 
the promoter is genuine, a number of random positions equal to the number of 
expressed TSSs were chosen on the chromosome and the median distribution of 
topoisomerase I and IIβ determined.  T-tests were performed between promoter and 
random data and the iteration repeated 30 times.  If the p-value of the random 
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iteractions was lower than that of the promoter in 2 or more of the 30 iteractions, 
then the difference was not significant.  Otherwise significance was determined 
based on the highest p-value attained by the random iterations (see Figure 3.17). 
 
2.8.7  Classifying promoters based on topoisomerase 
distribution 
To classify promoters based on topoisomerase distribution in an independent manner, 
kmeans clustering analysis was applied using the ‘kmeans’ function.  Setting the 
cluster number to 2 identified median topoisomerase distributions with a distinct 
peak and a distinct trough, providing a useful segregation of the data.     
 
2.8.8   Normalising the bTMP distribution of 
control/α-amanitin/wash-out data for genomic DNA 
The microarray hybridisations for control/α-amanitin/wash-out samples and genomic 
DNA samples were performed on HG18 and HG19 Nimblegen array platforms 
respectively.  The different array platforms have a complete probe re-design and 
were not directly comparable.  To compare the two, matrices of promoter distribution 
were produced separately for each data type.  The coordinates of the HG18 TSSs 
were converted to the corresponding HG19 TSSs and the centre point of each bin for 
each TSS identified as the ‘probe position’.  The data was subsequently rearranged 
into a dataframe containing the ‘chromosome’, ‘probe position’ and data for 
‘control’, ‘α-amanitin’, ‘wash-out’ and ‘genomic’.  A scale normalisation was 
performed to ensure the control/α-amanitin/wash-out and genomic DNA datasets 
have the same signal distribution.  Once normalised, the genomic data was subtracted 
from the control, α-amanitin and wash-out samples individually and the data returned 
to a matrix format, with rows representing TSSs and columns representing the binned 
data around the TSS.  These datasets, normalised for genomic DNA bTMP 




2.8.9  Ranking promoters on CpG island probability 
In order to rank promoters based on their probability of containing a CpG island 
sequence pattern, the hidden Markov model (HMM) based package ‘makeCGI’ was 
used (Irizarry et al., 2009; Wu et al., 2010).  This package determines the probability 
of elevated CpG and GC content compared to the local sequence context, rather than 
the more simplistic model used by the UCSC genome browser (Gardiner-Garden and 
Frommer, 1987).  By running the package with a low posterior probability threshold 
(0.5 for CpG, 0 for GC content) the majority of promoters identify some form of 
CpG island motif.  Taking the mean probability identified for motifs within the 
region 500 bp up-stream to 500 bp down-stream of the TSS, where most promoter 
associated CpG islands are located, gives a parameter on which the promoters can be 
ranked based on CpG likeness.  A small minority of promoters that did not contain 
any CpG-like motif within 1 kb centred on the TSS were added to the bottom of the 
distribution in an un-ordered fashion.  Previous studies have identified that a 
posterior probability threshold of 0.99 gives the canonical CpG island list used by the 
UCSC genome browser (Irizarry et al., 2009) identified by a dotted line in heatmap 
and inflection plots. 
 
2.8.10 Heatmap analysis of bTMP distribution 
To compare the distributions of bTMP at all promoters, ordered on their probability 
of containing a CpG island, the data was presented as a heatmap using the 
‘heatmap.2’ function in the ‘gplots’ package.  To see the distribution of data clearly, 
the extremes of the distribution were not plotted on the heatmap instead focussing on 
the range of signal intensity from 5% to 95%. 
 
2.8.11 Inflection plot for bTMP distribution 
To identify the inflections in the data, where either a peak or trough is observed, the 
‘turningpoints’ function in the ‘pastecs’ package was used.  To limit the noise in the 
data, TSSs ordered on the CpG island likeness were binned into 100 TSS bins and 
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the median distribution for the bin determined.  This distribution was smoothed with 
a slight loess smoothing (span=0.2), using the ‘loess’ function, and the inflections 
determined using ‘turningpoints’.  The inflections were plotted for each of the 206 
bins to give their relative distribution with respect to TSSs.  
 
2.8.12 Determining GC% matrix for promoters 
genome-wide 
The comparison of sequence distribution with bTMP distribution necessitated a 
matrix of GC% in the bins around each TSS.  To create this matrix the chromosome, 
bin start and bin end positions were identified for each bin of each transcription start 
site.  This information was then used in the ‘nuc’ option of BEDtools (Quinlan and 
Hall, 2010) to determine the GC% for each bin and the matrix re-assembled so that 
rows represent TSSs and columns represent the binned data around the TSS. 
 
2.8.13 Distribution of bTMP around protein binding 
sites 
The distribution of bTMP around transcription factor and structural protein binding 
sites was determined for several proteins with ChIP-chip data available in the A549 
epithelial cell lines through the ENCODE project.  A meta-analysis of the relative 
enrichment of bTMP with distance from the nearest protein binding site was 







3. Mapping DNA topoisomerase I, IIα and IIβ by 
chromatin immunoprecipitation 
 
3.1  Introduction 
 
The presence or absence of specific proteins or modifications at a DNA sequence can 
be used to determine or predict biological function in vivo.  For example, focal 
enrichment of the DNA binding protein P-300 generally identifies active enhancers 
(Visel et al., 2009), whereas focal enrichment for ERα at gene promoters identifies 
the potential for estrogen regulation (Fullwood et al., 2009) and a peak of H3K4me3 
generally identifies active gene promoters (Kouzarides, 2007).  Other proteins show 
a more local  enrichment that indicates genome regulation on a larger scale, 
including repressive chromatin proteins (e.g. HP1α, lamin-B1) and modifications 
(e.g. H3K9me2/me3, H3K27me3) (Ernst et al., 2011; Guelen et al., 2008).  The 
mapping of each of these factors by chromatin immunoprecipitation (ChIP) or DNA 
adenine methyltransferase identification (DamID) has transformed our understanding 
of gene regulation and allowed the functional annotation of eukaryotic genomes.  
This annotation is being performed most comprehensively by the ENCODE 
consortium, which has mapped hundreds of proteins/modifications in a broad range 
of human cell types (Dunham et al., 2012).  However, the catalogue of proteins and 
modifications investigated through the ENCODE project is limited, with numerous 
important factors involved in gene regulation and genome stability still unmapped.  
For example, the distribution of topoisomerase enzymes in the human genome has 
not been identified at high resolution, despite their very high abundance and critical 
function in genome organisation and regulation.  Many questions remain about 
topoisomerase function in vivo, including the distribution of these proteins with 
respect to genes, domains and one another.   
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3.1.1  Topoisomerase distribution in model systems 
Topoisomerases are found in all forms of cellular life to relieve DNA supercoils and 
drive chromosome decatenation (Section 1.2.4.2).  The distribution of 
topoisomerases in the human genome is known only for a handful of genes and at 
low resolution, but the conserved function of these proteins between species makes it 
likely that they have a conserved distribution with respect to genes and other 
genomic features.  In addition, differences in genome organisation may strongly 
influence the dissipation of DNA supercoils and the corresponding difference in 
topoisomerase distribution.  For example, the yeast genome is generally more 
expressed than the human genome, due to less non-coding DNA and fewer non-
expressed genes.  It may therefore be expected that DNA supercoiling is a more 
pervasive force in yeast and that topoisomerase distribution somehow reflects this.  
In the following section the likely distribution of topoisomerases in humans will be 
discussed based on a comparison of genome structure and topoisomerase distribution 
maps from yeast, fruit fly and non-human mammalian systems. 
The yeast genome is distinct from the human genome in ways which may directly 
influence DNA supercoiling, including an average gene length of ~1.6 kb (compared 
to 10-15 kb in human), a high gene density with only ~27% of the genome non-
coding (compared with 97% in human) and fewer non-expressed genes (Roger et al., 
2010).  Therefore, there is the potential for high levels of DNA supercoiling to 
transmit through the DNA to influence neighbouring genes that are in close spatial 
proximity.  Mapping topoisomerases by ChIP hybridised to tiling microarrays (ChIP-
chip) identifies that topoisomerase I and II are enriched in intergenic regions and 
particularly at regions flanking genes (Durand-Dubief et al., 2010).  (Durand-Dubief 
et al., 2010).  The distribution of topoisomerases within gene bodies is lower, and in 
the case of very highly expressed genes topoisomerase II binding is abolished 
altogether.  This suggests a model whereby DNA supercoiling generated within short 
yeast genes is relieved by topoisomerase I and II in inter-genic regions. 
The fruit fly genome is much more similar to that of human than yeast, with an 
average gene length of ~11.3 kb, low gene density with ~82% of the genome non-
coding and the highly variable gene expression pattern common to multicellular 
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organisms (Roger et al., 2010).  Interestingly, the distribution of topoisomerase I is 
distinct from that observed in yeast and is primarily enriched in the gene body of 
expressed genes (Gilmour et al., 1986).  The genome wide distribution of 
topoisomerase I was mapped by DamID, a technique that marks DNA with adenine 
methylation when in contact with the protein of interest, supports an association with 
transcriptionally active euchromatin (Filion et al., 2010).  In further contrast to the 
yeast model, topoisomerase II distribution is distinct from topoisomerase I in the fly 
genome.  Mapping of topoisomerase IIβ to a small number of sites identified 
enrichment at AT-rich nuclear attachment regions and at DNAaseI hypersensitive 
sites, in a transcription dependent manner (Käs and Laemmli, 1992).  A larger scale 
mapping of topoisomerase II cleavage patterns on genomic DNA in vitro also 
identifies an AT-rich preference, with cleavage sites extending over domains > 10 kb 
in length (Miassod et al., 1997).  This analysis could not determine a clear consensus 
binding sequence and they conclude that topoisomerase II preferentially binds DNA 
with intrinsic curvature.  Whether this distribution holds true in vivo is unknown, and 
several studies have identified significant differences between in vitro and in vivo 
(chromatin associated) topoisomerase cleavage sites (Käs and Laemmli, 1992; 
Udvardy and Schedl, 1991).  Together this data supports and association between 
topoisomerase I and active regions of the chromatin and indicates a role for 
topoisomerase II at both transcriptionally repressed regions and at DNAaseI 
hypersensitive sites in fly.  Based on the similarity of genome structure between 
human and fly, the fly distribution may represent a better model for the expected 
distribution of topoisomerase. 
The genome organisation of mouse and rat are highly similar to that of the human 
genome and would represent the best model for the expected distribution of 
topoisomerases in human.  However, the in vivo distribution of topoisomerase I has 
not been mapped in non-human mammalian systems.  On the other hand, 
topoisomerase II enzymes have been mapped to the promoters of several genes in 
mouse, with one study identifying topoisomerase IIβ at the promoter of five out of 
seven genes whose expression has been shown to be dependent on topoisomerase IIβ 
in knock-out experiments  (Lyu et al., 2006).  A more detailed analysis of one of the 
genes identifies an enrichment for topoisomerase IIβ through the Kcnd2 gene, 
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particularly at the promoter,  but not upstream of the transcription start site (Lyu et 
al., 2006).  A large scale map of topoisomerase IIβ activity in rat neuronal genes 
identifies enriched activity in AT-rich regions and at TSSs, including expressed and 
non-expressed genes (Sano et al., 2008).  Therefore, the distribution of 
topoisomerase IIβ at gene promoters and the identification of a minority of genes 
regulated by topoisomerase IIβ activity supports an important role for this enzyme at 
promoters in mammalian cells. 
The in vivo distribution of topoisomerases in human cells is very poorly 
characterised.  Topoisomerase I ChIP with ten sets of primers over a 5 kb locus 
identifies a subtle increase in topoisomerase binding over and downstream of the 
expressed H2A and H2B genes, whereas no such enrichment is observed at α-
satellite DNA (Khobta et al., 2006).  A similar small-scale mapping experiment of 
topoisomerase IIα and IIβ by ChIP identifies a subtle enrichment of each at the 
promoter of the MLL gene (Cowell et al., 2012).  To test the relationship between 
expression and topoisomerase binding Kouzine et al. (2013) performed ChIP for 
topoisomerase I and IIβ and identified their enrichment at a single position for 15 
gene promoters.  They identified a subtle increase in topoisomerase I binding with 
expression and a stronger increase in topoisomerase IIβ binding at highly expressed 
genes.  This lead them to propose a model whereby topoisomerase I acts in a diffuse 
manner upstream of a transcription start site, while in addition topoisomerase IIβ is 
focally enriched at the transcription start site in highly expressed genes.   
Based on the distributions of topoisomerases in non-human model organisms, and 
limited mapping data in human, several general properties of topoisomerase I and II 
have been observed. In general, the distribution of topoisomerase I associates with 
transcription and topoisomerase II with AT-rich regions and transcriptionally active 
gene promoters.  To identify if these patterns are true for human chromatin it is 
essential to map topoisomerases at high resolution across a significant proportion of 
the genome.   The aim of this chapter is to map topoisomerase I, IIα and IIβ by 
chromatin immunoprecipitation hybridised to microarrays (ChIP-chip) to identify 
topoisomerase distribution with respect to sequence, RNA polymerase, DNA 
structure and other parameters.  In addition, a detailed analysis of topoisomerase I 
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and II distribution at the transcription start sites (TSSs) of human genes will be used 
to test the model proposed by Kouzine et al. (2013).  This will provide the first 
comprehensive understanding of topoisomerase I and II localisation in human cells 
and can be used as a framework for better understanding the function of 
topoisomerase I and II in vivo.  
 
3.1.2  Chromatin immunoprecipitation (ChIP) as a tool 
for mapping DNA binding proteins in vivo. 
Chromatin immunoprecipitation identifies the DNA sequences bound by a protein of 
interest in living cells (Lee et al., 2006).  Depending on the strength of association 
between the protein of interest and DNA ChIP may be performed under ‘native’ 
conditions or following a chemical cross-linking step which stably associated protein 
to DNA (Figure 3.1a).  To isolate the chromatin for immunoprecipitation cell and 
nuclear membranes are lysed (Figure 3.1b) and the chromatin is fragmented to 300-
500 bp by MNase digestion (native ChIP) or sonication (cross-link ChIP) (Figure 
3.1c).  For immunoprecipitation the chromatin extract is incubated with an antibody 
to the protein of interest (Figure 3.1d) which is enriched for by immunoprecipitation 
with an appropriate immunogenic-protein coated bead (Figure 3.1e).  The DNA 
associated with the protein of interest is isolated from the immunoprecipitated 
chromatin (Figure 3.1f) and analysed by PCR (ChIP-PCR), microarray (ChIP-chip) 
or next generation sequencing (ChIP-seq) (Figure 3.1g).  Bioinformatic analysis of 
microarray or next generation sequencing data can identify relative enrichments of 
the protein of interest at high resolution across some/all of the genome and this data 
can be mined to inform and answer biological hypotheses.  This general protocol has 
been used widely to map many factors across the genome, including the many 







Figure 3.1 Chromatin immunoprecipitation experimental approach.  
The key experimental steps for ChIP (a-g).  Native ChIP does not require the 




3.2  Results 
 
3.2.1  Validating topoisomerase ChIP 
3.2.1.1 Validating topoisomerase antibodies 
The success of many molecular biology techniques is dependent on high quality 
antibodies specific to the protein of interest.  This is particularly important for ChIP, 
where non-specific binding could identify false positive binding sites, high 
background or a poor signal to noise ratio.  To ensure specificity seven 
topoisomerase antibodies were tested by western blot to confirm the detection of a 
single protein and immunofluorescence to ensure the nuclear localisation of this 




Table 3.1 Antibodies tested by western blot and 
immunofluorescence.  Western blot dilution for primary antibody incubation 
overnight at 4°C. Immunofluorescence yes/no indicates nuclear localisation 





Both topoisomerase I antibodies tested identify a single protein at the correct 
molecular weight of 91 KDa by western blot (Figure 3.2a).  However, the Santa Cruz 
antibody detected topoisomerase I with much higher affinity than the Abcam 
antibody.  This Santa Cruz antibody has nuclear localisation by immunofluorescence 
(Figure 3.2a).  Together this data supports the specificity of Santa Cruz anti-topoI 
(C21) for subsequent experiments. 
A further antibody to topoisomerase I was isolated from the blood of a patient with 
the SCL70 form of scleroderma (Guldner et al., 1986).  This antibody detects a band 
consistent with topoisomerase I alongside several other proteins (Figure 3.2d).  The 
most prominent band is at 70 KDa, which is consistent with the proteasome degraded 
form of topoisomerase I produced following enzyme activity (Guldner et al., 1986; 
Tomicic and Kaina, 2013). Why scleroderma patients produce antibodies to a 
minority isoform of topoisomerase I remains unknown.  Other bands, such as that 
~50 KDa, probably detect additional auto-antibodies commonly observed in 
scleroderma such as those of centromeric proteins (Hamdouch et al., 2011).  
Together, this data suggests that the SCL70 antibody is not suitable for a specific 
topoisomerase I ChIP. 
For topoisomerase IIα and IIβ a total of four antibodies were tested by western blot 
and immunofluorescence.  The topoisomerase IIα from Cell Signalling and 
topoisomerase IIβ antibody from Santa Cruz did not identify any bands by western 
blot under our experimental conditions.  The topoisomerase IIα antibody from Santa 
Cruz identifies a single band at ~170 KDa whilst the topoisomerase IIβ antibody 
from BD Biosciences identifies a single band at ~180 KDa (Figure 3.2b and 3.2c).  
Additionally, these antibodies detect proteins with nuclear localisation by 
immunofluoresence.  This demonstrates the specificity of these topoisomerase II 









Figure 3.2 Topoisomerase antibody validation.  a) - c) Western blot and 
immunofluorescence validation of antibody specificity.  d) Scleroderma 
patient serum detects several isoforms/proteins.  FL shows the full length 




3.2.1.2 Validating topoisomerase chromatin interaction 
ChIP experiments are reliant on stable interactions between the chromatin associated 
protein and DNA at specific loci.  To identify what proportion of each topoisomerase 
is in a stable protein complex a salt extraction method was used (Henikoff et al., 
2009).  Proteins that form loose associations with DNA dissociate at lower NaCl 
concentrations than tightly bound proteins.  In this experiment cell and nuclear 
membranes were lysed in a buffer containing 75, 150, 300, 500 or 1000 mM NaCl 
and large insoluble protein and nucleo-protein complexes were separated from 
soluble free protein and DNA by centrifugation.  Western blot analysis identified that 
the majority of topoisomerase is not chromatin associated at all salt concentrations 
(Figure 3.3).  At 150 mM NaCl the fraction of soluble topoisomerase is five fold 
higher for topoisomerase I, three-fold higher for topoisomerase IIα and two-fold 
higher for topoisomerase IIβ than the insoluble fraction.  On the other hand, the 
tightly chromatin-associated HP1α protein is 2 fold higher in the insoluble fraction 
than in the soluble fraction.  This identifies that the majority of topoisomerase in the 
cell is not stably associated in large protein or nucleo-protein complexes at the 
physiological salt concentration of nuclei (80 mM). 
The minority of topoisomerase that forms insoluble complexes is likely to be critical 
for genome stability and regulation.  One hypothesis is that topoisomerases form a 
structural component of the chromatin which, together with the nuclear matrix, 
regulate DNA structure within large DNA loops (Earnshaw and Heck, 1985).  In 
general, proteins that maintain chromatin structure are tightly associated with the 
nucleo-protein complex.  In the high salt fractions of the salt extraction assay (300 
mM – 1000 mM) topoisomerases dissociate and become soluble (Figure 3.3), 
indicating that these proteins are less strongly associated in complexes than HP1α 
(Figure 3.3) or linker histones, which dissociate at 500 mM (Van Holde, 1989).  
Because topoisomerases are not tightly associated, this supports the use of chemical 







Figure 3.3 A minority of topoisomerases form stable interactions with 
chromatin under physiological salt conditions.  Western blots for 
topoisomerase I, IIα and IIβ with HP1α as a positive control for protein 
association with chromatin.  Soluble and insoluble fractions display the 
concentration of NaCl in mM.  
 
 
To identify a level of cross-linking that stabilises topoisomerases in insoluble 
complexes, cells were incubated in different concentrations of formaldehyde and 
analysed by the salt extraction method.  Cell lysates were prepared in the presence of 
500 mM NaCl, which solubilises all topoisomerase under native conditions (Figure 
3.3) and matches the most stringent immunoprecipitation wash condition.  Pre-
treating the cells with 0.5% or 1% formaldehyde prior to cell lysis stabilises all 
topoisomerase I in insoluble complexes (Figure 3.4).  At lower formaldehyde 
concentrations topoisomerase I is present in both the soluble and insoluble fractions.  
In contrast, only a minority of the cytoplasmic protein GAPDH forms insoluble 
complexes at high formaldehyde concentrations (Figure 3.4).  This suggests that the 
shift of topoisomerase I from generally soluble to generally insoluble following 
formaldehyde treatment is a property of the nucleus, consistent with an increase in 






Figure 3.4 Formaldehyde cross-linking stabilises topoisomerase 
chromatin interactions.   A western blot for topoisomerase I and GAPDH in 
non-chromatin (soluble) and chromatin (insoluble) fractions, from 





The identification of topoisomerases in the insoluble fraction of the salt extraction 
assay identifies that they form protein and/or nucleo-protein complexes in the cell 
nucleus.  To identify if topoisomerases are associated with chromatin, as would be 
expected from their function in the relief of DNA supercoiling and knots, sucrose 
gradient sedimentation was performed on isolated chromatin fragments.  In this 
experiment, sucrose gradients separate protein, DNA and protein-DNA complexes 
based on their sedimentation rate, which is determined by mass and macro-molecular 
structure (Gilbert and Allan, 2001).  Chromatin was isolated from nuclei by partial 
digestion with MNase followed by an overnight incubation in a hypotonic solution 
that pierces the nuclear membrane and permits the diffusion of chromatin fibres into 
the supernatant.  It is important to optimise the MNase digestion for each cell type to 
obtain an optimum fragment length of ~ 1 kb.  Based on a digestion time-course 
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(Figure 3.5a) the digestion was optimised to 10 minutes at 10 U/ml.  Digested 
chromatin is sedimented on a 10-50% sucrose gradient at high speed and fractionated 
from low to high sucrose concentration.  Chromatin complexes are found in fractions 
2 through 5 as identified by the presence of DNA and protein.  The 
spectrophotometer trace identified a peak of DNA in fractions 4 and 5 (Figure 3.5b), 
which is consistent with agarose gel electrophoresis on DNA purified from the 
fractions (Figure 3.5c).  In addition, lower levels of DNA occur in fractions 2, 3 6 
and 7 (Figure 3.5c).  The distribution of protein, determined by coomassie stained 
SDS-PAGE, shows a similar distribution to that of DNA (Figure 3.5c).  Fractions 6 
and 7 contain DNA and histone proteins only, indicating that much of the protein 
complement of the chromatin has been stripped during the sedimentation process.  
Together, this data indicates that proteins associated with chromatin should be in 
fractions 2 through 5.  To identify if topoisomerases are associated with the 
chromatin, western blots were performed on protein samples taken from the sucrose 
gradient fractions (Figure 3.5d).  Consistent with chromatin association, 
topoisomerase I and IIβ are found in fractions 2 to 5.  As positive controls HP1α and 
histone H3 western blots were performed and confirm the co-localisation with 
chromatin associated fractions.  This data complements the salt extraction data, 
indicating that at least a proportion of the insoluble topoisomerase is chromatin 
associated, and supports subsequent experiments to determine the distribution of 











Figure 3.5 Topoisomerases are enriched in human chromatin.  a) 
MNase digestion series for chromatin preparation.  b) DNA trace measured 
by spectrophotometer at A260 during sucrose gradient fractionation.  c) DNA 
content by agarose gel electrophoresis (left) and protein content by 
coomassie stained SDS PAGE for the sucrose gradient fractions.  d) Western 
blot of sucrose gradient fractions for topoisomerase I, topoisomerase IIβ, 




3.2.1.3 Optimising sonication conditions 
The resolution of ChIP is depdendent upon DNA fragments size, with fragments of 
250-500 bp giving the optimum compromise between chromatin integrity and 
mapping resolution.  The efficiency of chromatin fragmentation is dependent on the 
complete lysis of the cell and nuclear membrane and the number of cycles of 
sonication used.  To identify the optimum sonication conditions whole cell extracts 
and nuclear extracts were sonicated in a buffer containing 1% or 0.1% SDS for 6, 10 
or 15 cycles of 30 seconds (Figure 3.6).  The difference between whole cell and 
nuclear extract was minimal.  However, the sociation buffer SDS concentration had a 
dramatic effect on DNA fragmentation efficiency, with 1% SDS showing much 
higher efficiency that 0.1% SDS.  The most important factor for obtaining the 
optimum fragment size is the number of cycles of sonication, with 6 cycles giving an 
average fragment size of 1 kb, 10 cycles giving an average of 500 bp and 15 cycles 
giving an average of 300 bp in 1% SDS sonication buffer.  Subsequent experiments 
identified that further sonication beyond 13 cycles had little effect on DNA fragment 
size (data not shown).  Therefore, 13 rounds of sonication on whole cell extracts in a 
sonication buffer containing 1% SDS gave an optimum chromatin fragment size of 













Figure 3.6 Optimising chromatin sonication conditions.  1.2% TBE 
agarose gel for sonicated whole cell extract (WCE) and nuclear extract (NE).  
The sonication buffers contained either 1% SDS (1%) or 0.1% SDS (0.1%).  
The extracts were sonicated for 6, 10 or 15 cycles (6x, 10x, 15x). 
 
 
3.2.1.4 Optimising immunoprecipitation conditions 
The choice of immunopreciptation reagents for the isolation of antibody-protein-
DNA complexes can further affect the efficiency of a ChIP reaction.  The most 
common protocols use agarose or paramagnetic beads coated in proteins that bind a 
specific immunoglobulin.  For example, protein A derived from the bacterium 
Staphylococcus aureus binds most efficiently to the human immunoglobulins IgG1 
and IgG2 (Johnstone, 1996).  To test the efficiency of antibody-bead interactions 
immunogenic beads were incubated in solutions containing different antibody 
concentrations and the amount of bound antibody quantified by western blot.  For 
example the protein A dynabeads bind more than half of the H3K4me3 antibody at 
500 µg of antibody per 1 ml of beads giving a binding capacity of 300 µg/ml (Figure 
3.7a).  The NEB protein  beads on the other hand bind around half of the antibody at 
250 µg  of antibody per 1 ml of beads giving a binding capacity of 125 µg/ml.  
Therefore, the dynabeads have more than twice the binding capacity of the NEB 
beads.  This was also confirmed for topoisomerase antibodies binding to protein G 
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dynabeads (Figure 3.7b).  This data suggests protein G dynabeads are optimal for the 
topoisomerase IIα and topoisomerase IIβ ChIP experiments. 
The most suitable topoisomerase I antibody for my experiments was an IgM 
antibody, which has a different protein structure and has a high binding affinity for 
protein L coated beads.  In developing the topoisomerase I approach protein L and 
anti-IgM beads were only available as agarose beads.  The binding capacity of both 
anti-IgM and protein L agarose beads was higher than the paramagnetic beads, with 
500 µg/ml and 800 µg/ml bound repsectively (Figure 3.7b).   Therefore, for 






















Figure 3.7 Antibody binding capacity of immunogenic beads.  a) 
H3K4me3 binding capacity quantified by western blot.  b) Western blot 







3.2.2.6  Topoisomerase inhibitors reduce topoisomerase 
protein concentration. 
The topoisomerase drugs camptothecin and ICRF193 stabilise DNA-protein 
interactions by preventing the release of topoisomerase I or topoisomerase II 
respectively from the DNA.  Camptothecin prevents the release of topoisomerase I 
by stabilising the bond formed between the enzyme and the 3’ strand of the DNA, 
whereas ICRF193 prevents the conversion of topoisomerase II from the closed-
clamp to the open-clamp form, in both cases trapping the enzyme on the DNA 
(Pommier, 2006; Roca et al., 1994).  These drugs have both been shown to enhance 
the ChIP signal at sites where topoisomerases are active (e.g. Käs and Laemmli, 
1992; Sano et al., 2008).  It has been established that prolonged exposure to 
camptothecin and ICRF193 can result in protein loss by proteasomal degradation 
(Desai et al., 1997; Isik et al., 2003).  A 50% reduction in topoisomerase I and IIβ 
was observed in protein extracts from cells treated with camptothecin and ICRF193 
respectively (Figure 3.8).   On the other hand, topoisomerase IIβ was unaffected by 
camptothecin treatment and topoisomerase IIα was unaffected by camptothecin or 
ICRF193 treatment.  Interestingly, topoisomerase I levels increase in the presence of 
the topoisomerase II inhibitor ICRF193.  Whether this upregulation performs a 
redundant functional role or is signalled by changes in DNA supercoiling following 



















Figure 3.8 Topoisomerase I and IIβ protein reduced by topoisomerase 
inhibitors.  Topoisomerase western blots in the presence of camptothecin 









3.2.3  Topoisomerase ChIP  
Having optimised the conditions for topoisomerase I, IIα and IIβ ChIP a series of 
experiments were performed to investigate the distribution of topoisomerases across 
selected loci of the human genome.  ChIP experiments were performed on untreated 
cells and cells treated with inhibitors that covalently associate topoisomerases with 
DNA.  For each experiment ChIP enriched ‘sample’ and a control ‘input’ DNA was 
amplified, labelled with Cy3 or Cy5 fluorescent dyes and hybridised to custom 
microarrays tiling interesting regions of the human genome (Section 2.7).  
Microarrays were scanned and quality control analysis performed at the VUMC 
microarray facility, generating the data for subsequent bioinformatic analysis. 
3.2.3.1 Raw data analysis 
To confirm that microarray hybridisations were of high quality the scanned images 
were inspected for localised spatial defects in fluorophore signal intensity, which can 
be caused by manufacturing defects or user error.  An analysis of both channels for 
each array confirmed the hybridisations were of high quality and appropriate for 
subsequent analysis.   
The comparison of fluorophore intensity in two colour microarray analysis can be 
strongly influenced by the different spectral properties of Cy3 and Cy5, as well as 
their varied response to experimental and environmental variation.  One striking 
example is the specific degradation of Cy5 by ozone, which can occur at levels found 
in the laboratory (Branham et al., 2007).  To test the relative spectral properties of 
Cy3 and Cy5 in the topoisomerase ChIP microarrays, the fluorescence intensity 
distributions were plotted for each microarray (Figure 3.9a).  The signal intensity 
distribution indicates a highly similar fluorescence distribution in the raw data within 
and between arrays (Figure 3.9a).  However, the arrays still suffer from an intensity 
dependent bias universal in two colour microarray experiments, which is a result of 
the fluorescent properties of the dyes.  A visualisation of this bias is presented in an 
MA plot, such as that for topoisomerase I sample A1 presented in Figure 3.9b.  In 
this plot the log signal ratio (log2(R)/log2(G)) is plotted against the average signal of 
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the two fluorophores ((log(R)+log(G))/2).  In an unbiased signal distribution the 
observed signal intensity ratio would not vary with the average signal intensity ratio 
and the plot would follow a horizontal line through zero.  It is clear that the raw data 
does not follow this distribution for topoisomerase I sample A1 (Figure 3.9b), 
particularly at lower signal intensities, and a similar bias was present in each 
microarray.  To reduce this technical bias several normalisation algorithms have been 
developed specifically for the analysis of microarray data. 
Variance stabilising normalisation (VSN) is based on the observation that the 
variance of signal intensity increases with mean signal intensity.  This is clear in the 
MA plot for unnormalised topoisomerase IA (Figure 3.9b), with a distinctly wedge 
shaped signal intensity ratio.  The measured intensities are transformed so that the 
variance becomes independent of the mean and calibrated to account for inter-array 
variation.  The MA plot of VSN normalised topoisomerase IA has a more even 
distribution over the full range of signal intensities (Figure 3.9b)  Furthermore, the 
intensity dependent bias of the raw data is reduced dramatically, with the data being 
roughly distributed around an intensity ratio of zero across the range of average 
signal intensities.  The relative distribution of signal intensity across arrays is also 
reduced, although several arrays no longer have the smooth normal distribution seen 
in the raw data (Figure 3.9a).  An alternative two-step normalisation of the 
microarray data gave even better normalisation within and between microarrays, 
through the combined use of loess and scale normalisations.  The loess normalisation 
adjusts for the intensity dependent bias observed in the MA plot by subtracting the 
bias estimated for a specified average signal intensity (i.e. adjusting the M value with 
respect to the A value).  The loess normalisation corrects for technical bias between 
fluorophores within an array.  To normalise between microarrays a scale 
normalisation is performed that standardises the distribution of all of the arrays by 
scaling the log-ratios to have the same median absolute deviation (MAD).  To 
calculate the MAD the intensity of each probe is divided by the median deviation of 
all probes on the array.  Following loess and scale normalisation there is no longer an 
intensity dependent bias in the MA plot (Figure 3.9b) and the relative distribution of 
signal intensity across arrays is more similar than in the unnormalised or VSN 
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normalised data (Figure 3.9a).  Therefore, subsequent analysis was performed on 







Figure 3.9 Microarray normalisation comparison.  a) Signal intensity 
distribution of topoisomerase ChIP microarray Cy3 (green) and Cy5 (red) 
channels with and without normalisation.  b) An example MA plot for 
topoisomerase I sample A1, indicating the intensity dependent bias prior to 







3.2.3.2 Inter-array variability 
ChIP replicates show high similarity for each of the topoisomerase experiments, with 
topoisomerase I and topoisomerase IIβ having especially strong reproducibility of 
distribution between replicates (Figure 3.10).  Treating the cells with camptothecin 
prior to topoisomerase I did not alter the distribution of topoisomerase I when 
compared to control samples (Figure 3.10).  This indicates that camptothecin has not 
stalled topoisomerase at specific points within the loci studied.  The camptothecin 
dependent degradation of topoisomerase I observed by western blot indicates that 
camptothecin is working in a manner similar to previous studies (Desai et al., 1997).  
Assuming the selection of gene rich/poor loci on the custom tiling arrays are 
representative of regions that topoisomerase I is likely to be active (see Section 2.7), 
there are a number of possible explanations for the similarity between camptothecin 
treated and non-treated samples.   For example, the majority of topoisomerase I may 
already be in close spatial proximity with certain regions in the chromatin.  This is 
supported by Dam-ID data in Drosophila where the distribution of topoisomerase I is 
identified in specific chromatin domains in an assay that identifies distribution 
independent of activity.  Chromatin stability experiments suggested that the majority 
of topoisomerase I is not stably associated with the chromatin (Figure 3.3 and 3.5), 
despite its nuclear localisation (Figure 3.2).  Together this data argues that 
topoisomerase I is enriched in certain regions of the genome and that camptothecin 
treatment does not enhance the detection of these regions.  Therefore, because of the 
similarity between camptothecin and non-treated topoisomerase I ChIP distributions, 
these samples were treat as quadruplicates and the mean value of the four samples 
was used in subsequent analysis, represented as the mean distribution in Figure 3.10. 
A similar situation is seen in the topoisomerase IIβ replicates, with a strong 
correspondence between replicates and between drug-treated and non-treated 
samples (Figure 3.10).  The distribution of topoisomerase I and topoisomerase IIβ 
samples are clearly distinct, supporting a ChIP specific enrichment for each protein 
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in different regions of the genome.  ICRF193 treated and non-treated samples were 
also treat as quadruplicates in subsequent analysis (mean distribution Figure 3.10). 
The variability between topoisomerase IIα replicates was higher than observed for 
topoisomerase I and IIβ, giving a less clear domain distribution (Figure 3.10).  
Furthermore, one of the ICRF193 treated replicates failed at the hybridisation stage 
and was discounted from subsequent analysis.  The mean distribution of the three 
remaining samples has a similar distribution to that of topoisomerase IIβ (Figure 
3.10), consistent with the observations of Cowell et al. (2012).  Subsequent analysis 






















Figure 3.10 Topoisomerase ChIP microarray replicates show 
reproducibility.  The distribution of topoisomerase ChIP data across the 
LDHA locus for each of the microarray experiments.  Topoisomerase I and 
IIβ show high levels of reproducibility which is clearly reflected in the mean 
distribution.  Topoisomerase IIα is more variable, but the mean distribution 




3.2.4  Topoisomerases are enriched in large 
chromosomal domains 
To identify the distribution of topoisomerase I, IIα and IIβ across loci the normalised 
probe intensities were submitted as custom tracks to the UCSC genome browser.  
This analysis identified domain scale enrichments of tens to hundreds of kilobases 
(Figure 3.11).  The domains of topoisomerase I and II proteins appear to be distinct, 
whilst topoisomerase IIα and IIβ show similar distributions, as illustrated across the 
LDHA and IGBP1 loci.  To determine the properties of these topoisomerase domains 
a rolling mean edge filter was used to determine the boundaries of topoisomerase 
enrichments (Materials and Methods Section 2.8.4.2).  Stringent cut-offs were used 
to determine the points where a consistent enrichment becomes a consistent 
depletion, or vice versa, and the median value determined between boundaries.  
Topoisomerase domains were defined as regions with a positive median value, 
identifying 94 topoisomerase I, 112 topoisomerase IIα and 102 topoisomerase IIβ 
domains with a mean size of 86 kb, 95 kb and 102 kb respectively.  These domains, 
displayed as coloured bars on Figure 3.11, were used for subsequent analyses of the 
inter-relationships between topoisomerases and the relationship between 
topoisomerase enzymes and other properties of DNA sequence, structure and 














Figure 3.11 Topoisomerases are enriched at a domain scale. 
Topoisomerase I, IIα and IIβ ChIP enrichment across the LDHA and IGBP1 
loci, with enriched domains marked as red, green or blue boxes respectively.  
Distribution taken from the UCSC genome browser using custom tracks 
smoothed with a 27 probe rolling median.  Enriched domains calculated 
using an edge filter, as described in Materials and Methods Section 2.8.4.2.  




3.2.4.1 Properties of topoisomerase domains 
To investigate the relative distributions of topoisomerase I, IIα and IIβ across human 
loci, the relative enrichment of each topoisomerase was identified for each type of 
topoisomerase domain (Figure 3.12).  Topoisomerase IIα and IIβ domains show 
strong enrichment for one another, supporting observations in the UCSC genome 
browser that these proteins are enriched at similar positions (Figure 3.11). On the 
other hand, topoisomerase I is not strongly enriched at topoisomerase II domains, 
and topoisomerase IIβ is depleted with high significance at topoisomerase I domains.  
This indicates a separation of topoisomerase I and II across the genome and suggests 























Figure 3.12  Topoisomerase enrichment within topoisomerase domains.  
Enrichment of topoisomerase I, IIα and IIβ in the topoisomerase domains.  
Black boxplots represent the probes not contained within the domain for each 
topoisomerase separately.  Scale is log2 enrichment, p is a two-tailed 





To identify the sequence, structural and functional characteristics of the 
topoisomerase domains, which may account for the separate distributions of 
topoisomerase I and II enzymes, a comparison was made with online and in-house 
datasets.  Comparing the nucleotide composition of topoisomerase domains 
identified that topoisomerase I domains are strongly enriched for GC, whereas 
topoisomerase IIα and IIβ domains are associated with more AT rich regions of the 
genome (Figure 3.13a).  At a simple level this indicates that topoisomerase I domains 
are associated with gene rich regions, which are typically GC rich, whereas 
topoisomerase II domains are likely to be in gene poor regions.  To test this directly 
the number of transcription start sites (TSSs) per 10 kb was quantified for each 
topoisomerase domain.  Topoisomerase I domains are strongly enriched for TSSs 
when compared to topoisomerase II domains (Figure 3.13b), further supporting the 
relationship between topoisomerase I, high GC and genes.    
The indication thus far is that topoisomerase I is associated with genes and 
topoisomerase II is associated with gene poor regions.  To identify if this 
corresponds to a relationship between topoisomerase I and transcription, the relative 
enrichment of RNA polymerase II was identified for each type of topoisomerase 
domain using RNA polymerase II ChIP data from within the lab (Naughton et al., 
2013a).  RNA polymerase II was strongly enriched in topoisomerase I domains 
compared to topoisomerase II domains, with a weak significant enrichment at 
topoisomerase IIα compared to topoisomerase IIβ domains (Figure 3.13c).  This 
argues that topoisomerase I is important for remodelling DNA structure at 
transcriptionally active regions within the genome (investigated further in Section 
3.2.5).   
The remodelling of DNA structure by topoisomerases is essential for efficient 
transcription and cell cycle progression, but the relationship between DNA 
supercoiling and topoisomerase distribution in humans is unknown.  To identify this 
relationship the relative enrichment of psoralen in each of the topoisomerase domains 
was identified using psoralen-IP data generated in the lab (Naughton et al., 2013a) .  
Psoralen binds preferentially to under-wound DNA, giving a relative indication of 
DNA supercoiling across the genome (see Sections 1.2.5 and 4.1).  Psoralen was 
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strongly enriched in topoisomerase I domains and depleted in topoisomerase IIα and 
IIβ domains (Figure 3.13d).  This identifies that topoisomerase I domains have a 
more under-wound DNA structure, which is associated with transcription and a more 
accessible chromatin structure (Bermúdez et al., 2010; Matsumoto and Hirose, 2004; 
Naughton et al., 2013a), whilst topoisomerase II have an over-wound DNA structure 
associated with gene repression (Bermúdez et al., 2010; Matsumoto and Hirose, 
2004; Naughton et al., 2013a).   
Together this data identifies for the first time how topoisomerases are distributed 
within the human genome.  The domain scale enrichment of topoisomerases is 
related to sequence, RNA polymerase II distribution and DNA structure.  To further 
characterise the relationship between topoisomerases, RNA polymerase II and DNA 


















Figure 3.13 Sequence, functional and structural properties of 
topoisomerase domains.  Topoisomerase I (red), IIα (green) and IIβ (blue) 
domain boxplots for a) GC percentage distribution, b) number of transcription 
starts sites per domain, c) RNA polymerase II enrichment and d) DNA 
supercoiling measured by psoralen enrichment.  GC percentage distribution 
is measured per domain to give the overall distribution across domains.  RNA 
polymerase II enrichment was derived from ChIP experiments and psoralen 
enrichment from psoralen-IP experiments performed in the lab for (Naughton 
et al., 2013a).  The dotted line in d) represents the boundary for under-wound 
DNA (enriched for psoralen relative to genomic therefore above the line) and 
over-wound DNA (depleted for psoralen relative to genomic therefore below 
the line).  Significance was identified by students t test with the p value 





3.2.5  RNA polymerase II and topoisomerase I co-
localise in vivo 
There is a clear positive correlation between topoisomerase I and RNA polymerase II 
in the analysis of topoisomerase domains (Figure 3.13c).  To further characterise this 
relationship, the distribution of topoisomerases and RNA polymerase was examined 
at a probe-by-probe scale.  The distribution of RNA polymerase II data across the 
loci displays a strong relationship with topoisomerase I, at a domain scale and at the 
scale of individual genes (Figure 3.14a).  A scatter plot confirms this close 
relationship, with the Pearson’s moment correlation coefficient between 
topoisomerase I and initiating RNA polymerase II of 0.79.  Therefore, the correlation 
between topoisomerase I and RNA polymerase II is comparable to the correlations 
between total and initiating RNA polymerase (Pearson’s 0.78) (Figure 3.14b), which 
also has a similar distribution at a gene and domain scale (Figure 3.14a).  Consistent 
with the domain scale observations, topoisomerase IIα shows a poor correlation with 
RNA polymerase II (Pearson’s 0.26) and topoisomerase IIβ shows no correlation 
(Pearson’s 0.09).  This is reflected in the domain and promoter scale distributions 
(Figure 3.14a) and in the scatter plots (Figure 3.14b).  Together this data identifies at 
high resolution the co-localisation of topoisomerase I and RNA polymerase II across 
megabase-scale loci of the human genome, and identifies no such general 
















Figure 3.14 Relative distribution of topoisomerases and RNA 
polymerase II.  a) Topoisomerase and RNA polymerase II distribution across 
the LDHA locus (left) and at the TMEM106 promoter (right).  b) Scatter plots 
of the relationship between topoisomerase and RNA polymerase II 
distribution from ChIP-chip experiments.  Initiating and total polymerase ChIP 





3.2.6  Topoisomerase I and II are strongly enriched in 
distinct DNA supercoiling domains. 
The observation that topoisomerase I domains are strongly enriched for under-wound 
DNA whereas topoisomerase IIα and IIβ domains are strongly enriched for over-
wound DNA identifies a relationship between topoisomerase and DNA supercoil 
distribution (Figure 3.13d).   To investigate the in vivo relationship between DNA 
supercoiling and topoisomerases further, the relative enrichment of topoisomerase I, 
IIα and IIβ was identified for the DNA supercoil domains characterised in Naughton 
et al. (2013).  These domains classify the genome into regions that are under-wound, 
stable or over-wound using a psoralen-IP approach.  Under-wound domains are 
associated with transcriptionally active GC rich sequences whereas over-wound 
domains are associated with inactive AT rich regions and stable domains have 
intermediate properties (Naughton et al., 2013a).  Topoisomerase I is significantly 
enriched in under-wound DNA supercoil domains and depleted in both the stable and 
under-wound domains (Figure 3.15a and 3.15b), supporting the model that the major 
function of topoisomerase I is in the maintenance of DNA supercoils at 
transcriptionally active regions.  Topoisomerase IIα and IIβ are both strongly 
enriched in over-wound DNA supercoil domains and depleted in under-wound 
domains (Figure 3.15a and 3.15b).  Therefore, distinct DNA supercoil domains are 









Figure 3.15 Topoisomerase enrichment in DNA supercoiling domains.  
a) DNA supercoil and topoisomerase distribution at the IGBP1 and 11p15.5 
loci.  DNA supercoiling analysis on data from C. Naughton.  DNA supercoil 
domains data from Naughton et al. (2013).  b) Boxplot of topoisomerase 
enrichemnt for the DNA supercoil domains.  T-test p values are: ‘ns’ not 





3.2.7  Topoisomerase depletion at telomeres and 
common fragile sites 
An analysis of the pattern of topoisomerase binding across loci identifies a number of 
sites at which the general relationships between topoisomerases and DNA 
supercoiling identified in Section 3.2.4 break down.  At the telomere of chromosome 
11 and fragile sites on chromosomes 1, 3, 16 and 17 there is an unusually strong 
depletion for topoisomerase I.  In the case of the p-arm telomeric end of chromosome 
11, there is a pronounced ~200 kb depletion of topoisomerase I followed by a low 
level enrichment 1 Mb downstream (Figure 3.16a).  Unusually, this topoisomerase I 
enrichment corresponds to a domain of over-wound DNA and not with an 
enrichment for topoisomerase IIα or IIβ.  The boundary of topoisomerase I 
enrichment and depletion does not correspond to a change in DNA supercoiling, 
indicating that the strong depletion for topoisomerase I does not significantly alter 
DNA structure at the chromosome end.  Together this data identifies that at human 
telomeres, the general patterns of topoisomerase and DNA structure identified 
elsewhere in the genome do not apply. In yeast, the introduction of over-wound DNA 
supercoils does not affect gene expression in the region < 100 kb from the telomeric 
end and it is likely that this is due to the free diffusion of supercoils from the DNA 
(Joshi et al., 2010).  This is consistent with the region of topoisomerase I depletion in 
human cells and indicates that human telomeres may also release DNA supercoiling 
independent of topoisomerase activity.  
Another breakdown in the relationship between topoisomerases and DNA 
supercoiling is observed at the common fragile sites FRA3B and FRA16D (Figure 
3.16b).  In both CFSs there is a strong depletion for both topoisomerase I and 
topoisomerase II over a ~1 Mb region.  Furthemore, at the RNU1 and RNU2 fragile 
sites, which are induced following adenovirus infection, a similar depletion is 
observed (data not shown).  The coordinated depletion of topoisomerase I, IIα and 
IIβ is not observed for any other loci investigated.  Furthermore, these sites have an 
unusual DNA structure, with a consistent over-wound DNA structure over several 
megabases.  Together this data indicates that a lack of topoisomerase I, IIα and IIβ 
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enzymes could contribute to the genome instability observed at fragile sites.  This 

























Figure 3.16 Topoisomerases are depleted at telomeres and common 
fragile sites.  a) Topoisomerase I is depleted at the telomeric end of 
chromosome 11p.  The plot shows the first 1.2 Mb of chromosome 11, with a 
scale bar to indicate genomic distance.  The scale of enrichment/depletion is 
consistent between the four samples (-2 to 1 log2 fold enrichment).  b) 
Topoisomerase I, IIα and IIβ are depleted at common fragile sites.  The plots 
show the FRA3B and FRA16D loci to the same scale.  The scale of 
enrichment is consistent between the four samples (-1 to 1 log2 fold 
enrichment).  DNA supercoiling data generated by Naughton et al (2013).  In 




3.2.8  Topoisomerase distribution at promoters 
supports distinct biological function 
The majority of coding and non-coding transcription occurs at gene promoter regions 
making promoters a hotspot for the generation of DNA supercoiling.  The 
distribution of topoisomerases at promoter regions has been proposed to regulate and 
maintain DNA supercoiling at these sites, but the general distribution of 
topoisomerase I and II at human promoters remains unknown.  Several studies have 
identified enhanced topoisomerase binding at transcription start sites (e.g. Cowell et 
al., 2012; Kouzine et al., 2013; Lyu et al., 2006; Sano et al., 2008) but no consensus 
as to the distribution of topoisomerases at TSSs has been established.  Most recently 
Kouzine et al. (2013) proposed a model whereby topoisomerase I has a diffuse 
activity upstream of the transcription start site whereas topoisomerase II has a more 
focal distribution at the transcription start site, particularly in highly expressed genes.  
To test this model and establish the distribution of topoisomerase enzymes with 
respect to gene promoters the topoisomerase ChIP data was analysed with respect to 
gene promoters. 
 
3.2.8.1 Topoisomerases have a focused enrichment at the 
transcription start site of expressed genes 
Topoisomerase distribution at transcription start sites on the Agilent custom tiling 
arrays identified peaks of topoisomerase I, IIα and IIβ at the TSS relative to a 
position 2.5 kb upstream (data not shown), but further analysis of this data was 
limited by the small number of transcription start sites (372 TSSs) on the array.  To 
investigate topoisomerase distribution at gene promoters in more detail, particularly 
with respect to gene expression, topoisomerase I and topoisomerase IIβ samples were 
hybridised to Nimblegen whole chromosome 11 microarrays (2,509 TSSs).  These 
samples were chosen due to their clear reproducibility and distinct distributions in 
earlier analysis (section 3.2.3.2).  Microarrays were analysed and normalised as 
described in Section 3.2.3.1.  
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To idenfity the distribution of topoisomerases at gene promoters, the mean ChIP 
enrichment over a 5 kb region centred on the transcription start site was identified for 
expressed genes (487 TSSs) compared to non-expressed genes (1161 TSSs).  
Topoisomerase I is clearly enriched at the transcription start site of expressed genes 
when compared with non-expressed genes (Figure 3.17a).  Topoisomerase IIβ is 
enriched 500 bp downstream of the transcription start site in the expressed compared 
to the non-expressed genes.  To identify if these enrichments could have occurred by 
chance, the distribution of topoisomerases around randomly selected points on the 
chromosome was performed for 487 points over thirty iterations.  The difference in 
topoisomerase binding was identified for four ranges within the dataset by students t-
test (-2500 to -2000, -500 to 0, 0 to 500 and 2000 to 2500 bp) with each iteration.  
After thirty iterations the topoisomerase I sample enrichment remained much more 
highly significant than the random samples at the transcription start site (Figure 
3.17b).  Furthermore, the upstream distribution of topoisomerase I was signficantly 
depleted compared to random iterations, making the TSS enrichment even more 
striking.  The topoisomerase I enrichment extends a short distance into the body of 
expressed genes, but by 2.5 kb downstream it is not significantly different from a 
random distribution.  Topoisomerase IIβ immediately downstream of the TSS (0-500 
bp) is also significantly enriched compared to random iterations, although the 
magnitude of this difference is clearly smaller than for topoisomerase I (Figure 
3.17b).  Downstream of the TSS at 2-2.5 kb there is a significant depletion of 
topoisomerase IIβ, consistent with the general depletion of topoisomerase IIβ at gene 
rich regions (Section 3.2.4).  This can be seen to continue upstream of the TSS, but at 
2-2.5 kb there is a non-significant difference between topoisomerase IIβ and random 
iterations for expressed genes.  What the significance of this upstream enrichment is 
not immediately obvious.  Together this data identifies a clear enrichment of 
topoisomerase I and IIβ at the transcription start sites of expressed genes.  The 
enrichment of both topoisomerases is focused at the TSS supporting the ‘focal mode’ 






Figure 3.17 Focal enrichment of topoisomerases at the TSS of gene 
promoters.  a) The distribution of expressed (blue) and non-expressed (red) 
genes over 5 kb centred on the TSS.  To assess the significance between 
distributions, Student’s t-tests were performed on four data ranges:  -2500 to 
-2000, -500 to 0, 0 to 500 and 2000 to 2500.  T-test values are recorded in 
the table for each of the data ranges.  b) Peak significance determined by 
iteration analysis on random positions.  To identify if the observed peaks 
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 could have occurred by chance, the distribution of topoisomerases was 
identified around 30 sets of random probes and a t-test performed between 
sample and each set of random probes for the same four data ranges.  The 
table records the highest p-value observed in the iterations, giving an 
indication of sample enrichment over random positions.  P-values were 
calculated from the 30 iterations: ns – not significant, hs – highly significant 
(p<1x10-10), p<0.05 – one p-value more than 0.05 out of 30, p<<0.05 – one 






3.2.8.2 RNA polymerase II and under-wound DNA 
supercoiling are enriched with topoisomerase at expressed gene 
promoters. 
To establish if the relationships between topoisomerase enrichment, gene expression, 
RNA polymerase II and DNA supercoiling that were observed for topoisomerase 
domains also hold true for gene promoters, the relative enrichment of RNA 
polymerase II and DNA supercoiling were analysed with respect to TSSs.  
Unsurprisingly RNA polymerase II is enriched at the TSSs of expressed genes 
compared to the distribution at non-expressed genes (Figure 3.18).  This enrichment 
follows the same distribution as that observed for topoisomerase I, supporting the 
domain analysis (Section 3.2.4) and probe-by-probe similarity (Section 3.2.5).  
Furthermore, the small peak of enrichment upstream of the TSS that is present in 
both non-expressed topoisomerase I and RNA polymerase II is indicative of paused 
polymerase, in agreement with previous data (e.g. Kwak et al., 2013).  On the other 
hand, there is no similarity between RNA polymerase II and topoisomerase IIβ 
distribution.  Therefore, RNA polymerase II and topoisomerase I co-localise at 
129 
 
transcription start sites as well as on a larger-scale, supporting in vitro data that they 
work together during transcription to relieve DNA supercoiling.   
To establish how DNA supercoil distribution is affected by RNA polymerase II and 
topoisomerase enrichment at TSSs, the relative enrichment of psoralen was identified 
for expressed and non-expressed genes.  Both expressed and non-expressed genes 
show a relative under-winding across the 5 kb centred on the TSS (control minus 
genomic value > 0), with the greatest enrichment for expressed genes (Figure 3.18).  
The under-wound structure of expressed promoters is interrupted by a more over-
wound structure at the TSS, an observation that is discussed further in Chapter 4.  
Together this data shows that there is a distinct expressed-promoter under-wound 























Figure 3.18 RNA polymerase II and under-wound DNA supercoils are 
enriched at TSSs in expressed genes.  The distribution of RNA 
polymerase II and DNA supercoiling over 5 kb centred on the TSS.  RNA 
polymerase expressed (blue) and non-expressed (red) shows a focal 
distribution around TSSs.  Psoralen is enriched in chromatin compared to 
genomic DNA at both expressed (blue) and non-expressed (red) TSSs.  DNA 
structure is more under-wound above the dotted line through zero and more 






3.2.8.3 Topoisomerase IIβ peaks at promoters do not 
correlate with increased expression 
To separate the role of topoisomerase I and II, promoters were identified with a peak 
of topoisomerase I only, topoisomerase IIβ only and both topoisomerase I and 
topoisomerase IIβ.  To achieve this, the distribution of each topoisomerase was 
seperated by kmeans clustering analysis into two clusters based on the mean-
normalised distribution around the TSSs.  In both topoisomerase I and topoisomerase 
IIβ the cluster seperated the promoters into a ‘peak class’ and a ‘trough class’, and in 
both cases the peak class had significantly higher expression (Figure 3.19a).  This is 
consistent with previous analysis identifying a relationship between expression and 
topoisomerase enrichment at TSSs (Section 3.2.8.1).  The overlap between 
topoisomerase I and IIβ peaks was established (Figure 3.19b) to identify TSSs that 
show singular or combined topoisomerase enrichment.  The majority of transcription 
start sites with a peak of topoisomerase have a peak for both topoisomerase I and IIβ 
(63%), with a notable minority having just topoisomerase I (21%) or topoisomerase 
IIβ (16%) peaks.  The expression level of promoters with a topoisomerase I peak or 
both a topoisomerase I and IIβ peak are not significantly different, but are 
significantly enriched compared to TSSs with a topoisomerase IIβ peak only.  This 
suggests that the presence of a peak of topoisomerase IIβ, either together with 
topoisomerase I or alone, does not correlate with increased expression.  To confirm 
that this is the case, a comparison was made between promoters with a 
topoisomerase IIβ peak only and the topoisomerase IIβ ‘trough class’ promoters 
(Figure 3.19c).  Despite a clear difference in the distribution of topoisomerase IIβ 
around the TSS, there is no significant difference in expression between genes with a 
topoisomerase IIβ peak only at the TSS and the ‘trough class’ of promoters.  
Together this data refutes the model proposed by Kouzine et al. (2013), supporting 
an alternative model where topoisomerase I is focally enriched in an expression 
dependent manner, whereas topoisomerase IIβ is enriched at promoters in an 









Figure 3.19 Topoisomerase IIβ peaks at TSSs are expression 
independent.  a)  Classifying promoters based on topoisomerase 
distribution.  Promoters clustered by k-means analysis with two clusters 
identify a ‘peak class’ and ‘trough class’ for both topoisomerase I and 
topoisomerase IIβ.  A comparison of expression between these clusters 
supports a relationship between topoisomerase peaks and expression.  
Significance determined by Student’s t-test.  b)  Classifying promoters based 
on the presence of topoisomerase I and IIβ peaks.  Venn diagram identifies 
that most promoters have both topoisomerase I and IIβ peaks.  Expression 
analysis of promoters with either topoisomerase I peaks, topoisomerase IIβ 
peaks or both identifies significantly lower expression in topoisomerase IIβ 
peak only promoters by Student’s t-test.  c)  Comparing topoisomerase IIβ 
only promoters with the topoisomerase IIβ trough class identifies no 










To provide the first high resolution analysis of topoisomerase I, IIα and IIβ in the 
human genome, ChIP-chip was performed in a human cell line.  During the 
validation of this ChIP protocol topoisomerases were shown to have a diffuse nuclear 
distribution in which the majority of topoisomerase is not tightly associated with the 
chromatin.  Despite this, ChIP analysis identified variable enrichment of 
topoisomerases across the genome.   
To identify the importance of topoisomerase enrichments, the distribution of each 
topoisomerase with respect to the underlying sequence was investigated more 
thoroughly.  An open question regarding topoisomerases was whether they form 
domain-scale or more focal enrichments in the human genome.  An analysis of the 
distribution of topoisomerases across the loci investigated identified large scale 
domains of enrichment with a mean span of ~100 kb.  These are similar in size to 
other large-scale regulatory domains in the human genome, including supercoiling 
domains (Naughton et al., 2013a), topological domains (Dixon et al., 2012) and 
cytologically determined chromosome loops (Earnshaw and Heck, 1985; Paulson 
and Laemmli, 1977).  Additionally, the co-transcriptional regulation of genes through 
a ‘transcription ripple effect’ has been shown to act at scales of 100 kb (Ebisuya et 
al., 2008), potentially through DNA supercoiling, and could be influenced by 
topoisomerase distributions at this scale.  The domains of topoisomerase I are 
enriched for GC, TSSs and RNA polymerase II, supporting the observations in 
Drosophila that topoisomerase I is found at transcriptionally active euchromatin 
(Filion et al., 2010).   
The relationship between topoisomerase I and RNA polymerase II is particularaly 
tight, with a correlation similar to that between different RNA polymerase II 
antibodies.  This supports the direct relationship between topoisomerase I and RNA 
polymerase II identified in Drosophila (Gilmour et al., 1986).  Based on RNA 
polymerase II and topoisomerase I ChIP, the major function of topoisomerase I in 
vivo is likely to be the resolution of transcription induced DNA supercoils.  Whether 
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topoisomerase I performs a similar role in replication cannot be determined from our 
data and may be difficult to measure by ChIP, due to variability in the position, 
timing and rate of replication in a population of cells.  However, experiments in 
Drosophila indicate that topoisomerase I activity is essential for cell proliferation 
(Zhang et al., 2000).   
The combined enrichment of RNA polymerase II, topoisomerase I and under-wound 
DNA supercoiling identifies that supercoiled DNA can be maintained in the presence 
of topoisomerase I in vivo.  The presence of under-wound DNA has been shown in 
vitro to promote transcription by increasing the rate of transcription intiation at the 
TSS (Tabuchi and Hirose, 1988).  One mechanism that could account for the 
maintainance of under-wound DNA is the fifty fold higher efficiency of 
topoisomerase I in the release of over-wound supercoils (Koster et al., 2005).  The 
significant depletion of topoisomerase I in topoisomerase IIβ domains suggests that 
the presence of over-wound DNA alone is not determining topoisomerase I 
distribution, as topoisomerase IIβ domains have a more over-wound DNA structure.  
Therefore, it may be that topoisomerase I is excluded from over-wound or 
topoisomerase IIβ domains to prevent the relaxation of the repressive DNA structure 
in these regions. 
The distribution of topoisomerase IIα and IIβ domains in the genome are distinct 
from the topoisomerase I domains.  The enrichement of topoisomerase IIα and 
topoisomerase IIβ is highly similar across domain scale enrichments, supporting at a 
gross-scale the observations at the MLL gene (Cowell et al., 2012).  Topoisomerase 
II domains are present in AT-rich, gene poor regions of the genome, supporting 
previous observations in Drosophila (Käs and Laemmli, 1992; Miassod et al., 1997) 
and rat (Sano et al., 2008).  This contradicts the study which presents topoisomerase 
II as the major relaxase in chromatin (Salceda et al., 2006), as the sites with the 
highest supercoil generation (i.e. most transcriptionally active) are those with the 
lowest levels of topoisomerase II.  Predictions from cytological data suggest that 
topoisomerase II forms the base of chromatin loops and is enriched in 
matrix/scaffold attached regions (MARS/SARS) (Earnshaw and Heck, 1985).   These 
MARS/SARS have not been mapped at high resolution, so the length of DNA 
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associated with them remains unknown.   In vitro topoisomerase II activity assays in 
Drosophila identify >10 kb enrichments of topoisomerase activity, which they say 
coincide with SARS.  However, the domain-scale enrichments of topoisomerase II 
observed by ChIP-chip are generally in excess of 100 kb.  This indicates that 
topoisomerase IIα or IIβ do not form points of focal enrichment at defined 
topological boundaries.  Attempts to analyse the distribution of topoisomerases at the 
boundaries of characterised domains, including LADs (Guelen et al., 2008), 
supercoiling domains (Naughton et al., 2013a) and topological domains (Dixon et al., 
2012), were unsuccessful due to a paucity of boundaries within the regions analysed 
and the poorly defined nature of these ‘boundary’ regions.  However, it seems likely 
that the model proposed in cytological studies is incomplete, with some domains 
being enriched in topoisomerase II over considerable genomic distance.  A model 
whereby over-wound DNA domains are enriched in topoisomerase II is not 
contradictory to the data presented in these cytological papers, as the proteins 
associated with the looped DNA regions is removed by high salt to expose the 
underlying nuclear matrix (Earnshaw and Heck, 1985).  Therefore topoisomerase II 
may be associated with the nuclear matrix and within some loops of the chromatin, 
perhaps in a continuous domain.  To established if this is the case, the precise 
molecular and genomic characteristics of MARS/SARS must be identified and 
compared with the distribution of topoisomerase II in vivo. 
Further characterisation of the topoisomerase II domains identified a relative over-
winding of the DNA structure in these regions.  Over-wound DNA has been 
associated with gene repression (Naughton et al., 2013a), supported by the depletion 
of RNA polymerase II in ChIP experiments.  A further potential function of over-
wound supercoiling is in the decatenation of chromosomes, a phenomenon that has 
been observed in prokaryotes (Martínez-Robles et al., 2009) and yeast plasmids 
(Baxter et al., 2011).  The co-localisation of a decatenating DNA structure and the 
decatenating enzymes topoisomerase IIα and IIβ could indicate that decatenation 
hotspots occur in gene poor regions of the genome.  As decatenation introduces 
transient double strand breaks into the DNA, which increase the potential for 
deleterious mutation, restricting this process to gene poor regions could be one 
mechanism to limit DNA damage in coding regions.  The enrichment of 
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topoisomerase IIα in these regions particularly supports this hypothesis, as it is 
predominantly expressed in S/G2/M phases of the cell cycle for the decatenation of 
chromosomes (Woessner et al., 1991).  To further establish whether topoisomerase II 
and over-wound DNA supercoiling work together in the cell-cycle to separate and 
package chromosomes, topoisomerase ChIP and psoralen-IP should be performed 
over a time course in synchronised cells.   
Mapping topoisomerases by ChIP-chip has identified that topoisomerase primarily 
form domain scale enrichments that correspond to different regions of the genome, 
with topoisomerase I enriched in active, under-wound euchromatin and 
topoisomerase IIα/β enriched in inactive, over-wound repressed chromatin.  Another 
important aim of this chapter was to identify the validity of the model of 
topoisomerase distribution at promoters proposed by Kouzine et al. (2013). In this 
model topoisomerase I has a diffuse enrichment upstream of the TSS, in an 
expression dependent manner, and topoisomerase II is enriched in a focal manner at 
highly expressed genes.  By analysing the distribution of topoisomerase I and IIβ 
over a 5 kb region centred on the TSS for 2,509 promoters I have established that the 
proposed model is incorrect.  Both topoisomerase I and topoisomerase II form focal 
distributions at gene promoters for around half of the genes, with no diffuse 
enrichment observed at the scale of the promoter region.  Separating promoters into 
those with a shared or those with an individual peak of topoisomerase I and II 
allowed the identification of the relationship between the topoisomerase peak and 
expression in vivo.  Genes with a topoisomerase I peaks at the promoter were 
generally expressed, as suggested by Kouzine et al. (2013).  However, genes with a 
peak of topoisomerase I and II at the promoter did not have a higher expression level 
than those with only a topoisomerase I peak.  Furthermore, those genes with a 
topoisomerase II peak only had significantly lower expression than either 
topoisomerase I only or topoisomerase I and II.  This contradicts the model by 
Kouzine et al. (2013) by suggesting that topoisomerase II forms a peak at many gene 
promoters independent of expression.  Other studies have observed topoisomerase II 
enrichment in non-expressed genes, with a study comparing gene expression in WT 
and topoisomerase IIβ KO rat brains suggesting only ~2% of genes were dependent 
on topoisomerase IIβ for their regulation (Lyu et al., 2006).  Therefore, the model 
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proposed by Kouzine et al. (2013) is inappropriate as a general model for 
topoisomerase function, but it is possible that it applies to a small subset of genes.  
Based on the extensive topoisomerase ChIP-chip data generated, a model in which 
topoisomerase I forms an expression depdendent peak of enrichment at the TSS 
whereas topoisomerase II is present at many promoters in an expression independent 
capacity is more appropriate.  This model is further supported by the ratchet like 
mechanism of topoisomerase I, which releases more DNA supercoils per reaction 
when the tension in the DNA is higher (Koster et al., 2005).  Topoisomerase II, on 
the other hand, is limited to the release of two supercoils per reaction independent of 
DNA supercoil intensity.  Therefore, the role of topoisomerase I activity in the 
release of DNA supercoils at expressed gene promoters is clear, whereas the 
mechanism of topoisomerase II remains unclear. 
The aim of this chapter was to provide a comprehensive understanding of 
topoisomerases in the human genome.  Through a ChIP approach topoisomerases 
have been shown to form diffuse distributions over large domains and more focal 
distributions at transcription start sites.  This suggests that both topoisomerase I and 
II proteins function at different scales in the human genome.  Topoisomerase I is 
associated with active regions and at the promoters of active genes, maintaining an 
under-wound structure through a diffuse distribution at a ~100 kb scale and a focal 
distribution at transcription start sites.  Topoisomerase II proteins are found in gene 
poor regions  and at the transcription start sites of around half of the genes analysed 
in an expression independant manner.  The function of topoisomerase II proteins in 
these locations is uncharacterised in vivo.  One interesting possibility is that 
topoisomerase II enriched regions are decatenation hotspots,  with further work 
necessary to test this hypothesis.  The distribution of topoisomerases at transcription 
start sites does not follow the model proposed by Kouzine et al. (2013) and a new 
model is proposed in which topoisomerase I is the major factor in the relief of 








The distribution of topoisomerases (Chapter 3) and the identification of DNA 
supercoil domains (Naughton et al., 2013a) in the human genome  raises questions 
about the role of DNA supercoiling in regulating gene expression in vivo.  A number 
of studies have indicated that the DNA supercoiling primarily influences expression 
through the modification of gene promoter structure (Mizutani et al., 1991a, 1991b; 
Tabuchi and Hirose, 1988).  For example, an in vitro experiment that separates the 
transcription of the Bombyx mori fibroin gene into a) initiation complex formation, b) 
conversion to the elongation complex and c) subsequent elongation, identifies that 
only the initiation complex formation is positively influenced by under-wound DNA 
supercoiling (Tabuchi and Hirose, 1988).   The identification of a focused 
enrichment of under-wound DNA supercoils at gene promoters in human, fly and 
hamster supports this mechanism in vivo (Jupe et al., 1993; Ljungman and Hanawalt, 
1992, 1995).  Furthermore, two recent analyses of several hundred human promoters 
have identified that an ‘average’ gene promoter has a transcription dependent under-
wound structure (Kouzine et al., 2013; Naughton et al., 2013a).  To better understand 
the role of DNA supercoiling at human gene promoters a much larger-scale analysis 
is required, in which promoters can be separated by known and novel structural 
properties.   
Two general approaches have been developed to determine the distribution of DNA 
supercoiling, taking advantage of the characteristic transitions in DNA twist and 
writhe.  One of these methods utilises the differential migration of relaxed and 
supercoiled plasmid DNA through gradients/gels and separates them based on 
plasmid structure, whereas the second method utilises a psoralen based probe that 
preferentially intercalates into under-wound DNA.  Using variations on these two 




Early studies of DNA plasmids by sucrose gradient sedimentation identified that 
different structures exist in a sample containing only plasmids of equal molecular 
weight.  The nature of this structural difference was identified by Vinograd et al. 
(1965), who showed that a single-strand nick caused the sedimentation of a single 
structure and that plasmid DNA usually had a ‘twisted circular structure’, 
subsequently named supercoiled DNA.  The gross structural difference between 
relaxed and supercoiled DNA plasmids measured in these sucrose gradient 
experiments are now utilised in several assays for DNA supercoiling.  In each case 
supercoiled plasmids move through the gradient/gel more rapidly than relaxed 
plasmids, due to their more compact structure. In agarose gel electrophoresis the 
difference between relaxed and supercoiled plasmids is particularly clear, with each 
topoisomer forming a distinct enrichment to give a ‘ladder’ of DNA molecules with 
different levels of supercoiling (Figure 4.1a).  One dimensional (1D) agarose gel 
electrophoresis clearly displays the difference between supercoiled and relaxed 
plasmids, but a modification of this protocol in a second dimension allows the 
resolution of a wider range of topoisomers including the identification of positively 
and negatively supercoiled plasmids.  In 2D agarose gel electrophoresis plasmids are 
initially separated through a gel as in 1D agarose gel electrophoresis.  The gel is then 
soaked in a buffer containing the intercalating agent ethidium bromide, which 
introduces over-wound supercoils into the plasmids, and run at 90° to the original 
electrophoresis separating the plasmids in a second dimension (Figure 4.1b).  These 
techniques have been used extensively to model the properties of supercoiled DNA 
in vitro, but are limited to plasmid systems.  However, an elegant adaptation of the 
cre-lox system has allowed the characterisation of DNA supercoiling at a limited 
number of sites in vivo  (Kouzine et al., 2008).  This study aimed to identify the 
structural properties of the FUSE sequence under in vivo DNA supercoiling 
conditions.  To do this a construct containing loxP sites flanking the region of 
interest was stably transfected into human cells and the cre-lox system used to excise 
DNA minicircles in the in vivo supercoiled state for analysis by 2D gel 
electrophoresis.  Using this technique it was established that under-wound DNA 
upstream of promoters increases with transcription and that supercoiling can cause 
the FUSE element to adopt a non-B DNA conformation that recruits specific 
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transcription factors.  This clearly demonstrates the importance of DNA supercoiling 







Figure 4.1 Differential migration of relaxed and supercoiled DNA 
plasmids.  a) Agarose gel electrophoresis of DNA in a supercoiled state and 
progressively relaxed with topoisomerase I clearly identifies topoisomers.  
Image from Li et al. (2005).  b) Two dimensional (2D) agarose gel 
electrophoresis.  Topoisomer 15 is relaxed DNA, topoisomers 14 to 1 are 
more over-wound and topoisomers 16 to 28 are more under-wound.  Image 






To characterise the genome-wide distribution of DNA supercoiling in vivo, 
techniques have been developed based on the relative intercalation of psoralen.  
There is a linear relationship between DNA supercoiling and psoralen intercalation, 
with an increase from over-wound, through relaxed to under-wound DNA 
(Bermúdez et al., 2010).  This preference occurs because the intercalation of psoralen 
into DNA induces a slight over-wound twist to the double helix, which is more 
energetically favourable on an under-wound template.  Once intercalated a psoralen 
molecule can be covalently cross-linked to the DNA by UV irradiation and the 
relative enrichment determined on purified DNA.  Initial analysis focussed on the 
difference between prokaryotic and eukaryotic genomes, concluding that the genome 
of E. coli is maintained in an unrestrained under-wound state whereas eukaryotic 
genomes have no net unrestrained DNA supercoiling (Sinden et al., 1980).  
Subsequent analyses at specific promoters, enhancers and genomic loci have 
identified that there is in fact variability in DNA supercoiling across eukaryotic 
genomes, including yeast, fly and human (Bermúdez et al., 2010; Jupe et al., 1993; 
Kouzine et al., 2013; Ljungman and Hanawalt, 1992, 1995; Matsumoto and Hirose, 
2004; Naughton et al., 2013a).  Two recent papers have adapted the use of psoralen 
for the identification of DNA supercoiling over large regions of the genome by 
microarray analysis.  To enrich for psoralen bound DNA, Kouzine et al. (2013) UV 
cross-linked psoralen to DNA stands and, after denaturation, digested the unbound 
single stranded DNA.  Our lab has developed a second approach to enrich for 
psoralen, using a biotinylated trimethylpsoralen (bTMP) which can be selectively 
immunoprecipitated using streptavidin coated beads (Naughton et al., 2013a).  I have 
used this approach to investigate the distribution of DNA supercoiling at human gene 
promoters to understand the role of DNA supercoiling in regulating promoter 
structure and function 
Psoralen is a tricyclic compound, composed of a furan ring and a coumarin, that 
forms covalent bonds with pyrimidine bases upon photo-crosslinking (Cimino et al., 
1985).  A number of derivatives of psoralen have been isolated either as a natural 
plant product or through chemical synthesis, including isopsoralen, 8-
methoxypsoralen, 4,5’ ,8-trimethylpsoralen, 4’ –hydroxymethyl-4,5’ ,8-
trimethylpsoralen and 4’aminomethyl-4,5’ ,8-trimrthylpsoralen.   The most 
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commonly used psoralen molecule for the investigation of DNA structure is 4,5’,8-
trimethylpsoralen (Figure 4.2a) (TMP). TMP is a cell permeable planar molecule that 
intercalates between base pairs in the DNA double helix and forms stable photo-
crosslinks with pyrimidine nucleotides upon exposure to near UV light (Cech and 
Pardue, 1977).  TMP can form mono-adducts or inter-strand cross-links in the DNA 
double helix between the 4’,5’ furan double bond and/or the 3,4 pyrone double bond 
of the TMP molecule (Figure 4.2a) and the 5,6 double bond of cytosine or thymine 
(Figure 4.2b, available bond in red, unavailable bind in blue) (Kanne et al., 1982).  
Despite available interaction sites for both thymine and cytosine nucleotides, a 
number of studies have indicated that TMP has a preference for thymine cross-links 
(Esposito et al., 1988; Kanne et al., 1982; Song and Ou, 1980).  Whether this 
preference results from differences in nucleotide structure or the structure of helices 
containing cytosines is currently unknown.  Further analysis of the sequence 
preference of TMP identified a complicated and unpredictable relationship, with a 
preference for 5’TA over 5’AT, a strong influence of flanking bases up to 3 bp either 
side of the interaction site and potential long range effects over tens of base pairs 
(Esposito et al., 1988).  The clear influence of the local sequence context on TMP-
DNA interactions suggests that the DNA helical structure is important for TMP 















Figure 4.2 bTMP and nucleotide structures indicate potential cross-
linking sites.  a)  The structure of bTMP.  The molecule is made up of a 
biotin, a linker and a TMP.  BTMP forms adducts with nucleotides at the 4’,5’ 
furan double bond and/or the 3,4 pyrone bond, both marked in red.  b) The 
structure of the nucleotides in DNA.  BTMP forms adducts with the 5,6 
double bond, which is available in pyrimidines (marked red) and unavailable 





The intercalation of TMP into the DNA introduces over-wound DNA supercoils into 
the DNA, in a mechanism similar to other intercalating agents including ethidium 
bromide and chloroquine (Bates and Maxwell, 2005).  As the over-winding of an 
under-wound DNA helix towards a more relaxed state is more energetically 
favourable than further over-winding an already over-wound helix, the intercalation 
of TMP favours an under-wound DNA helix.  This relationship between DNA 
supercoiling and TMP intercalation has been shown to be linear in a plasmid system 
(Bermúdez et al., 2010), indicating that TMP binding gives a good representation of 
the underlying DNA supercoiling.  Using TMP derivatives a number of groups have 
identified regions of relative under-/over- winding in the genomes of model 
organisms (Bermúdez et al., 2010; Jupe et al., 1993; Ljungman and Hanawalt, 1995; 
Matsumoto and Hirose, 2004) and human cell lines (Kouzine et al., 2013; Ljungman 
and Hanawalt, 1992; Naughton et al., 2013a).  Together with in vitro studies which 
suggested that under-wound DNA increases transcription efficiency and promotes 
the formation of a pre-initiation complex (Mizutani et al., 1991a, 1991b; Tabuchi and 
Hirose, 1988), it became apparent that DNA supercoiling at gene promoters had the 
potential to regulate gene expression in eukaryotes.  However, a genome-wide 
analysis of DNA supercoiling at human gene promoters has not been examined. 
Two recent publications have taken the first steps in understanding the general 
principles of DNA supercoiling at transcription start sites in human cells.  Using a 
novel bTMP pull-down approach, our lab performed a meta-analysis on the 
promoters of 584 genes and identified a topoisomerase and transcription dependent 
peak of under-wound DNA at gene promoters, which was particularly enriched at 
expressed genes (Naughton et al., 2013a).   A second study identified a similar 
under-wound structure in the absence of transcription inhibitors through a meta-
analysis of 445 gene promoters (Kouzine et al., 2013).  These studies identify 
transcription dependent differences in DNA supercoiling at gene promoters but, due 
to their small-scale, are unable to identify DNA supercoiling promoter sub-types.   
To establish structural and functional classes of gene promoter based on DNA 
supercoiling, I have performed a more extensive analysis of gene promoters using the 
bTMP pull-down approach.  In this technique a cell-permeable bTMP molecule 
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(Figure 4.3) (Saffran et al., 1988) is added to the culture media and after a short 
incubation period the cells are cross-linked by irradiation at 365 nm.  Cells are then 
lysed, the DNA is fragmented by sonication, purified and immunoprecipitated using 
streptavidin coated magnetic beads.  The enriched psoralen-bound DNA and 
corresponding inputs are amplified, labelled and hybridised to 2 colour microarrays 
covering regions of interest.    Using this technique, my study will characterise the 
supercoiling properties of gene promoter using genome wide promoter microarrays 
and to relate this to topoisomerase binding (Chapter 4) and other genomic features 
including transcription and base composition.  This analysis aims to identify novel 
properties of gene promoters and provide a comprehensive understanding of 




















Figure 4.3 bTMP immunoprecipitation.  Cells were incubated with bTMP 
(red structure) and cross-linked by irradiation at 365 nm.  Cells were lysed 
and the DNA fragmented by sonication and purified.  To enrich for under-
wound DNA samples were immunoprecipitated using streptavidin magnetic 
beads (blue circles) and as a control non-immunoprecipitated input samples 
were retained.  The immunoprecipitated and input samples were heat treated 
in formamide to reverse the bTMP cross-link.  These DNA samples were 
amplified and labelled (red and green circles) before hybridisation to 






4.2.1  bTMP pull-down validation 
4.2.1.1 Synthesis and characterisation of the psoralen 
molecule 
In order to characterise DNA supercoiling at gene promoters bTMP was synthesised 
in conjunction with the group of Mark Bradley at the University of Edinburgh 
Chemistry Department.  The bTMP molecule was based on the molecule described in 
Saffran et al. (1988) and synthesised from trioxsalen as previously described 
(Naughton et al., 2013a; Saffran et al., 1988).   To confirm the purity of the bTMP an 
aliquot was analysed by high performance liquid chromatography mass spectrometry 
(HPLC-MS), identifying a single prominent peak by HPLC (Figure 4.4a), which 
together with NMR and ELSD data (data not shown) indicates a high level of sample 
purity.  HPLC-MS on this peak identifies two clear peaks at 555.1/556.3/557.2 and 
577.3/578.3/579.1 (Figure 4.4b).  The first peak corresponds to bTMP (molecular 
weight 554 Da) plus one/two/three protons whilst the second peak corresponds to 
bTMP plus two sodium and one/two/three p.  There are a number of peaks which do 
not correspond to the major constituent chemicals of the synthesis reaction, including 
trioxsalen (MW 228.24), 4’-(chloromethyl)trioxsalen (MW 276.7), 1,2-
dimethyldiaminoethane (MW 88.15) or NHS biotin (MW 341.38).  It is difficult to 
draw conclusions about these other masses, but it is clear that the synthesis reaction 
















Figure 4.4 HPLC-MS confirms bTMP synthesis.  a) HPLC identifies a 
single strong peak in the bTMP synthesis product.  b) MS identifies bTMP 









4.2.1.2 bTMP preferentially binds thymine in vitro 
Psoralen molecules have a reported binding preference for the nucleotide thymine, 
despite an available binding site in both cytosine and thymine (Figure 4.2).  In 
addition, several structural features of our bTMP molecule (Naughton et al., 2013a) 
could influence the reaction with DNA compared to other psoralens, including the 
charged linker region and increased molecular weight.  To establish the sequence 
preference of our bTMP a photo-crosslinking experiment was performed on poly-
d(AT) and poly-d(GC) oligonucleotides.  To establish the size of the commercial 
poly-purine:pyrimidine oligonucleotides DNA samples were run on a TBE agarose 
gel prior to photo-crosslinking (Figure 4.5a).  The poly-d(A)T oligonucleotides had a 
length of 500-1200 bp whereas the poly-d(GC) had a length ~400 bp, therefore each 
oligonucleotide has the potential to bind many bTMP molecules.  Photo-crosslinking 
experiments between these DNA fragments and bTMP identifies a reaction with 
poly-d(AT), but not with poly-d(GC) (Figure 4.5a).  Therefore, under these 
experimental conditions bTMP binds only thymine at detectable levels within this 
sequence context.   
The identification that DNA sequence can influence psoralen intercalation tens of 
base pairs from the site of interaction suggests that the helical structure of DNA is 
important factor in intercalation frequency (Esposito et al., 1988).  It is well 
established that poly-d(GC) oligonucleotides have a propensity to form non-B form 
DNA structures, including Z form structures (Thamann et al., 1981), which may 
influence bTMP intercalation.  To establish under a broad range of sequence contexts 
the binding preference of bTMP a photo-crosslinking reaction was performed on 
fragmented human genomic DNA (Figure 4.5b), followed by digestion to 
mononucleotides and analysis by HPLC-MS.  This experiment was performed once 
and identified a peak corresponding to bTMP bound thymine (MW 796 Da) in the 
photo-crosslinked sample (Figure 4.5b), but not in the non-crosslinked control.  No 
peak corresponding to bTMP bound cytosine (MW 781 Da) was identified in either 
the cross-linked or non-crosslinked sample.  Therefore under our experimental 
conditions in vitro bTMP binds detectably to thymine, but not to cytosine.  This 
supports the preferential binding of psoralen to thymine observed in previous studies, 
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Figure 4.5 bTMP binds to thymine.  a) bTMP preferentially binds to poly-
AT.  Left panel shows the size distribution of poly-AT and poly-GC 
oligonucleotides by agarose gel electrophoresis.  Right panel shows a dotblot 
probed for biotin following a bTMP photo-crosslinking reaction for each 
oligonucleotide.  b)  bTMP binds thymine in genomic DNA.  HPLC-MS for 
digested genomic DNA cross-linked to bTMP.  Inset shows a dotblot of the 
bTMP bound DNA sample, with and without cross-linking (XL) by irradiation 
at 365 nm, identified with avidin-HRP. 
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4.2.1.3 Binding of bTMP to A-form and B-form DNA 
helices 
In an attempt to characterise the DNA structure preference of bTMP further, photo-
crosslinking experiments were performed on DNA oligonucleotides with different 
helical structures.  Previous studies have analysed the structure of specific 
oligonucleotide sequences by X-ray crystallography and established that different 
sequences adopt distinct helices (Hays et al., 2005).  These helices can have 
markedly different structures, which may expose or conceal psoralen binding sites in 
the DNA helix (Section 1.1.1.2).  To establish if TMP based molecules can 
differentiate between stable helices, in addition to their preferential intercalation into 
under-wound DNA, a photo-crosslinking experiment was conducted on 
oligonucleotides with an A, B or AB intermediate structure (for sequence see 
Materials and Methods Section 2.2.6.1).  Photo-crosslinking of bTMP to these DNA 
sequences identified preferential binding to the AB intermediate, but no detectable 
binding to the specific A or B forms of DNA (Figure 4.6).  The AB intermediate 
oligonucleotide sequence has four thymines compared with two for the A and B form 
molecules, which may account for this difference in bTMP binding independent of 
helical structure.  Crystal structure analysis has not identified a suitable 
oligonucleotide sequence with a defined A or B form helix that contains more than 
two thymines (Hays et al., 2005). Therefore, under these experimental conditions it 
was not possible to determine whether bTMP preferentially binds A, B or A/B form 
















Figure 4.6 bTMP photo-crosslinking to A, B and AB oligonucleotides.  
Dotblot experiment in which ‘samples’ are DNA purified from A, B and AB 
oligonucleotides incubated with bTMP, with and without photo-crosslinking.  
‘Controls’ are DNA oligonucleotides with a single modified base containing a 
biotin.  The concentration therefore represents the concentration of DNA 









4.2.1.4 bTMP binding in vivo 
To confirm that bTMP is cell permeable and to establish the crosslinking frequency 
in the genome, a photo-crosslinking experiment was performed in Retinal Pigmented 
Epithelial (RPE1) cells.  Cells were incubated with bTMP and UV irradiated, 
followed by DNA isolation, purification.  Dot-blot analysis with a streptavidin 
conjugated horseradish peroxidase showed that bTMP bound to DNA following UV 
irradiation in vivo (Figure 4.7), in agreement with previous studies (Naughton et al., 
2013a; Saffran et al., 1988).  The cross-linking frequency, calculated with respect to 
the biotin-oligonucleotide standards, is around one bTMP per 900 bp of double 
stranded DNA.  At this level of cross-linking our lab had previously identified peaks 
of bTMP at transcription start sites (Naughton et al., 2013a), indicating that this 






Figure 4.7 bTMP binding in vivo.  Dotblot for DNA isolated from a bTMP 
photo-crosslinking experiment in RPE1 cells.  Standards are DNA 
oligonucleotides with a single modified base containing a biotin.  The 
standards show the concentration of DNA oligonucleotides and therefore 




4.2.2  bTMP pull-down  
4.2.2.1 Hybridisation of bTMP enriched DNA to genome 
wide promoter microarrays 
To identify the structural properties of promoters genome wide, the bTMP 
immunoprecipitation samples from Naughton et al. (2013) were re-labelled and 
hybridised to Nimblegen 2.1M promoter arrays at the VUMC microarray facility (for 
bTMP-IP experimental procedure see Materials and Methods Section 2.6.5).  
Samples included non-treated cells (‘control’) and those treated with the transcription 
inhibitor α-amanitin for 5 hours (‘α-amanitin’) followed by a 3 hour wash-out 
(‘wash-out’).  As a control for DNA sequence bias bTMP immunoprecipitation on 
naked genomic DNA (‘genomic’) was also hybridised to microarrays.  Together this 
data enables the investigation of promoter DNA structure under ‘steady state’ 
conditions and following transcription perturbation and recovery, which disrupts 
promoter DNA structure in vivo (Kouzine et al., 2013; Naughton et al., 2013a).  
Following sample labelling and array hybridisation, the VUMC facility provided the 
raw data, which was processed as outlined in Section 3.2.3.1 for quality control and 
signal normalisation.  Subsequent analysis was performed on this normalised dataset 
consisting of control, α-amanitin, α-amanitin wash-out and genomic bTMP 
immunoprecipitation samples. 
 
4.2.2.2 bTMP immunoprecipitation of genomic DNA 
identifies a subtle thymine preference 
To identify bioinformatically whether the bTMP thymine preference observed at the 
scale of single nucleotides influences the pull-down efficiency of genomic DNA 
fragments (~ 300 bp) of different nucleotide composition, the relative enrichment of 
bTMP was compared to GC percentage for all DNA probes on the microarray.  A 
subtle negative relationship was observed between GC% and bTMP enrichment 
(Figure 4.8).  However, there is not a strong depletion for bTMP, even at very high 
GC% (i.e. low thymine %).  This result is surprising, given the in vitro experiments 
discussed previously, but has been observed previously in our lab.  We interpret this 
157 
 
result as a reflection of a poor understanding of the mechanism of bTMP binding, 
beyond an association with under-wound DNA.  For example, the presence of a 
small number of thymine residues on a 300bp fragment of DNA may be sufficient 
for the binding of bTMP.  This could occur if the binding of one bTMP molecule 
precluded the binding of more molecules to a fragment.  In which case, the 
proportion of thymine nucleotides on a fragment would have a lower than expected 
influence on the binding of bTMP.    Figure 4.8 shows that under the experimental 
conditions of the bTMP pull-down there is not a general GC sequence bias, therefore 
subsequent analysis is based on this assumption.  A subsequent aim, beyond the 
scope of this thesis, is to test this assumption more thoroughly through additional 
experiments and analysis of recently published datasets (see Discussion).  
An additional potential bias identified by previous studies is the complex relationship 
between local nucleotide sequence and psoralen binding, where nucleotides several 
base-pairs away can influence binding dynamics (Esposito et al., 1988).  To account 
for this complex bias and to characterise the combined influence of chromatin and in 
vivo DNA supercoiling on DNA structure, subsequent analysis of in vivo bTMP 


















Figure 4.8 bTMP has limited thymine sequence preference in 
sonicated genomic DNA.  Scatterplot showing the relationship between 
GC% and bTMP enrichment, data taken from a bTMP immunoprecipitation 
experiment on genomic DNA.  The black line represents the median signal 









4.2.3  bTMP binding identifies distinct DNA 
supercoiling structures at human gene promoters 
bTMP binding is influenced by DNA supercoiling, DNA sequence and base 
composition in vivo.  To identify the structural properties of human gene promoters 
in the context of chromatin, independent of base composition and DNA sequence, 
that may have unknown structural parameters, the in vivo bTMP pull-down probes 
were each corrected for sequence by subtracting the genomic DNA bTMP pull-down 
values.  This correction permits the direct interrogation of DNA supercoiling at 
steady-state (‘control’) and following transcription inhibition (‘α-amanitin’) and 
recovery (‘wash-out’).   
 
4.2.3.1 Transcription dependent peak of DNA supercoiling 
at TSS 
To identify if the transcription dependent peaks of under wound DNA, previously 
observed at a sub-set of gene promoters (Kouzine et al., 2013; Naughton et al., 
2013a), is a general property of promoters genome-wide the median distribution of 
bTMP was identified across 20,631 promoters.  The ‘Control’ dataset has an 
enrichment for under-wound DNA around the promoter regions (Figure 4.9), 
consistent with previous studies.  Surprisingly, at the transcription start site (TSS) 
itself there is a dip of bTMP binding, identifying an over-wound DNA region.  This 
over-wound structure at the TSS may have been missed in previous analyses, due to 
the application of smoothing algorithms, the investigation of a larger domain around 
the TSS or the relatively small number of TSSs assayed.  This distribution is, 
however, consistent with an analysis performed on the promoters of expressed genes 
across the chromosome 11 array (Figure 3.18).  Therefore, the DNA structure at an 
‘average’ human promoter is under-wound 1 kb up-/down- stream of the TSS and 
over-wound DNA at the TSS. 
To investigate the role of transcription in the organisation of DNA supercoiling at 
gene promoters, the median distribution of bTMP binding was identified for 
promoters genome wide following transcription inhibition with α-amanitin.  
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Transcription inhibition remodels promoter DNA supercoiling, which adopts a 
similar pattern to that of genomic DNA (dotted line through zero) (Figure 4.9).  This 
re-organisation appears less substantial than that observed by Naughton et al. (2013), 
although this is likely to be a technical rather than biological observation.  In the 
present analysis the investigation of bTMP distribution is limited to promoter regions 
only, due to the design of the microarray, therefore the within array normalisations 
only covers sequences around promoter regions.  In the analysis by (Naughton et al., 
2013a) the bTMP binding was assayed across whole megabase scale loci and a sub-
set of the normalised data taken for promoter analysis.  This means that the generally 
under-wound structure observed across the promoters in Naughton et al. (2013a) 
cannot be identified in a specific promoter array analysis, as the normalisation 
corrects half of the data to be relatively over-wound.  Therefore, in the promoter 
array analysis the shift of the α-amanitin sample to be more under-wound upstream 
of the TSS and more over-wound around the TSS signifies a strong remodelling of 
promoter DNA structure toward a more genomic like structure (Figure 4.9), similar 
to previous observations (Naughton et al., 2013a).  This data supports at a genome-
wide scale the transcription dependent under-wound structure of gene promoter 


















Figure 4.9 Promoters genome-wide have a transcription dependent 
DNA structure.  The median distribution of bTMP in the region 7 kb 
upstream to 3 kb downstream of TSSs genome-wide for control and α-
amanitin samples.  Corrected for genomic DNA bTMP enrichment, which is 






4.2.4  DNA supercoil distribution is influenced by the 
presence of a CpG island 
The stable structure at the TSS identified in the distribution of bTMP binding across 
gene promoters may result from a DNA sequence with unusual structural properties.  
The most common sequence feature at TSSs is the CpG island, a region of elevated 
CpG density extending for ~1 kb surrounding the TSS of most human genes (Bird, 
1986; Bird et al., 1985; Jones, 2012).  Furthermore, CpG islands are known to form 
unusual DNA structures (Lipps and Rhodes, 2009; Rich and Zhang, 2003) and have a 
less flexible DNA conformation than AT rich regions (Bates and Maxwell, 2005).  
To identify how CpG islands influence DNA supercoil distribution, promoters were 
ranked based on their probability of having a CpG island and the relative distribution 
of bTMP binding identified.  A probabilistic approach to CpG island classification 
has been developed (Irizarry et al., 2009; Wu et al., 2010) to replace the arbitrary 
definition proposed by Gardiner-Garden and Frommer (1987), in which a CpG island 
is defined as having an observed-to-expected CpG ratio greater than 0.6 and a GC 
content greater than 0.5.  Using the hidden Markov model (HMM) based approach, 
promoters were ranked based on the probability of enriched CpG ratio and GC 
content when compared to the surrounding sequence context.  Plotting a heatmap of 
ranked promoter supercoil distribution identifies a striking pattern in the data (Figure 
4.10), in which promoters with the highest CpG island probability have strong peaks 
of enrichment up-/down- stream of the TSS and a strong over-wound structure at the 
TSS whilst promoters with the lowest CpG island probability have no clear DNA 
supercoil distribution.  The dotted line through the heat plot represents the cut-off 
used for a canonical list of CpG islands, similar to those used in the UCSC genome 
browser which are based on Gardiner-Garden and Frommer (1987) algorithm 
(Irizarry et al., 2009).  This line clearly differentiates the DNA supercoil data into 
regions with a CpG island-like structure and those with a non-CpG island structure.  
To establish how the distribution of DNA supercoils across promoters relates to the 
peak-trough-peak distribution seen in the median distribution, inflections were 
established for the median distribution of 100 promoter bins in the ranked dataset 
(Figure 4.10).  Inflections are positions in the distribution that form a peak (yellow 
circles) or trough (blue circles).  The inflections plot corroborates the heatmap by 
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showing that CpG island promoters have a peak-trough-peak distribution, similar to 
that of the genome-wide median distribution, whereas non-CpG island promoters 
have a wide peak at the promoter and in most cases show no trough at the TSS.  A 
second striking observation from the turnpoints plot is the regularity of DNA 
structure at gene promoters, compared to the high variability in structure up- and 
down- stream.  Together, this data supports a model whereby gene promoters have a 
distinct DNA structure compared to surrounding DNA and that this structure is 























Figure 4.10 DNA supercoil distribution differs for CpG and non-CpG 
island promoters.  The left panel shows a heatmap for bTMP distribution at 
promoters genome wide, ranked on the probability of having CpG island 
properties.  The colours represent log2(control-genomic) bTMP enrichment 
from depleted (red) to enriched (green) following the ‘colour key and 
histogram’.  The right panel shows the inflections for the same promoter 
distribution established from the median distribution of 100 promoter bins.  
Yellow dots represent upward inflections (peaks) and blue dots represent 
downward inflections (troughs).  The dotted line through both panels 
represents the probability cut-off for canonical CpG island promoters (Irizarry 






The classification of gene promoters by DNA supercoiling identified a clear 
separation into CpG island and non-CpG island promoters.  To further investigate 
DNA supercoiling properties the median distribution of bTMP binding was analysed 
at promoters with CpG islands (12,786 TSSs) compared to those without (7,843 
TSSs) (Figure 4.11).  Separating the promoters based on the presence of a CpG 
island shows that the over-wound TSS is associated with CpG island promoters but is 
absent from non-CpG island promoters.  The striking distribution of DNA 
supercoiling at CpG island promoters identifies a substantial difference in structure 
between the CpG island itself and the DNA 1 kb up-/down- stream.  The distribution 
of DNA supercoils at non-CpG island promoters is more gradual, with an over-
wound upstream region becoming progressively more under-wound towards the 
TSS.  This difference in promoter structure between CpG island and non-CpG island 
promoters could be an important signal for genetic regulation.   To address this 
subsequent analysis will focus on how the DNA structure of CpG and non-CpG 

















Figure 4.11  DNA supercoil distribution at CpG island and non-CpG 
island promoters.  The median distribution of bTMP over 7 kb upstream to 3 
kb downstream of human promoters genome wide (blue dashed line), CpG 
island promoters (green line) or non-CpG island promoters (red line).  
Corrected for bTMP sequence preference by subtracting the genomic IP 






4.2.5  Non-CpG island promoter DNA supercoiling is 
extensively modified in expressed genes. 
To identify the influence of gene expression on promoter structure genes were 
separated into highly expressed (top quartile) and non-expressed (bottom quartile) 
and the relative DNA supercoiling identified for CpG island and non-CpG island 
promoters (Figure 4.12).  In both CpG island and non-CpG island gene promoters the 
relative distribution of DNA supercoiling is extensively modified compared to 
genomic DNA (dotted baseline through zero) for expressed and non-expressed genes.  
The distribution of DNA supercoiling around CpG island promoters is similar in 
expressed (4,286 TSSs) and non-expressed (4,186 TSSs) genes, displaying the 
characteristic under-wound structure 1 kb up-/down- stream of the TSS and relatively 
over-wound TSS.   The magnitude of under-winding at expressed genes is elevated, 
supporting previous observations that the extent of DNA supercoiling is correlated 
with gene expression.  The distribution of DNA supercoiling at non-CpG island 
promoters displays a more striking difference between expressed (963 TSSs) and 
non-expressed (4,947 TSSs) genes.  In both expressed and non-expressed promoters 
there is a more under-wound TSS compared to the upstream region, however the 
magnitude and breadth of enrichment at expressed gene promoters is considerably 
more enriched than in CpG island promoters.  Furthermore, non-expressed non-CpG 
island promoters have a relatively over-wound DNA structure, which may facilitate 
gene repression.  This indicates that DNA supercoiling is strongly related to both 

















Figure 4.12 DNA supercoiling at expressed and non-expressed 
promoters.  The median distribution of bTMP for expressed (expression 
array value > 155) and non-expressed (expression array value < 60) CpG 
island and non-CpG island promoters.  The position of the TSS is marked by 






4.2.6  CpG island and non-CpG island promoter DNA 
supercoiling is maintained by transcription 
Previous studies have identified a relationship between transcription and DNA 
supercoiling at gene promoters.  To establish if this relationship applies to the 
distinct structures observed at CpG island and non-CpG island promoters, the 
relative distribution of bTMP binding was compared between pull-down experiments 
performed on ‘control’, ‘α-amanitin’ and ‘wash-out’ samples (Figure 4.13).  In each 
case the data was first normalised with genomic DNA bTMP pull-downs to give the 
in vivo DNA supercoil state.  In samples treated with the RNA polymerase II 
inhibitor α-amanitin much of the DNA supercoil structure at gene promoters is lost, 
indicating that transcription maintains the structure of both CpG and non-CpG island 
promoters.  The remaining DNA supercoil distribution following α-amanitin 
treatments may represent residual DNA supercoils that have not been released 
following transcription inhibition, or a structural property of CpG and non-CpG 
island promoters in the chromatin context which is absent from genomic DNA.  The 
over-winding of DNA observed at CpG island promoters following α-amanitin 
treatment suggests that topoisomerases continue to remove DNA supercoils in the 
absence of transcription, in agreement with Naughton et al. ( 2013).  The median 
distribution of non-CpG island promoters, on the other hand, becomes more under-
wound in the presence of α-amanitin.  This observation is consistent with previous 
work in the lab, although the mechanism through which DNA supercoils can be 
introduced independent of transcription are unknown.   
Further confirmation of the relationship between transcription and promoter DNA 
supercoil structure comes from the structural recovery observed in the ‘wash-out’ 
sample.  In this case cells were incubated for 3 hours in fresh media following 
treatment with α-amanitin.  The DNA supercoil distribution of CpG island and non-
CpG island promoters recovered, showing a much more similar distribution to the 
‘control’  sample than the ‘α-amanitin’ sample.  This is similar to the domain scale 
recovery seen by Naughton et al. (2013).  Together this data shows that a peak of 
relatively under-wound DNA is formed at gene promoters with the onset of 
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Figure 4.13 Transcription maintains promoter DNA structure.  The DNA 
supercoil distribution at CpG island and non-CpG island promoters is 
remodelled by transcription inhibition and returns with the wash-out of the 






To identify if the DNA supercoil differences between the promoters of expressed and 
non-expressed genes are caused by transcription, the distribution of bTMP at 
expressed and non-expressed gene promoters was identified for the ‘α-amanitin’ 
samples.  For both CpG and non-CpG island promoters the difference in DNA 
supercoil distribution between expressed and non-expressed genes is markedly 
reduced with α-amanitin (Figure 4.14).  Therefore, the difference in DNA 
supercoiling between expressed and non-expressed genes is maintained by 
transcription.  For CpG island promoters both expressed and non-expressed genes 
have a more over-wound DNA structure following transcription inhibition, indicating 
that CpG island promoter DNA supercoiling is generally maintained in an 
active/poised conformation.  On the other hand, DNA supercoiling at active non-
CpG island promoters is maintained by transcription in an under-wound 
conformation and at inactive non-CpG island promoters DNA is maintained in an 
over-wound conformation.  The transcription dependent over-wound DNA structure 
of non-expressed non-CpG island promoters indicates that a repressive DNA 
supercoiling state is maintained by transcription at these genes and, in addition to the 
role of under-wound DNA in facilitating transcription, extends the function of gene 


















Figure 4.14  Expressed and non-expressed promoter DNA structure is 
maintained by transcription.  DNA supercoiling distributions of α-amanitin 
samples for the expressed/non-expressed gene categories analysed in 
Figure 4.12 (shown in grey).  Identifies a change in DNA supercoil structure 







4.2.7  Promoter DNA supercoiling identifies expression 
differences independent of the underlying sequence 
composition 
DNA supercoiling at CpG and non-CpG island promoters is distinct (Section 4.2.4).  
To further investigate promoter DNA structure, CpG island and non-CpG island 
promoters were each classified based on DNA supercoil distribution using a k-means 
cluster analysis with 3 clusters.  By separating promoters based on DNA supercoil 
distribution, the relative influence of sequence and expression on promoter 
supercoiling can be determined. 
 
4.2.7.1 CpG island promoters    
The classification of CpG island promoters by DNA supercoil distribution identifies 
promoter structures that vary at both the TSS and across the locus, independent of 
one another (Figure 4.15a).  For example ‘class 1’ and ‘class 3’ promoters have a 
similar distribution of DNA supercoiling at the TSS but very different distributions 
from 1 kb up-/down- stream.  ‘Class 1’ and ‘class 2’ on the other hand have similar 
distributions of DNA supercoiling 5 kb upstream but very different distributions at 
the TSS.  To identify how sequence and gene expression relate to these promoter 
classes, nucleotide composition and expression profiles were determined for each. 
The identification of a distinct over-wound DNA supercoil distribution at CpG 
islands (Figure 4.15a) indicates a relationship between sequence and DNA supercoil 
distribution.  To determine whether the pattern of DNA supercoiling is purely a 
reflection of sequence distribution, or represents a distinct structural feature at gene 
promoters, the median GC% distribution was plotted for each CpG island promoter 
class (Figure 4.15b).   The level of over-wound DNA supercoiling at the CpG island 
is related to GC%, with more GC rich CpG islands being more over-wound.  
However, the peaks of under-wound DNA identified in ‘class 1’ CpG island 
promoters cannot be accounted for by gross differences in sequence, as the GC% of 
all three CpG island promoter classes is highly similar in the region 1 kb up-/down- 
stream of the TSS.  Furthermore, ‘class 1’ and ‘class 3’ promoters show the largest 
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difference in DNA structure but have almost identical GC% distributions.  This 
confirms that DNA sequence and DNA supercoiling structure are distinct 
phenomenon in the in vivo chromatin context.  On the other hand, ‘class 2’ promoters 
have a distinct sequence distribution and DNA structure, and in this case the more 
intense peak of GC% at the TSS of ‘class 2’ genes may account for the more over-
wound DNA structure observed by bTMP binding.  Together, this data indicates that 
promoter DNA supercoil distribution is related to sequence, but that sequence alone 
cannot explain the intensity of DNA supercoiling in ‘class 1’ or ‘class 3’ promoters.  
This supports supercoiling as an independent structural feature of human DNA.  
Previous analysis identified a relationship between expression and DNA supercoil 
distribution, with under-wound promoters being more highly expressed (Section 
4.2.5).  To identify the relationship between expression level and DNA supercoil 
distribution in the three promoter classes, the relative expression of the genes in each 
class was determined from expression array data (Figure 4.15c).   ‘Class 1’ 
promoters are associated with high expression level, while ‘class 2’ and ‘class 3’ 
promoters have lower expression.  The major feature of ‘class 1’ CpG island 
promoters is the intense under-wound DNA peaks 1 kb up-/down- stream of the TSS, 
which are absent in both ‘class 2’ and ‘class 3’ promoters.  Therefore, the DNA 
supercoil distribution of highly expressed gene promoters (‘class 1’) is distinct from 
lowly expressed gene promoters (‘class 2’ and ‘class 3’), but expression cannot be 
used to determine difference in DNA supercoiling between ‘class 2’ and ‘class 3’ 
promoters. 
This analysis determined that differences in DNA supercoil distribution between 
‘class 1’ and ‘class 3’ promoters are not due to DNA sequence distribution, but can 
be explained by differences in gene expression.  Conversely, the difference between 
‘class 2’ and ‘class 3’ promoters cannot be explained due to differences in 
expression, but can be explained by differences in DNA sequence.  Together, this 
identifies that DNA sequence and gene expression are both important for the 









Figure 4.15  CpG island promoter classification. a) K-means clustering of 
CpG island promoters into 3 classes based on bTMP binding distribution.  b) 
GC percentage sequence distribution for the three CpG island promoter 
classes.  c) Boxplot of gene expression levels in RPE1 cells for the three 





4.2.7.2 Non-CpG island promoters    
A similar classification was performed for non-CpG island promoters to identify the 
relationship between DNA structural features, sequence and expression.  This 
clustering analysis identified promoter structures with a very different distribution to 
those observed for CpG island promoters (Figure 4.16a).  The strongest determinant 
of class membership is the overall level of bTMP bound across the 10 kb window, 
therefore separating promoters based on local DNA structure rather than the specific 
structure at the transcription start site.  All three classes of promoter have a relatively 
under-wound peak at the TSS, although this is more prominent in ‘class 1’ and ‘class 
3’ promoters.  To determine whether the DNA supercoil distribution at these clusters 
is determined by sequence, the median distribution of GC% was plotted for each 
class of promoters (Figure 4.16b).  ‘Class 1’ and ‘class 2’ promoters have highly 
similar sequence distributions whereas ‘class 3’ promoters show the same pattern of 
sequence distribution, but with a much lower GC% magnitude.  Therefore, non-CpG 
island promoters also show differences in DNA supercoil distribution that cannot be 
attributed to sequence, further supporting supercoiling as an independent structural 
feature of DNA. 
To identify the relationship between non-CpG island promoter DNA structure and 
gene expression, the relative expression level of genes within the promoter classes 
was determined (Figure 4.16c).  Similar to previous observations (Section 4.2.5), an 
over-wound DNA structure is associated with gene repression and an under-wound 
structure is associated with gene expression.  The expression difference between 
each of the non-CpG island promoter classes is highly significant, indicating that 
expression level can be used to differentiate between these promoter classes. 
Together this data shows that for non-CpG island promoters, gene expression more 
clearly differentiates promoter class than sequence.  This is particularly clear for 
‘class 1’ and ‘class 2’ promoters which have very similar sequence distributions, but 
distinct expression levels.  For ‘class 3’ promoters the role of expression and 
sequence cannot be separated, as these promoters have a distinct sequence 
distribution and gene expression level.  Therefore,  sequence is likely to have some 
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influence on DNA supercoiling, but expression is a more important determinant of 



























Figure 4.16 Non-CpG island promoter classification. a) K-means 
clustering of non-CpG island promoters into 3 classes based on bTMP 
distribution.  b) Boxplot of gene expression levels in the three non-CpG island 
promoter classes.  c) GC percentage sequence distribution for the three non-





Together, the distribution and classification of DNA supercoiling at CpG island and 
non-CpG island promoters identifies a number of common themes.  In each case 
there is a class with a different sequence distribution which has a distinct DNA 
structure and a low expression level.  However, in the case of CpG island promoters 
this class has a higher GC content whereas in the case of non-CpG islands this class 
has a lower GC content.  Together this suggests that it is not the sequence per se that 
is repressing gene expression, but the DNA structure itself.  In which case, this 
identifies a GC and an AT associated repressive DNA structure.  The pattern of DNA 
structural distribution between the remaining two classes of CpG and non-CpG 
island promoters identify an average difference in bTMP cross-linking of around 2 
fold between the expressed and non-expressed class, independent of sequence.  This 
is consistent with the observations of Kouzine et al. (2013) and indicates that CpG 
island and non-CpG island promoters have an expressed DNA supercoil distribution 
that can be detected through an unsupervised classification of supercoil distribution. 
 
4.2.8  Generally expressed genes maintain an ‘active’ 
DNA supercoil distribution independent of expression 
Genes can be categorised into those that are expressed in most human cell types and 
those that are not.  The features that differentiate generally expressed and generally 
repressed genes are not well characterised, although genomic structure and 
epigenetic modifications have been implicated (Eisenberg and Levanon, 2003; She et 
al., 2009).  To identify if generally expressed/repressed genes have distinct DNA 
supercoil structure, the distribution of bTMP was identified for these categories 
based on the expression data of 43 normal human tissues (Chang et al., 2011).   
Generally expressed genes are more under-wound with a CpG island like distribution 
whereas generally repressed genes are more over-wound with a less pronounced dip 
at the TSS (Figure 4.17).  Expression array data for our cell line supports the gene 
classification, with the generally expressed class being much more highly expressed 
than the generally repressed class.  To confirm that the underlying structure of the 
generally expressed genes is mostly CpG island promoters and the generally 
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repressed is mostly non-CpG island promoters, as indicated by the distributions, the 
relative CpG/non-CpG island level was established.  For generally expressed 
promoters 84% have a CpG island compared to 37% of generally repressed 
promoters.  Therefore, although CpG islands are associated with generally expressed 
genes, the presence of CpG islands at generally repressed genes indicates that this 
sequence parameter alone is not sufficient to identify if a gene has a general 


























Figure 4.17  DNA supercoil distribution at generally expressed and 
repressed genes.  a) DNA supercoil distribution around the TSS of generally 
expressed (2281 TSSs) and non-expressed (2961 TSSs) genes.  b) Relative 
expression of generally expressed and generally repressed genes.  **** 








To identify if a specific DNA supercoil pattern for generally expressed and generally 
repressed promoters exists, the distribution of bTMP at these gene promoters was 
investigated more thoroughly.  Previous analyses have shown that CpG island and 
non-CpG island promoters have distinct structures (Section 4.2.5), therefore further 
analysis of generally expressed and generally repressed genes was performed 
separately on these promoter classes.   For generally expressed genes CpG island 
(2492 TSSs) and non-CpG island  (459 TSSs) promoters have a similar magnitude of 
bTMP binding, but a different distribution, indicating similar levels of under-wound 
supercoiling distributed in a different promoter structure (Figure 4.18a).  The 
distribution of generally repressed CpG island promoters (846 TSSs) maintains an 
under-wound DNA structure around the TSS, although the magnitude is reduced 
compared to that of ‘generally expressed’ promoters.  On the other hand, the 
distribution of ‘generally repressed’ non-CpG island promoters (1435 TSSs) is more 
over-wound.  Together the CpG and non-CpG island data supports previous 
observations that expressed genes are more under-wound (Section 4.2.5; Kouzine et 
al., 2013; Naughton et al., 2013a).   
To establish the relationship between the structure of generally expressed genes and 
the structure of genes expressed in RPE1 cells, a comparison was made between 
genes that are generally expressed but are not expressed in RPE1 cells and genes that 
are generally repressed but are expressed in RPE1 cells (Figure 4.18b).  Surprisingly, 
both CpG and non-CpG island promoters for generally expressed genes maintain 
their structure independent of whether they are expressed in RPE1 cells.  Both the 
magnitude of bTMP intercalation and its distribution around the TSS are highly 
similar, supporting the existence of a generally expressed DNA promoter structure.   
On the other hand, the generally repressed promoters have very different structures 
between those that are expressed and non-expressed in RPE1 cells, with expressed 
genes having a more under-wound structure.  Sequence distribution analysis 
identifies that the difference observed between expressed and non-expressed genes in 
the four categories (‘generally expressed’ CpG/nonCpG, ‘generally repressed’ 
CpG/non-CpG) cannot be accounted for by differences in the GC% distribution at 
the promoter.  Therefore, there is a DNA supercoiling component of generally 
expressed gene structure, which cannot be accounted for by sequence or gene 
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expression.  This suggests that genes which are expressed in most cell types are 
maintained in a DNA supercoiling conformation associated with gene activity, 
whereas genes which are generally repressed in most cell types have a generally 








Figure 4.18  Generally expressed genes have a more under-wound 
DNA structure at gene promoters, independent of gene expression.  a) 
DNA supercoiling distribution and expression of generally expressed and 
generally repressed genes for CpG and non-CpG island promoters.  The 
expression levels of generally expressed (gold) and generally repressed (red) 
genes are on different scales to show the difference between CpG and non-
CpG islands promoters.  Student’s t-test performed between datasets with a 
p-values of **<0.005 and ****<0.00005.  Generally expressed CpG – 2492 
TSSs, generally expressed non-CpG – 459 TSSs, generally expressed non-
CpG – 846 TSSs and generally repressed non-CpG – 1435 TSSs.  b) DNA 
supercoiling and sequence distribution at generally expressed and generally 
repressed promoters classified on actual expression in our RPE1 cells.  
Expressed promoters have a value greater than the third quartile of the 
expression array dataset, whereas non-expressed genes have an expression 
less than the first quartile.  Loess smoothing applied.  Expressed ‘generally 
expressed’ CpG island – 1728 TSSs, non-expressed ‘generally expressed’ 
CpG island – 222 TSSs, expressed ‘generally expressed’ non-CpG island – 
273 TSSs, non-expressed ‘generally expressed’ non-CpG island – 62 TSSs, 
expressed ‘generally repressed’ CpG island – 125 TSSs, non-expressed 
‘generally repressed’ CpG island – 524 TSSs, expressed ‘generally 
repressed’ non-CpG island – 61 TSSs and repressed ‘generally repressed’ 








4.2.9  Transcription factor, enhancer and insulator 
binding sites have distinct DNA supercoiling profiles. 
DNA supercoiling has been shown to regulate transcription through changes in DNA 
structure and through the recruitment of DNA structure specific transcription factors.  
To identify if DNA binding proteins have distinct DNA supercoiling profiles, the 
distribution of bTMP binding was determined at transcription factors, enhancer and 
insulator binding sites.  Using ChIP-seq data available from the ENCODE 
consortium for the A549 epithelial cell lines the position of actual protein binding 
sites in vivo, as opposed to consensus binding sequences, was determined for three 
transcription factors, two enhancer proteins and an insulator protein.  The distribution 
of DNA supercoils 2.5 kb either side of the protein binding site was then determined 
from our RPE1 cell line (Figure 4.19).  The transcription factors each show an 
enrichment for under-wound DNA around the binding site, with a more over-wound 
structure at the protein binding site itself.  This distribution is most similar to that of 
active genes, although there is some difference between the three transcription 
factors.  ELF1 in particular shows a more under-wound structure across the region 
analysed.  The distribution of DNA supercoiling at enhancer proteins is less 
consistent, with p300 showing some similarities with transcription factors whereas 
CEBP1 has a very different distribution.  The p300 distribution shows a peak of 
under-wound DNA supercoiling 1 kb from the protein binding site and a less intense 
trough at the binding site than observed for transcription factors.  On the other hand, 
CEBP1 has a gradual low level enrichment of under-wound DNA associated with the 
protein binding site.  Finally, there is almost no peak of under-wound DNA 
supercoiling at promoter associated CTCF binding sites.  The slight peak of under-
wound DNA 1 kb from the binding site and slight over-winding at the binding site 
are somewhat similar to the distribution seen at transcription factors and p300, but 
with a very low magnitude.   Together this data identifies that different DNA binding 
proteins have a different distribution of DNA supercoiling around their biding sites 











Figure 4.19 DNA supercoiling around protein binding sites.  Protein 
binding sites determined from ChIP-seq data in A549 epithelial cells from the 
ENCODE project.  Distribution identifies distribution up to 2.5 kb from the 







The current study provides the first genome-wide analysis of the distribution of DNA 
supercoiling at human gene promoters.  The increased resolution of a promoter scale 
analysis of DNA supercoiling, when compared to the domain scale analysis of 
Naughton et al. (2013), necessitated a more detailed characterisation of the sequence 
preference of the bTMP molecule.  Photo-crosslinking bTMP with DNA 
oligonucleotides of defined sequence (e.g. poly-d(AT) compared to poly-d(GC)), and 
on genomic DNA, identified interactions with the thymine only.  This supports 
previous studies that identify that TMP has a preference for thymine (Esposito et al., 
1988; Kanne et al., 1982; Song and Ou, 1980).  These experiments cannot rule out an 
interaction between bTMP and cytosine, which may occur infrequently and below 
the threshold of detection.  Supporting this, the one study that identifies TMP bound 
cytosine performed the photo-crosslinking reaction several times with a very high 
concentration of TMP prior to analysis by mass spectrometry (Kanne et al., 1982).  
Consequently, unless the biotin and charged linker moieties altered the affinity of 
TMP for cytosine, it is unlikely that under my experimental conditions I would be 
able to detect bTMP bound cytosine.  The thymine preference of bTMP is not 
unusual for a DNA binding molecule.  For example, the ubiquitous cross-linking 
reagent formaldehyde only binds to guanine nucleotides (Lu et al., 2010) and the 
topoisomerase II poison etoposide preferentially stabilises cleavage complexes at 
cytosine nucleotides (Wu et al., 2011).  However, it is important to take any 
nucleotide bias into account for subsequent analyses.   
To determine whether this thymine preference alters the pull-down efficiency of 
genomic DNA following bTMP photo-crosslinking, which could bias subsequent 
analysis, bioinformatic analysis was performed on bTMP bound genomic DNA pull-
down experiments.  A subtle negative correlation was observed between GC% and 
bTMP, indicating a subtle bias, although a strong depletion was not observed even at 
high GC% and structural factors in addition to thymine preference could account for 
lower bTMP binding (e.g. the formation of Z form DNA (Thamann et al., 1981)).  In 
order to identify structural features which may influence bTMP binding, an 
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experiment was performed which compared the relative photo-crosslinking of bTMP 
to oligonucleotides with defined A, B or AB form DNA structures.  Under these 
experimental conditions no difference attributable to DNA structure was identified, 
although the limited availability of oligonucleotides with known helical structures 
prevented a more thorough analysis of the relationship between bTMP binding and 
DNA helical structure.  However, it has been shown that psoralen can have a 
sequence preference that is more complex than the proportion of GC (Esposito et al., 
1988), therefore to account for this unknown bias bTMP pull-down experiments (e.g. 
control, α-amanitin and reverse) were corrected at a microarray probe level for 
bTMP enrichment in genomic DNA. 
The absence of a strong sequence bias in the analysis of bTMP pull-down microarray 
data was surprising, given the bias observed in earlier experiments, but has been seen 
previously in our lab.  It is possible that at the scale of 300bp fragments the 
relationship between bTMP and sequence is distinct from that of bTMP and single 
nucleotides (such as the HPLC MS experiment in Section 4.2.1.2).  Furthermore, the 
chemical structure of cytosine should permit psoralen photo-crosslinking, and has 
been shown to do so under high psoralen conditions (Kanne et al., 1982).  The 
HPLC-MS experiments that aimed to identify bTMP sequence preference in 
heterogeneous DNA sequences may not have been sensitive enough to pick up a 
smaller population of bTMP bound cytosine, which could have a significant 
influence on the enrichment of high GC fragments.   
To test more thoroughly the relationship between bTMP binding and DNA sequence 
within genomic DNA, I am currently performing a number of additional 
bioinformatic analyses and laboratory experiments.  Firstly, a new dataset has 
become available in which psoralen binding has been established genome-wide in 
Drosophila (Teves and Henikoff, 2014).  Through a detailed analysis of this data I 
can validate the observed relationship between genomic DNA and psoralen binding.  
In addition, I am performing an experiment in which bTMP-bound DNA is 
fractionated based on sequence through a CsCl gradient (Scott et al., 2005) and the 
level of bTMP quantified by dot-blot.  This experiment is analogous to the 
bioinformatic analysis performed in Section 4.2.2.2.  Performing this gradient 
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analysis on bTMP bound naked DNA and on DNA extracted from RPE1 cells in the 
presence and absence of the nicking agent bleomycin will give an additional, albeit 
crude, indication of how chromatin influences bTMP-DNA binding at sequences 
with different GC compositions.  Together, these analyses will be used to validate the 
observations and conclusions presented in this chapter.  
My genome-wide analysis of promoter DNA supercoiling supports the transcription 
dependent under-wound DNA structure identified in Kouzine et al. (2013) and 
Naughton et al. (2013a).  One clear difference between the distribution observed in 
my genome-wide study, when compared with previous studies, is the presence of a 
more over-wound structure at the transcription start site compared to the more under-
wound regions ~1 kb up- and down-stream.  This structure may not have been picked 
up in previous studies for several reasons including the application of smoothing 
algorithms, the investigation of a wider domain around the TSS and the relatively 
small number of transcription start sites assayed.  In this study there is no smoothing 
algorithm applied to the genome-wide analysis of promoter DNA supercoiling, and 
as such it is a true representation of the average supercoil state.   
To characterise further the distribution of DNA supercoiling at the start of genes, 
promoters were classified based on known characteristics.  A well characterised 
property of most human promoters is the presence of a CpG island, which is believed 
to have an important role in gene regulation (Ehrlich et al., 1982).  Ranking 
promoters on their probability of containing a CpG island (Irizarry et al., 2009; Wu 
et al., 2010) identifies two distinct promoter DNA supercoil distributions and it is 
immediately apparent that the over-wound DNA structure observed at the TSS is 
associated with CpG islands.  At CpG island promoters the relatively over-wound 
TSS may repress gene transcription and it may be that CpG islands act as a general 
transcription repressor which must be overcome prior to gene expression, perhaps 
through the activity of DNA helicases (Singleton et al., 2007).  As genes with CpG 
islands are generally highly expressed, it may be that the over-wound CpG island 
DNA prevents leaky expression in a chromatin environment that promotes 
transcription.  On the other hand, non-CpG island gene are generally tissue specific 
and may be regulated primarily by other means, such as the concentration of 
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appropriate transcription factors.  As the DNA supercoil distribution of CpG and 
non-CpG island promoters was so clearly distinct, all subsequent analysis was 
performed separately for these classes of promoter. 
A second known characteristic of gene promoters in RPE1 cells is the gene 
expression level, as identified by expression array analysis.  Previous studies have 
identified for a few hundred gene promoters that expressed genes have a more under-
wound DNA structure (Kouzine et al., 2013; Naughton et al., 2013a).  To identify the 
influence of expression on CpG island and non-CpG island promoter structure, the 
distribution of DNA supercoiling was determined for the promoters of expressed and 
non-expressed genes.  For CpG island promoters the expressed and non-expressed 
genes each show a highly similar distribution, but with a relatively subtle enrichment 
of under-wound DNA in the expressed genes over non-expressed.  This enrichment 
of under-wound DNA occurs across the 10 kb measured, indicating that the CpG 
islands of expressed genes are generally more under-wound than their non-expressed 
counterparts.  This could influence gene expression by relieving some of the 
repression that may be associated with the relatively over-wound DNA structure of 
CpG islands.  There is a much more extensive rearrangement in DNA structure in 
non-CpG island promoters between non-expressed and expressed genes, with a 
greater enrichment for under-wound DNA in the expressed genes.  The DNA 
supercoil distribution of expressed genes resembles that of CpG island promoters, 
suggesting that active gene promoters generally have an under-wound DNA 
supercoil structure that peaks in a region ~1 kb up-stream to ~1 kb down-stream.  In 
addition, the over-wound DNA supercoil structure of non-expressed non-CpG island 
promoters could represent a novel form of transcription regulation in eukaryotic 
genome through the repression of strand separation.  Several reports have discussed 
the positive regulatory potential of more under-wound DNA at gene promoters 
(Dunaway and Ostrander, 1993; Hirose and Suzuki, 1988; Kouzine et al., 2004, 
2008, 2013; Naughton et al., 2013a, 2013b; Tabuchi and Hirose, 1988), but no study 
has explicitly discussed the potential of relatively over-wound DNA in the repression 
of gene expression.  To identify if the relationship between gene expression and 
DNA supercoil distribution is a consequence of transcription, the distribution of 
bTMP was identified in the same gene categories following transcription inhibition.  
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Under these conditions, the under-wound DNA of CpG island/expressed non-CpG 
island promoters and the over-wound DNA of non-expressed CpG island promoters 
is lost.  Together, this supports a model that extends the role of transcription 
dependent DNA supercoiling from under-wound DNA facilitating expression to 
include over-wound DNA maintaining repression. 
To determine the attributes of DNA supercoiling at CpG island and non-CpG island 
promoters independent of known parameters, promoters were clustered based purely 
on the distribution of DNA supercoils by kmeans analysis.  For both CpG island and 
non-CpG island promoters it is clear that sequence has an important influence on 
DNA supercoil distribution, but does not determine it.  For example, in both CpG 
island and non-CpG island promoters there are promoter classes with identical 
sequence distributions but distinct DNA supercoil distributions, and in both cases the 
more under-wound class has a higher expression level.  Furthermore, in both CpG 
and non-CpG island promoters there is one class with a substantially different 
sequence distribution, and in both cases this sequence is associated with lower 
expression.  Surprisingly, the ‘repressive’ sequence distribution in CpG island 
promoters is GC rich whereas in non-CpG island promoters it is GC poor, indicating 
that GC and AT associated repressive DNA structures occur in vivo.  The GC 
associated repressive structure may be accounted for by the more over-wound DNA 
at the TSS, which in my model of transcriptional repression by CpG islands would 
require additional rearrangement for strand separation at the TSS.  In the case of AT-
rich repressive structures, the higher flexibility of AT-rich sequences may be more 
amenable to over-wound DNA supercoils in the generation of a   repressive DNA 
supercoil environment.  Together, this data clearly demonstrates that differences in 
promoter DNA supercoiling are determined by the combined influence of sequence 
and gene expression.  This suggests a model whereby gene sequence can produce a 
permissive environment for the storage of under- or over- wound DNA supercoils 
that can facilitate gene expression or repression in vivo.   
To test whether permissive or repressive DNA supercoil distributions are associated 
with genes that are generally expressed or repressed across a wide range of tissue 
types, a comparison was made between the distribution of DNA supercoiling at 
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genes which are generally expressed/repressed and expressed in our RPE1 cells and 
genes which are generally expressed/repressed and not expressed in our RPE1 cells.  
This analysis determined that generally expressed genes have a permissive under-
wound DNA structure independent of expression and generally repressed genes are 
only under-wound when expressed in our cell type.  This supports DNA supercoiling 
as an additional factor in establishing the promoter structure of generally expressed 
genes.  In addition, the distribution of DNA supercoiling at generally repressed genes 
further supports a model whereby transcription remodels DNA supercoiling to a 
more under-wound state that is permissive for subsequent transcription from the 
same promoter.    
In addition to the direct influence of DNA supercoiling on transcription from gene 
promoters, through an increased efficiency of initiation and elongation (Ma et al., 
2013a; Tabuchi and Hirose, 1988), it is likely that supercoil dependent changes in 
DNA structure influence transcription factor binding.  For example, the melting of 
the FUSE element upstream of Myc by under-wound DNA supercoiling results in the 
binding of FBP (Kouzine et al., 2008).  To identify if distinct DNA supercoil 
distributions can be seen at promoter associated DNA binding proteins, an analysis 
of bTMP was carried out on regions surrounding transcription factor binding sites 
and structural proteins.  This analysis indicates that transcription factors occupy sites 
with distinct DNA supercoiling profiles from other DNA binding proteins, such as 
the structural protein CTCF.  Furthermore, there is a subtle difference in DNA 
supercoil distribution between the transcription factors ELF1, SP1 and USF1 which 
may be indicative of different supercoil preferences.  To determine with precision 
how DNA sequence and structure work together with DNA supercoiling to form a 
preferential substrate for DNA binding proteins, future work must determine the 
distribution of DNA supercoiling at the scale of DNA binding protein sequence 
motifs (i.e. through deep  sequencing).    
The aim of this study was to characterise the distribution of DNA supercoiling at 
human gene promoters.  The most striking observation is the distinct structures of 
CpG and non-CpG island promoters and in both cases a model of gene regulation 
through DNA supercoiling is proposed.  In addition, an analysis of DNA supercoil 
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distribution around DNA binding proteins tentatively supports the hypothesis that 
different DNA binding proteins bind different DNA structures in vivo and 
necessitates the investigation of more proteins by ChIP-seq and a higher resolution 
mapping of bTMP using next generation sequencing.  Together, this data confirms a 
relationship between DNA supercoiling, sequence and gene expression, supporting 
























Common fragile sites (CFSs) are conserved regions of human chromosomes that 
form breaks, constrictions, gaps and rearrangements following partial DNA 
replication inhibition (Section 1.3.1).  The mechanism of fragility at these sites is 
unknown, although several molecular characteristics implicate DNA supercoiling.  
Supporting this, I have identified regions of stable over-wound DNA supercoiling 
and topoisomerase depletion at the FRA3B and FRA16D CFSs (Section 3.2.7).  This 
indicates that these CFSs have a reduced ability to maintain DNA supercoils under 
normal culture conditions, which may be accentuated by replicative stress.  However, 
changes in DNA supercoiling have not been measured under conditions of replicative 
stress and the relationship with CFSs remains theoretical.  To determine whether 
DNA supercoiling may contribute directly to the instability of CFSs, a bTMP pull-
down approach was used to measure changes in DNA supercoils at the FRA3B and 
FRA16D loci following replication inhibition. 
 
5.1.1  Molecular properties of CFSs 
The distribution and molecular basis of CFSs are generally determined following the 
partial inhibition of DNA replication with the DNA polymerase inhibitor aphidicolin 
(Lukusa and Fryns, 2008).  Under these conditions, metaphase chromosomes exhibit 
aberrations clearly visible by light microscopy (expressed CFSs).  Additionally, in 
interphase aphidicolin treatment causes DNA damage, which is thought to contribute 
to CFS activity and can be detected by an increase in the number of γH2AX foci 
(Schwartz et al., 2005).  Why partial replication inhibition reproducibly damages 
DNA and activates fragility at defined loci is largely unknown, although certain 
properties of CFSs have been determined. 
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To map the location of expressed CFSs in metaphase, the DNA is stained with either 
giemsa or DAPI to give a precise banding pattern to the chromosomes, based on an 
affinity for AT-rich DNA (Gosden, 1994).  The chromosome karyotype is then used 
to determine where on a chromosome a particular CFS lies, for example FRA3B is 
found within band 3p14.2 and FRA16D is found within 16q23.2 (Figure 5.1).  Using 
this technique to determine the distribution of CFSs in human lymphoblastoid, 
fibroblast, epithelial and erythroid cells, it has become apparent that the complement 
of expressed CFSs is cell type dependent (Le Tallec et al., 2011, 2013).  For 
example, in lymphoblastoid cells FRA3B and FRA16D are the most expressed CFSs 
whereas in fibroblasts it is 3q13.3 and 1p31.1.   
To identify the cytological position of CFSs (Figure 5.1 karyotype) on the DNA 
sequence (Figure 5.1 genomic position) FISH based approaches have been used.  In 
these studies fluorescent DNA probes with sequences tiling the band of interest are 
hybridised to aphidicolin treated metaphase chromosomes and investigated for their 
proximity to the CFS break point.  This enabled the identification of CFSs as large 
unstable domains covering as much as 4 Mb, such as at FRA3B (Becker et al., 2002).  
To determine the sequence properties of these CFS domains, the boundaries 
determined by FISH have been mapped onto the human genome.  In general, CFSs 
are AT-rich with a highly flexible DNA structure (Lukusa and Fryns, 2008) which 
can melt easily and form alternative DNA structures in the presence of DNA 
supercoiling (Bacolla et al., 1997; Burrow et al., 2010; Zlotorynski et al., 2003).  
CFSs are generally associated with long genes (> 300 kb), for example FHIT at 
FRA3B and WWOX at FRA16D, and are enriched for AT-rich DNA (Helmrich et 
al., 2006; Le Tallec et al., 2013).  There is some controversy as to whether 
transcription at these long genes increases chromosome fragility through the collision 
of polymerases and replication fork arrest, with evidence both for (Helmrich et al., 
2006) and against (Le Tallec et al., 2013).  However, the mapping of many CFSs to 
regions close to, rather than within, large genes suggests that transcription per se 
does not set the borders of CFSs (Le Tallec et al., 2013).  The identification of large 
genes and DNA structural properties associated with CFS formations suggests that 
sequence is an important factor.  However, the cell-type specificity of CFSs indicates 








Figure 5.1 The position of FRA3B and FRA16D common fragile sites.  
The karyotype for human chromosome 3 and 16 with the position of CFSs 
FRA3B (3p14.2) and FRA16D (16q23,2) as identified in Becker et al. (2002) 
and Letessier et al. (2011).  Chromosome length is given at the top right of 




To determine how changes in replication timing following aphidicolin treatment 
relate to the distribution of CFSs in a particular cell type, the origin and progression 
of DNA replication was determined at several loci in lymphoblastoid and fibroblast 
cells (Le Tallec et al., 2011).  In each cell type the expressed CFSs were located in 
regions devoid of replication initiation and at points of replication fork convergence.  
Furthermore, the expressed CFSs tend to be late replicating, indicating that the 
problems of fragility may occur at all CFSs but only persist to metaphase in those 
positions that have been unable to fully repair before cell division.  This indicates 
that the DNA replication profile is likely to influence the expressed CFSs in a cell 
type dependent manner.  However, the basis of the instability at CFSs which 
becomes exposed at late replicating regions by replication inhibition is unknown. 
One hypothesis that could explain genome instability at late replicating, AT-rich 
regions is that replication introduces DNA supercoils which distort DNA structure, 
slow DNA polymerase and prevent the completion of DNA replication or assembly 
of metaphase chromosome structure prior to cell division.  DNA polymerase 
introduces supercoils into the DNA that over-wind the helix ahead and under-wind 
both newly formed helices behind (Section 1.2.4.1.2).  As two polymerases 
converge, over-wound DNA supercoils are introduced on an ever shorter length of 
DNA.  The relief of these DNA supercoils may be further hampered at AT-rich 
sequences, which can absorb more DNA supercoils due to a higher flexibility in their 
structure (Burrow et al., 2010; Lukusa and Fryns, 2008; Le Tallec et al., 2011).  In 
addition, the under-wound DNA upstream of each polymerase may stabilise 
alternative DNA structures or melt the DNA helix, which has been shown to stall 
RNA polymerase in vitro (Ma et al., 2013a).  The build-up of over- and under-wound 
DNA supercoils associated with polymerases are usually relieved by the action of 
topoisomerase I and II, however at CFSs these enzymes are depleted (Section 3.2.7) 
which may further influence genome stability.  Furthermore, the identification of 
stable over-wound DNA domains at FRA3B and FRA16D provides some indication 
that DNA supercoiling is involved at CFSs.  To investigate whether DNA supercoil 
distribution changes at expressed CFSs it is necessary to map DNA supercoiling at 





5.2.1  RPE1 cells do not show fragility at FRA3B or 
FRA16D 
The location and frequency of expressed CFSs varies between cell types, with 
FRA3B and FRA16D being the best characterised and most frequently expressed 
(Lukusa and Fryns, 2008; Le Tallec et al., 2011).  However, the distribution of 
expressed CFSs in retinal pigmented epithelial cells (RPE1) is unknown.  To identify 
appropriate conditions for the expression of CFSs by partial replication stress, cells 
were treated with three concentrations of aphidicolin and γH2AX foci quantified in 
interphase nuclei by immunofluorescence (Figure 5.2a).  The number of cells with 
more than 5 foci did not dramatically increase with aphidicolin treatment (from 25% 
to 38%) (Figure 5.2b).  This indicates that the majority of cells either do not form, or 
do not identify for repair, DNA breaks in interphase following aphidicolin treatment.  
In those cells with more than five foci, replication stress increases the number of 
γH2AX foci (Figure 5.2c).  In the control cells, 35% of nuclei with γH2AX foci have 
more than 15 foci, whereas following 0.6 µM aphidicolin treatment this proportion 
increases to 92%.  This indicates that in RPE1 cells aphidicolin increases γH2AX 
foci in cells that already show evidence of DNA damage, but hardly increases the 
proportion of cells with γH2AX foci contrary to observations in other cells (Schwartz 
et al., 2005).  This may be due to differences in progression through the cell cycle, 
DNA damage repair mechanisms or chromatin structure between these cell lines.  
However, the presence of γH2AX foci on metaphase chromosomes indicates that 















Figure 5.2 Replication inhibition increases DNA damage foci in RPE1 
cells.  a) Representative immunofluorescence images of γH2AX foci (red) in 
interphase and metaphase nuclei (DAPI – blue).  b)  Quantification of γH2AX 
foci in interphase cells following different aphidicolin treatments.  Foci were 
quantified for 50 nuclei per condition.  c)  Quantification of foci in nuclei with 





To identify if FRA3B and FRA16D are expressed CFSs in RPE1 cells, breaks were 
identified and mapped by karyotype analysis in giemsa treated metaphase 
chromosomes (Figure 5.3a).  The two concentrations of aphidicolin used gave very 
different metaphase yields, with 0.6 µM aphidicolin producing almost no metaphases 
compared to 0.4 µM aphidicolin (data not shown).  Using 0.4 µM aphidicolin, 12% 
of expressed CFSs were mapped to chromosome 3, although the majority of these 
breaks were not at FRA3B (Figure 5.3b).   No expressed CFSs were mapped to 
chromosome 16.  The most expressed CFSs were on chromosome 1, in particular at 
FRA1C (chromosome 1p31.2), indicating that RPE1 cells have a different expressed 
CFS profile to lymphoblastoid and fibroblast cells.  Cells not treated with aphidicolin 
showed no expressed CFSs by karyotype analysis.  Therefore, the topoisomerase, 
DNA supercoiling and other properties associated with FRA3B and FRA16D do not 























Figure 5.3 Karyotype analysis of RPE1 CFSs.  a) Example metaphase 
for aphidicolin treat RPE1 cells showing 3 expressed CFSs (red circles).  b) 
Proportion of CFSs on each chromosome for RPE1 cells. (Quantification 









5.2.2  Neo3 lymphoblastoid cells show fragility at 
FRA3B and FRA16D 
To relate changes in DNA supercoiling at expressed CFSs to other established 
properties, an initial analysis should focus on the well-defined regions at FRA3B and 
FRA16D.  As RPE1 cells do not show fragility at these CFSs several lymphoblastoid 
cell lines were assayed for good metaphase chromosome morphology and the 
appropriate expressed CFSs.  Karyotype analysis of untreated metaphases  (Figure 
5.4) identified poor chromosome morphology for sweig and sato lymphoblastoid cell 
lines (e.g. sweig in Figure 5.4).  These ‘fuzzy’ chromosomes were observed for 
several metaphase preparations, including a preparation alongside RPE1 
chromosomes which gave good morphology.  On the other hand, the neo3 
lymphoblastoid cell line produced giemsa stained metaphase spreads with good 
chromosome morphology and were investigated further to identify which CFSs are 






Figure 5.4 Metaphase morphology cell line comparison.  Sweig cells 




To identify conditions of partial replication stress that induce DNA damage which 
may lead to CFS activation, neo3 cells were treated with three concentrations of 
aphidicolin.  Following aphidicolin treatment there is a notable increase in the 
number of metaphases with more than 5 γH2AX  foci, from 11% through to 58% 
(Figure 5.5a).  This is a much higher proportion than observed for RPE1 cells 
(Section 5.2.1) and in line with other studies (Schwartz et al., 2005), indicating a 
higher level of aphidicolin induced DNA damage in neo3 cells.  Analysis of giemsa 
stained chromosomes following 0.4 µM and 0.6 µM aphidicolin identifies a much 
higher proportion of chromosomes in metaphase than observed for RPE1 cells (data 
not shown), and allows the analysis of CFSs following 0.6 µM aphidicolin.  The 
proportion of metaphases with breaks was roughly proportional to the proportion of 
interphase nuclei with greater than 5 γH2AX, 50% and 58% respectively.  Mapping 
these breaks by karyotype analysis identifies frequent breaks on the chr3p (38%) and 
16q (23%) arms, consistent with the positions of FRA3B and FRA16D (Figure 5.5b 
and 5.5c).  Further confirmation of fragility at FRA3B was achieved by FISH 
analysis on metaphase chromosomes (Figure 5.5b).  We were unable to distinguish 
between chromosomes 13, 14 and 15 through analysis of the neo3 karyotype, but it is 
likely that a single CFS occurs on one of these chromosomes and accounts for ~25% 
of breaks in aphidicolin treated neo3 metaphases.  Therefore, consistent with reports 
in other lymphoblastoid cell lines, neo3 cells have expressed CFSs at FRA3B and 
















Figure 5.5  Mapping CFSs in neo3 cells.  a)  Quantification of γH2AX foci 
in interphase cells following different aphidicolin treatments (none - 113 
nuclei, 0.1 µM – 238 nuclei, 0.3 µM – 153 nuclei, 0.6 µM – 92 nuclei).  b) 
Example metaphase showing FRA3B and FRA16D CFSs by giemsa staining 
(arrows) and FRA3B CFS by FISH (red probe).  c) Proportion of CFSs 






5.2.3  bTMP pull-down identifies changes in DNA 
supercoiling at expressed CFSs 
To identify whether changes in DNA supercoiling occur at expressed CFSs bTMP 
pull-down experiments were performed on neo3 cells, in the presence and absence of 
the DNA replication inhibitor aphidicolin, and hybridised to custom tiling 
microarrays (see section 2.7 for the design).  As with previous experiments, a bTMP 
pull-down was performed on genomic DNA, as a control for the sequence preference 
of the drug.  Furthermore, as a comparison with data for RPE1 cells a bTMP pull-
down was performed on cells treated with the transcriptional inhibitor α-amanitin.  
Bioinformatic analysis of the microarray data was then performed to identify changes 
at the FRA3B and FRA16D CFSs.  
To validate bTMP crosslink formation in non-adherent neo3 cells, a photo-
crosslinking experiment was performed with two drug concentrations.  At both 
concentrations bTMP is bound to the DNA following exposure to UV light, but not 
in the non-UV treated controls (Figure 5.6a).  The level of photo-crosslinking in the 
high bTMP condition (1.4 mg/ml) is equivalent to one biotin every ~800 bp, which is 
similar to the previous analysis in RPE1 (one biotin every ~900 bp) (Section 4.2.1.4).  
Therefore, bTMP is cell-/nuclei- permeable and photo-crosslinks into DNA in neo3 
cells, indicating that the bTMP pull-down technique described in Naughton et al. 
(2013) can be used in different cell types.   
Further experimental validation confirms a reduction in DNA replication and 
transcription following inhibition with aphidicolin and α-amanitin respectively.  
Following aphidicolin treatment the cell cycle slowed, with a reduced number of 
cells in metaphase (data not shown).  To confirm a reduction in transcription 
following α-amanitin treatment, cells were pulse labelled with tritiated uridine for 30 
minutes and the relative incorporation of radioactivity into the RNA measured by 
scintillation counting.  In α-amanitin treat cells there is a ~50% reduction in RNA 
production compared to control cells (Figure 5.6b).  This incomplete loss of 
transcription may be accounted for by RNA polymerase I transcription, which is not 
inhibited at low doses of α-amanitin (Lindell et al., 1970).  The inhibition of 
replication with aphidicolin also reduced RNA production, but only by ~20% (Figure 
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5.6b), possibly as a result of cell stress associated with replication inhibition.  
Therefore, this validation of bTMP photo-crosslinking and drug treatments indicates 
that these conditions in neo3 cells produce similar results to those observed in RPE1 
cells (Naughton et al., 2013a) and should be appropriate for the identification of 







Figure 5.6 Validating bTMP pull-down experimental conditions.  a) 
bTMP photo-crosslinking dotblot analysis.  500 ng DNA incubated with high 
(1400 µg/ml) and low (140 µg/ml) bTMP.  The standards show the 
concentration of biotin.  b)  Tritiated uridine uptake as measure by scintillation 
counting identifies the relative RNA production over 30 minutes under 
different drug treatments.  Counts per minute detects the rate of ionisation 






A bTMP pull-down was performed on neo3 cells and hybridised to microarrays tiling 
several loci including FRA3B and FRA16D.  Microarray quality assessment and 
normalisation were performed (as in Section 3.2.3.1), using a VSN normalisation for 
consistency with Naughton et al. (2013a), and subsequent analysis was carried out on 
this data.  An initial comparison between ‘control – amanitin’ bTMP distribution in 
neo3 and RPE1 cell lines identifies some similarity between DNA supercoiling in 
these cell types.  For example, at the chromosome 11p15.5 locus (1 bp – 2800000 
bp) of RPE1 and neo3 cells there is a general under-winding of the DNA with α-
amanitin treatment over most of the locus, except at the most telomeric ~100 kb 
which becomes more over-wound (Figure 5.7).  The IGBP1 locus on chromosome X 
(68369744 bp – 70369744 bp) shows some similarity in the ‘control – amanitin’ 
distribution between RPE1 and neo3 cells, with complementary regions of under-
winding (Figure 5.7).  However, the two distinct domains of over-winding observed 
in RPE1 cells are not present in the neo3 cells.  This indicates that some DNA 
supercoil domains are cell type specific between RPE1 and neo3 cell lines.  As a 
final example, the FRA3B locus on chromosome 3 (58600001 bp – 63700000 bp) 
again shows similarity between RPE1 and neo3 bTMP distribution, with a general 
depletion across the locus and similar regions of enrichment at several places, 
including the leftmost region of the plot (Figure 5.7).   
The ‘control – aphidicolin’ distribution at these same loci identify no striking pattern 
of enrichment/depletion at the 11p15.5 or IGBP1 loci and look somewhat similar to 
the ‘control – α-amanitin’ distribution (Figure 5.7).  This may be a reflection of the 
partial transcription inhibition observed following aphidicolin treatment (Figure 5.6).  
On the other hand, the FRA3B locus has a defined region of bTMP enrichment right 
of centre, indicative of a change in DNA supercoiling following DNA replication 









Figure 5.7 bTMP pull-down comparison between cell lines.  Three 
regions from the custom tiling arrays covering chr11:1-2800000, 
chrX:68369744-70369744 and chr3:58600001-63700000 respectively.  In 
each case the y-axis scale is either log2 (control / amanitin) or log2 (control / 





To identify how DNA supercoiling changes following CFS expression in neo3 cells, 
the distribution of bTMP was analysed at FRA3B and FRA16D (Figure 5.8). The 
relationship between the FRA3B position defined in Becker et al. (2002), the 
topoisomerase depletion identified in RPE1 cells (Section 3.2.7) and an enrichment 
for bTMP in the ‘control – aphidicolin’ distribution (Figure 5.8) indicates a 
relationship between DNA supercoiling and the expression of CFSs following 
replication stress.  Based on the distribution of these three factors, a core region was 
defined for FRA3B (Figure 5.8).  The relationship between the FRA16D CFS as 
defined by Letessier et al. (2011) and an enrichment for ‘control – aphidicolin’ again 
suggests a relationship between CFS expression and DNA supercoiling.  However, in 
this case the depletion of topoisomerase I in RPE1 cells is adjacent to the CFS 
position (Figure 5.8).  Whether the depletion of topoisomerase I can effect CFS 
expression without their distributions overlapping, as shown for long genes (Le 
Tallec et al., 2013), or the distribution of topoisomerase I is different between RPE1 
and neo3 cells is unknown.  In the case of FRA16D, as the relationship with 
topoisomerase I is less clear the core region was defined based on the position of the 
cytologically mapped CFS.  Together, this data indicates a relationship between 
DNA supercoiling and the expression of CFSs at FRA3B and FRA16D. 
To further identify how DNA supercoiling changes at the FRA3B CFS following 
aphidicolin treatment the ‘control – aphidicolin’ distribution was compared to the 
‘control’ and ‘aphidicolin’ distributions.  There is a clear peak of bTMP in the 
‘control – aphidicolin’ profile core region, particularly for FRA3B (Figure 5.8).  The 
enrichment is significant and corresponds to a general shift to a more over-wound 
structure across the core region in samples treat with aphidicolin.  Therefore, despite 
considerable variability over the FRA3B core, the under-wound regions become less-
so and the over-wound regions become more over-wound generating the general shift 
to a more over-wound DNA structure.  This indicates that at FRA3B, under 
conditions that induce visible CFSs at metaphase in ~20% of cells, the net change in 
DNA structure at the core region is over-wound compared to control.   
To identify if a similar change in DNA supercoiling occurs at FRA16D, which 
induces visible CFSs at metaphase in ~10% of cells, a similar analysis of ‘control – 
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aphidicolin’, ‘control’ and ‘aphidicolin’ was performed.  There is a significant 
difference between ‘control – aphidicolin’ bTMP between the core and flanking 
regions of the FRA16D CFS (Student’s t test p < 2.2x10
-16
).  Following aphidicolin 
treatment the DNA within the CFS is generally more over-wound, similar to FRA3B.  
This indicates that partial replication inhibition leads to an over-winding of the DNA 
structure at these two CFSs and a relative under-winding of flanking sequences.  
Therefore, changes in DNA supercoiling occur at CFSs, supporting theoretical 




















Figure 5.8 bTMP distribution at CFSs changes with partial replication 
inhibition.  CFS regions are from Becker et al. (2002) (FRA3B) and 
Letessier et al. (2011) (FRA16D).  Core refers to the region of the fragile site 
that is most commonly broken and flank to the surrounding sequence.  
Boxplots show the distribution of enrichment for ‘control – aphidicolin’ 
between the core and flanking regions.  Students t test identifies a p value < 
2.2x10-16 for FRA3B and FRA16D.  Scale equals log2 (condition #1 / 
condition #2 bTMP enrichment) except topoisomerase which is log2 






The hypothesis that DNA supercoiling is important for genome stability at regions of 
flexible AT-rich DNA, including CFSs, is well supported by theoretical predictions 
(Section 5.1.1) but has not been determined experimentally.  To identify in vivo if 
DNA supercoiling changes under conditions that activate CFSs, a bTMP pull-down 
was performed with and without aphidicolin treatment in lymphoblastoid cells.  At 
the core of the expressed CFSs FRA3B and FRA16D a change in DNA supercoiling 
to a more over-wound DNA helix was observed following partial DNA replication 
inhibition, but not following transcription inhibition.  In contrast, the DNA flanking 
these more over-wound regions becomes more under-wound following partial 
replication inhibition, indicating that the distribution of DNA supercoils varies 
considerably over the CFS loci.  This data provides the first experimental evidence 
for a relationship between DNA supercoiling and the expression of CFSs in vivo.   
Previous studies of DNA supercoiling at flexible regions of DNA have indicated that 
alternative DNA structures form following the introduction of under-wound DNA 
supercoils (Burrow et al., 2010; Gellibolian et al., 1997; Wojciechowska et al., 
2006), and it has been proposed that these alternative DNA structures can slow the 
DNA polymerase and produce genome instability (Lukusa and Fryns, 2008).  
However, in the present study the DNA within defined CFSs is generally over-
wound following partial replication inhibition, which will inhibit the DNA 
unwinding required for the formation of alternative DNA structures.  This indicates a 
different mechanism for instability at CFSs, whereby over-wound DNA slows the 
replication machinery by inhibiting strand separation.  The flanking DNA, which 
becomes more under-wound with aphidicolin treatment, may contribute to the strand 
slowing by a mechanism involving alternative DNA structures, but does not 
normally form the breakpoint.  This supports a model whereby genome instability at 
CFSs results from a reduced ability to release over-wound DNA supercoils generated 
ahead of converging replication complexes, which is accentuated following 
replication inhibition.  Sequence properties, topoisomerase depletions and 
converging replication forks at CFS loci can together reduce the efficiency of DNA 
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supercoil relaxation.  The late replication of these regions, further slowed by 
aphidicolin, may cause chromosome breaks in metaphase due to the incomplete 
replication of DNA or the incomplete condensation of chromatin prior to cell 
division (Lukusa and Fryns, 2008).  
Further analysis of DNA supercoiling at CFSs subsequent studies must apply the 
bTMP pull-down approach to analyse a much broader range of CFSs across several 
cell types.  The relative change in DNA supercoiling across FRA3B and FRA16D is 
small, but significant.  This may be due to the over-wound DNA structure occurring 
at different positions across the ~1 Mb region in a population of cells, consistent with 
the broad domain of genome instability.  Therefore, an ‘average’ genome has a low 
level over-winding across a large domain composed of more significant over-wound 
structures at more localised regions of single genomes.  It is not known whether 
over-winding occurs at all CFSs following partial replication inhibition or whether 
this is a property of expressed CFSs.  To determine this, a bTMP pull-down must be 
performed on loci containing CFSs not expressed in a particular cells line, for 
example FRA16D in RPE1 cells.   If changes in DNA supercoiling upon aphidicolin 
treatment occur only at expressed CFSs, then a meta-analysis of bTMP may be 
performed at expressed CFSs across a number of cell lines to identify whether a 
consistent structural change occurs.  Either case will provide an important 
contribution in determining the role of DNA supercoiling at CFSs, with a presence 
only at expressed CFSs indicating a direct relationship with genome instability at 
these regions.  Current work in the lab will focus on these experimental questions. 
In addition to identifying for the first time changes in DNA supercoiling associated 
with CFSs, a number of other properties of CFSs and DNA supercoiling were 
identified.  The distribution of CFSs in RPE1 cells was found to be distinct to those 
in lymphoblastoid, fibroblast and other epithelial cells, with FRA3C being the most 
expressed CFS (Le Tallec et al., 2011, 2013).  This supports the observation of Le 
Tallec et al. (2011) that different cell types have different expressed CFSs and 
provides the first analysis of CFSs in RPE1 cells.  The distribution of bTMP in the 
RPE1 and neo3 cell lines is also distinct at a number of the loci investigated.  For 
example the depletions in bTMP observed in the RPE1 ‘control – amanitin’ 
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distribution are not present in the equivalent neo3 distribution.  Previous studies have 
indicated that DNA domains are relatively stable between cell lines and are 
conserved between species (Dixon et al., 2012).  An attractive model for coordinated 
gene regulation is one in which domain boundaries remain constant, but the degree 
of DNA supercoiling within the boundaries varies with environmental conditions 
and/or cell type.  A comparison between neo3 and RPE1 bTMP distribution provides 
tentative evidence for a cell-type dependent distribution of DNA supercoils at some 
loci.  A more extensive analysis, such as that of the whole of chromosome 11 
performed in (Naughton et al., 2013a), will provide important information regarding 
the role of DNA supercoiling in genome regulation. 
In summary, this analysis has identified several crucial parameters of DNA 
supercoiling with relation to gene regulation and disease.  By identifying similarities 
and differences in the distribution of bTMP between RPE1 and neo3 cells, the 
regulatory potential of this structural change is clarified.  Furthermore, identifying 
changes in DNA supercoiling with the activation of CFSs at FRA3B and FRA16D 
supports experimentally the theoretical relationship between DNA structure and 
genome instability at these regions.  Both of these observations form important pilot 













DNA supercoiling is important for regulating the expression of genes.  For many 
years DNA supercoiling has been studied in plasmids and in the genomes of 
prokaryotes, but the distribution of unrestrained DNA supercoiling in the human 
genome was unknown.  Recent work in our lab has identified large-scale DNA 
supercoiling domains in the human genome (Naughton et al., 2013a).  Additionally, 
meta-analysis of several hundred gene promoters has identified an under-wound 
DNA supercoil distribution around the TSS (Kouzine et al., 2013; Naughton et al., 
2013a).  Both large-scale and promoter-scale distributions of DNA supercoiling are 
regulated by transcription and topoisomerase activity.  However, the distribution of 
topoisomerases in the human genome remain poorly understood (Cowell et al., 2012; 
Khobta et al., 2006; Kouzine et al., 2013).  In this thesis I have studied 
topoisomerases and DNA supercoiling to better characterise their relationship with 
gene expression and genome stability.  Firstly, I have shown that topoisomerases 
form domain-scale and promoter-scale enrichments, in which topoisomerase I co-
localises with RNA polymerase II and under-wound DNA whereas topoisomerase II 
co-localises with over-wound DNA.  Secondly, I have characterised the distribution 
of DNA supercoiling at promoters genome-wide, identifying a more over-wound 
structure around the TSS of CpG island promoters which may be important for the 
regulation of these genes.  Finally, I have identified changes in DNA supercoiling 
associated with CFS expression, an experimental observation which has not 
previously been made. 
I have identified for the first time the distribution of topoisomerases in the human 
genome.  The observation that topoisomerase I forms domains distinct from 
topoisomerase II suggests that two mechanisms of DNA supercoil release are 
required in different regions of the genome.  Topoisomerase I is associated with 
RNA polymerase II and under-wound DNA, indicating a role in resolving the 
supercoils generated by transcription.  This makes mechanistic sense, as the 
controlled rotation mechanism of topoisomerase I relaxes DNA supercoils in a 
manner dependent on the degree of supercoiling in the fibre (Koster et al., 2005).  
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Therefore, in regions with higher transcription activity topoisomerase I can rapidly 
release DNA supercoils without reaching saturation.  Furthermore, topoisomerase I 
releases over-wound DNA fifty times faster than under-wound DNA (Frøhlich et al., 
2007), which may contribute to the maintenance of the under-wound structure.  
Therefore, by virtue of its mechanism human topoisomerase I may both relax DNA 
supercoils and also contribute to the maintenance of an under-wound DNA structure, 
in a similar manner to prokaryotic topoisomerase IA (Kirkegaard and Wang, 1985).  
I have shown that the domain-scale distribution of topoisomerase II enzymes is 
distinct from that of topoisomerase I, but the distributions of topoisomerase IIα and 
IIβ are highly similar.  Topoisomerase II domains are generally over-wound, which 
may facilitate the repression of genes (Ma et al., 2013b) or have other functional 
consequences in these regions.  For example, the relationship between topoisomerase 
II enrichment at AT-rich, over-wound, gene poor DNA and the temporal distribution 
of topoisomerase IIα through the cell cycle (Woessner et al., 1991) may indicate that 
these domains are decatenation hotspots, taking advantage of the decatenation 
activity of topoisomerase II rather than its relaxase activity (Carpenter and Porter, 
2004; McClendon et al., 2005; Woessner et al., 1991).  Decatenation is critical in S 
through to G2-M and has been associated with both topoisomerase II and over-
wound DNA, most notably in the decatenation of a yeast plasmid system (Baxter et 
al., 2011).  Therefore, topoisomerase II domains may be decatenation hotspots, 
which occur in gene poor regions to limit the formation of potentially deleterious 
double strand breaks in coding regions of the genome.   
In addition to a domain-scale distribution, I have identified that topoisomerases form 
a more local distribution at human gene promoters.  A recent study suggested a 
general model of topoisomerase distribution, based on limited experimental data, in 
which topoisomerase I forms an invariant enrichment upstream of the TSS whereas 
topoisomerase II forms a peak of enrichment at the TSS in an expression dependent 
manner (Kouzine et al., 2013).  My data suggests this model is incorrect, based on 
ChIP-chip experiments that determine the distribution of topoisomerase I and IIβ at 
high resolution around 2,509 TSSs.  Topoisomerase I forms a peak at the TSS which 
is strongly enriched in expressed genes compared to non-expressed genes, whereas 
topoisomerase IIβ forms a peak that is independent of gene expression.  Therefore, at 
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the promoter scale topoisomerase I is the critical topoisomerase for the maintenance 
of DNA supercoils.  This agrees with my observations at a domain-scale, showing 
that topoisomerase I releases supercoils generated by transcription through a torsion 
dependent release mechanism at different scales in the genome.  The function of 
topoisomerase II at gene promoters is less clear.  A previous study in rat identified 
that topoisomerase II regulates gene expression in a minority of promoters (Sano et 
al., 2008) and in some cases this may occur at human promoters, but my analysis 
suggests that this is not a general mechanism for the regulation of DNA supercoiling 
at human gene promoters.  Additionally, structural roles have been suggested for 
topoisomerase II which may account for some of the enrichment at promoters, 
including the association with chromatin remodelling complexes (Varga-Weisz et al., 
1997). 
Previous work has shown at a small sub-set of human gene promoters that a focal 
enrichment of under-wound DNA supercoiling occurs around the TSS (Kouzine et 
al., 2013; Naughton et al., 2013a).  Using high density genome-wide promoter 
microarrays I have identified that a transcription dependent under-wound DNA 
structure is common at the promoter regions genome-wide.  However, CpG island 
promoters show a strong depletion for under-wound DNA supercoiling in the ~1.5 kb 
surrounding the TSS which is not seen in non-CpG island promoters.  As CpG 
islands make up the majority of human gene promoters an ‘average’ promoter 
genome-wide has this peak-trough-peak DNA supercoil distribution.  Previous 
studies did not identify this structure, probably due to the use of data smoothing on 
the small number of genes analysed.  My data suggests that the distribution of 
supercoiling at the TSS of CpG island promoters acts as a barrier to DNA supercoils 
and may impede strand separation.  Therefore, as most CpG island promoters exist in 
an active chromatin environment, the relatively over-wound DNA structure may act 
as a general repressor of transcription initiation which can be released through DNA 
helicases (Singleton et al., 2007) or a transient increase in under-wound DNA 
supercoiling as a result of divergent transcription (Naughton et al., 2013b).  Non-
CpG island promoters do not have this structure at TSS, suggesting that a relatively 
over-wound TSS is not important for the regulation of these genes.  As non-CpG 
island promoters are generally tissue-specific, it is likely that a general mechanism to 
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repress transcription initiation is unnecessary and these genes are instead regulated 
through the presence of tissue-specific transcription factors.  I analysed promoters 
with respect to sequence and expression and identified that both are important for the 
structure of CpG island and non-CpG island promoters, but that neither one 
determines the DNA supercoil distribution alone.  A comparison of expressed and 
non-expressed genes identifies that while CpG island promoters show a subtle 
change in DNA supercoil distribution, non-CpG island promoters show a strong 
rearrangement from an over-wound to an under-wound structure with expression.  
The DNA of non-expressed non-CpG island promoters has the most over-wound 
structure of any category of promoters analysed and may act as a general mechanism 
of transcription repression.  The repressive role of relatively over-wound DNA 
supercoiling has not been discussed explicitly in previous studies and I present a 
model whereby over-wound DNA at the TSS of CpG island genes or across the 
promoter region of non-CpG island genes represses transcription initiation.  In the 
case of CpG island genes, I propose that this repression is transiently released by 
helicase activity or the generation of additional supercoils by divergent transcription, 
whereas non-CpG island promoters give a more complete repression of expression.  
Further work is required to resolve the function of the relatively over-wound DNA I 
have observed at gene promoters in vivo.  In addition, a comparison of generally 
expressed and generally repressed genes identified an expression independent under-
wound DNA structure at genes which are expressed across a suite of tissue samples, 
but are not expressed in my cell line.  This suggests that these promoters are being 
maintained in a paused supercoiling state, as observed in at a single locus in 
Ljungman and Hanawalt (1995).  To identify how non-coding transcription may 
maintain an under-wound structure at expressed and non-expressed genes my current 
research is focusing on the relationship between DNA supercoiling, transcription and 
paused polymerase through an analysis of bTMP pull-down, CAGE and GRO-seq 
data. 
The role of DNA supercoiling in genome stability is well established in the 
segregation of chromosomes during the cell cycle (Carpenter and Porter, 2004), but 
the predicted relationship between DNA supercoiling and chromosome instability at 
fragile sites has not been demonstrated experimentally.  I have now shown that under 
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conditions of chromosome fragility at CFSs FRA3B and FRA16D the core regions 
become more over-wound compared to flanking DNA sequences.  In addition, a 
strong depletion of both topoisomerase I and topoisomerase II is observed in the 
vicinity of FRA3B and FRA16D.  This identifies for the first time a relationship 
between DNA supercoiling and CFS expression in human cells.  In addition, I have 
shown that RPE1 cells have an expressed CFS profile distinct from lymphoblastoid, 
fibroblast, erythroid or other epithelial cells.  The observation that FRA1C is the 
most expressed CFS in RPE1 cells, which is not expressed in five other epithelial cell 
types, highlights our poor understanding of the relationships between cell type and 
epigenetic inheritance of expressed CFS loci.   
The results from my thesis suggest that DNA supercoiling plays an important role in 
gene expression and genome stability in human cells.  I have characterised the inter-
relationships between topoisomerases, RNA polymerase II and DNA supercoiling at 
domain- and promoter- scales and identified novel properties related to promoter 
structure and regulation.  In addition, I have identified changes in DNA supercoiling 
at expressed CFS which support a role for DNA supercoiling in the stability of these 
regions.  Future experiments will identify the relationship between transcription and 
DNA supercoil distribution, through an analysis of CAGE data, to complete the 
model of gene regulation through the maintenance of promoter DNA supercoil 
distribution.  This study provides the basis for a complete understanding of the 
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